0001193125-23-140808.txt : 20230510 0001193125-23-140808.hdr.sgml : 20230510 20230510164014 ACCESSION NUMBER: 0001193125-23-140808 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 58 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230510 DATE AS OF CHANGE: 20230510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Screaming Eagle Acquisition Corp. CENTRAL INDEX KEY: 0001893325 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 981634100 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41203 FILM NUMBER: 23907192 BUSINESS ADDRESS: STREET 1: 955 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10075 BUSINESS PHONE: (310) 209-7280 MAIL ADDRESS: STREET 1: 955 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10075 10-Q 1 d457148d10q.htm 10-Q 10-Q
falseQ10001893325--12-3100-0000000Retroactively adjusted for the three months ended March 31, 2022 to reflect the surrender of 2,812,500 Class B ordinary shares for no consideration on February 19, 2022 (see Note 5).Reflects the surrender of 2,812,500 Class B ordinary shares for no consideration on February 19, 2022 (see Note 5).Estimates of 11% and 9% based on public trading of rights for SPACs and their implied business combination probabilities as of March 31, 2023 and December 31, 2022, respectively. 0001893325 2023-01-01 2023-03-31 0001893325 2022-12-31 0001893325 2023-03-31 0001893325 2022-01-01 2022-03-31 0001893325 2022-01-10 2022-01-10 0001893325 2022-01-10 0001893325 2021-12-31 0001893325 2021-12-13 0001893325 2022-03-31 0001893325 us-gaap:CommonClassBMember 2023-03-31 0001893325 us-gaap:CommonClassAMember 2023-03-31 0001893325 us-gaap:FairValueInputsLevel3Member scrm:PrivatePlacementWarrantsMember 2023-03-31 0001893325 srt:MinimumMember 2023-03-31 0001893325 srt:MaximumMember 2023-03-31 0001893325 scrm:PrivatePlacementWarrantsMember 2023-03-31 0001893325 scrm:PublicWarrantsMember 2023-03-31 0001893325 scrm:WorkingCapitalLoansMember scrm:SponsorMember 2023-03-31 0001893325 scrm:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember scrm:RedemptionOfWarrantsMember us-gaap:CommonClassAMember 2023-03-31 0001893325 scrm:UnitedStatesTreasuryBillsMember 2023-03-31 0001893325 us-gaap:CommonClassBMember scrm:SponsorMember 2023-03-31 0001893325 scrm:AdministrativeServicesAgreementMember 2023-03-31 0001893325 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2023-03-31 0001893325 scrm:FounderSharesMember us-gaap:CommonClassBMember 2023-03-31 0001893325 us-gaap:MeasurementInputSharePriceMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001893325 us-gaap:MeasurementInputExercisePriceMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001893325 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001893325 us-gaap:MeasurementInputExpectedTermMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001893325 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001893325 us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001893325 us-gaap:FairValueInputsLevel3Member scrm:MeasurementInputProbabilityRateMember 2023-03-31 0001893325 scrm:MeasurementInputProbabilityRateMember scrm:SpacMarketDataPublishedByThirdPartyMember 2023-03-31 0001893325 scrm:PrivatePlacementWarrantsMember 2023-01-01 2023-03-31 0001893325 us-gaap:CommonClassAMember us-gaap:IPOMember 2023-01-01 2023-03-31 0001893325 scrm:PublicWarrantsMember 2023-01-01 2023-03-31 0001893325 scrm:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember us-gaap:CommonClassAMember 2023-01-01 2023-03-31 0001893325 scrm:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember scrm:RedemptionOfWarrantsMember us-gaap:CommonClassAMember 2023-01-01 2023-03-31 0001893325 us-gaap:CommonClassAMember 2023-01-01 2023-03-31 0001893325 us-gaap:CommonClassBMember 2023-01-01 2023-03-31 0001893325 scrm:RedeemableCommonStockMember us-gaap:CommonClassAMember 2023-01-01 2023-03-31 0001893325 scrm:NonRedeemableCommonStockMember us-gaap:CommonClassBMember 2023-01-01 2023-03-31 0001893325 us-gaap:CommonClassAMember scrm:NonRedeemableCommonStockMember 2023-01-01 2023-03-31 0001893325 us-gaap:OverAllotmentOptionMember 2023-01-01 2023-03-31 0001893325 us-gaap:IPOMember 2023-01-01 2023-03-31 0001893325 us-gaap:PrivatePlacementMember 2023-01-01 2023-03-31 0001893325 scrm:AdministrativeServicesAgreementMember scrm:SponsorMember 2023-01-01 2023-03-31 0001893325 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001893325 scrm:FounderSharesMember 2023-01-01 2023-03-31 0001893325 us-gaap:CapitalUnitsMember 2023-01-01 2023-03-31 0001893325 us-gaap:WarrantMember 2023-01-01 2023-03-31 0001893325 scrm:WarrantLiabilityMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001893325 scrm:PrivatePlacementWarrantsMember 2022-01-01 2022-03-31 0001893325 us-gaap:CommonClassAMember 2022-01-01 2022-03-31 0001893325 us-gaap:CommonClassBMember 2022-01-01 2022-03-31 0001893325 us-gaap:CommonClassAMember scrm:NonRedeemableCommonStockMember 2022-01-01 2022-03-31 0001893325 us-gaap:CommonClassBMember scrm:NonRedeemableCommonStockMember 2022-01-01 2022-03-31 0001893325 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001893325 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001893325 scrm:AdministrativeServicesAgreementMember scrm:SponsorMember 2022-01-01 2022-03-31 0001893325 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001893325 scrm:WarrantLiabilityMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-03-31 0001893325 us-gaap:CommonClassAMember scrm:RedeemableCommonStockMember 2022-01-01 2022-03-31 0001893325 us-gaap:CommonClassAMember us-gaap:IPOMember 2022-01-10 2022-01-10 0001893325 us-gaap:IPOMember 2022-01-10 2022-01-10 0001893325 us-gaap:PrivatePlacementMember scrm:PrivatePlacementWarrantsMember 2022-01-10 2022-01-10 0001893325 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember scrm:PrivatePlacementWarrantsMember 2022-01-10 2022-01-10 0001893325 us-gaap:CommonClassAMember us-gaap:IPOMember 2022-01-10 0001893325 scrm:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2022-01-10 0001893325 us-gaap:IPOMember scrm:PublicWarrantsMember us-gaap:CommonClassAMember 2022-01-10 0001893325 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember scrm:PrivatePlacementWarrantsMember 2022-01-10 0001893325 us-gaap:CommonClassAMember 2022-12-31 0001893325 us-gaap:CommonClassBMember 2022-12-31 0001893325 us-gaap:FairValueInputsLevel3Member scrm:PrivatePlacementWarrantsMember 2022-12-31 0001893325 scrm:UnitedStatesTreasuryBillsMember 2022-12-31 0001893325 scrm:AdministrativeServicesAgreementMember 2022-12-31 0001893325 us-gaap:FairValueInputsLevel1Member scrm:U.s.GovernmentTreasurySecuritiesMember 2022-12-31 0001893325 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2022-12-31 0001893325 us-gaap:MeasurementInputSharePriceMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001893325 us-gaap:MeasurementInputExercisePriceMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001893325 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001893325 us-gaap:MeasurementInputExpectedTermMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001893325 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001893325 us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001893325 us-gaap:FairValueInputsLevel3Member scrm:MeasurementInputProbabilityRateMember 2022-12-31 0001893325 scrm:UnitedStatesTreasuryBillsMember 2022-12-31 0001893325 scrm:MeasurementInputProbabilityRateMember scrm:SpacMarketDataPublishedByThirdPartyMember 2022-12-31 0001893325 scrm:RedeemableCommonStockMember us-gaap:CommonClassAMember 2021-11-03 2021-12-31 0001893325 us-gaap:CommonClassBMember scrm:NonRedeemableCommonStockMember 2021-11-03 2021-12-31 0001893325 us-gaap:CommonClassBMember 2021-11-05 2021-11-05 0001893325 us-gaap:CommonClassBMember scrm:SponsorMember 2021-11-05 2021-11-05 0001893325 us-gaap:CommonClassBMember scrm:SponsorMember 2021-12-13 0001893325 scrm:SponsorMember scrm:AdministrativeServicesAgreementMember 2021-12-13 0001893325 us-gaap:CommonClassBMember 2021-12-13 0001893325 scrm:SponsorMember us-gaap:CommonClassBMember 2021-11-05 0001893325 scrm:PromissoryNoteIssuedToTheSponsorMember scrm:SponsorMember 2021-11-05 0001893325 us-gaap:CommonClassBMember 2021-11-05 0001893325 us-gaap:CommonClassBMember 2021-12-13 2021-12-13 0001893325 scrm:FounderSharesMember us-gaap:CommonClassBMember 2021-12-13 2021-12-13 0001893325 scrm:FounderSharesMember 2021-12-13 2021-12-13 0001893325 us-gaap:CommonClassBMember 2022-02-19 2022-02-19 0001893325 us-gaap:CommonClassBMember 2022-02-19 0001893325 us-gaap:CommonClassAMember 2022-02-19 0001893325 scrm:FounderSharesMember scrm:SponsorMember 2022-02-19 0001893325 us-gaap:SubsequentEventMember 2023-04-01 2023-04-01 0001893325 us-gaap:CommonClassAMember 2023-05-10 0001893325 us-gaap:CommonClassBMember 2023-05-10 0001893325 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-12-31 0001893325 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-12-31 0001893325 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001893325 us-gaap:RetainedEarningsMember 2022-12-31 0001893325 scrm:WarrantLiabilityMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001893325 scrm:WarrantLiabilityMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001893325 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-03-31 0001893325 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-03-31 0001893325 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001893325 us-gaap:RetainedEarningsMember 2023-03-31 0001893325 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001893325 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2021-12-31 0001893325 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001893325 us-gaap:RetainedEarningsMember 2021-12-31 0001893325 scrm:WarrantLiabilityMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001893325 scrm:WarrantLiabilityMember us-gaap:FairValueInputsLevel3Member 2022-03-31 0001893325 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001893325 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-03-31 0001893325 us-gaap:RetainedEarningsMember 2022-03-31 0001893325 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 iso4217:USD xbrli:shares utr:Day xbrli:pure utr:Month utr:Year iso4217:USD xbrli:shares utr:Y
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
10-Q
 
 
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2023
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
For the transition period from                 to                
Commission file number:
001-41203
 
 
SCREAMING EAGLE ACQUISITION CORP.
(Exact name of registrant as specified in its charter)
 
 
 
Cayman Islands
 
N/A
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification Number)
   
955 Fifth Avenue
New York, New York
 
10075
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code: (310)
209-7280
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of Each Class:
 
Trading
Symbol(s)
 
Name of Each Exchange
on Which Registered:
Units, each consisting of one Class A ordinary share, $0.0001 par value, and
one-third
of one redeemable warrant
 
SCRMU
 
The Nasdaq Stock Market LLC
Class A ordinary shares, 0.0001 par value
 
SCRM
 
The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
 
SCRMW
 
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  
    No  
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, a smaller reporting company or an emerging growth company. See the definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer      Accelerated filer  
       
Non-accelerated
filer
     Smaller reporting company  
       
         Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act).    Yes      No  ☐
As of May 10, 2023,
 
there were
75,000,000
Class A ordinary shares, par value $0.0001, issued and outstanding, and
18,750,000
Class B ordinary shares, $0.0001 par value, issued and outstanding.
 
 
 


SCREAMING EAGLE ACQUISITION CORP.

FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2023

TABLE OF CONTENTS

 

Part I. Financial Information

     1  

Item 1. Interim Financial Statements

     1  

Condensed Balance Sheets as of March 31, 2023 (Unaudited) and December 31, 2022

     1  

Condensed Statements of Operations For the Three Months Ended March 31, 2023 (Unaudited) and March 31, 2022 (Unaudited)

     2  

Condensed Statements of Changes in Shareholders’ Equity (Deficit) For the Three Months Ended March 31, 2023 (Unaudited) and March 31, 2022 (Unaudited)

     3  

Condensed Statements of Cash Flows For the Three Months Ended March 31, 2023 (Unaudited) and March 31, 2022 (Unaudited)

     4  

Notes to Unaudited Condensed Financial Statements

     5  

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     18  

Item 3. Quantitative and Qualitative Disclosures about Market Risk

     23  

Item 4. Controls and Procedures

     23  

Part II—Other Information

     23  

Item 1. Legal Proceedings

     23  

Item 1A. Risk Factors

     23  

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

     23  

Item 3. Defaults Upon Senior Securities

     24  

Item 4. Mine Safety Disclosures

     24  

Item 5. Other Information

     24  

Item 6. Exhibits

     24  

Part III

     25  

Signatures

     25  

 


0.110.11
PART I. FINANCIAL INFORMATION
ITEM 1. INTERIM FINANCIAL STATEMENTS
SCREAMING EAGLE ACQUISITION CORP.
CONDENSED BALANCE SHEETS
 
    
UNAUDITED
       
    
March 31,
2023
   
December 31,
2022
 
ASSETS:
 
       
Current assets:
                
Cash
   $ 72,520     $ 117,696  
Prepaid expenses
     499,201       581,784  
    
 
 
   
 
 
 
Total current assets
     571,721       699,480  
Cash and investments held in Trust Account
     767,542,768       759,712,942  
    
 
 
   
 
 
 
Total assets
  
$
768,114,489
 
 
$
760,412,422
 
    
 
 
   
 
 
 
LIABILITIES AND SHAREHOLDERS’ (DEFICIT):
 
       
Current liabilities:
                
Accounts payable and accrued expenses
   $ 500,758     $ 338,004  
    
 
 
   
 
 
 
Total current liabilities
  
 
500,758
 
 
 
338,004
 
Warrant liability
     2,816,000       3,285,333  
Deferred underwriting compensation
     26,250,000       26,250,000  
    
 
 
   
 
 
 
Total liabilities
  
$
 
29,566,758
 
 
 
29,873,337
 
Commitments and contingencies
              
Class A ordinary shares subject to possible redemption; 75,000,000 and 75,000,000 shares at $
10.20
and $10.09 redemption value at March 31,
 
2023 and December 31, 2022, respectively
     764,942,768       756,862,942  
Shareholders’ (deficit):
                
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
                  
Class A ordinary shares, $0.0001 par value; 400,000,000 shares authorized; none issued or outstanding (excluding
75,000,000 shares subject to possible redemption)
                  
Class B ordinary shares, $0.0001 par value; 80,000,000 shares authorized; 18,750,000 shares issued and outstanding at March 31, 2023 and December 31, 2022
     1,875       1,875  
Additional
paid-in
capital
                  
Accumulated deficit
     (26,396,912     (26,325,732
    
 
 
   
 
 
 
Total shareholders’ (deficit)
  
 
(26,395,037
)
 
 
 
(26,323,857
    
 
 
   
 
 
 
Total liabilities and shareholders’ (deficit)
  
$
768,114,489
 
 
$
760,412,422
 
    
 
 
   
 
 
 
The accompanying notes are an integral part of these unaudited condensed financial statements
.
 
1

SCREAMING EAGLE ACQUISITION CORP.
CONDENSED STATEMENTS OF OPERATIONS
(UNAUDITED)
 

 
  
For the three
months ended
March 31, 2023
 
 
For the three
months ended
March 31, 2022
 
Operating costs
   $ 540,513     $ 447,352  
    
 
 
   
 
 
 
Loss from operations
     (540,513     (447,352 )
Other income (expense):
                
Interest from investments held in Trust Account
     8,079,826       136,279  
Allocation of offering costs to warrant liability
              (20,182
Change in fair value of warrant liability
     469,333       10,208,000  
    
 
 
   
 
 
 
Net income
  
$
8,008,646
 
 
$
9,876,745
 
    
 
 
   
 
 
 
Weighted average number of Class A ordinary shares subject to possible redemption outstanding
     75,000,000       67,500,000  
    
 
 
   
 
 
 
Basic and diluted net income per share, Class A ordinary shares subject to redemption
  
$
0.09
 
 
$
0.11
 
    
 
 
   
 
 
 
Weighted average number of Class B ordinary shares outstanding
(1)
     18,750,000       18,750,000  
    
 
 
   
 
 
 
Basic and diluted net income per share, Class B ordinary shares
  
$
0.09
 
 
$
0.11
 
    
 
 
   
 
 
 
(1)
Retroactively adjusted for the three months ended March 31, 2022 to reflect the surrender of
 2,812,500 Class B ordinary shares for no consideration on February 19, 2022 (see Note 5).
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
2

SCREAMING EAGLE ACQUISITION CORP.
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT)

 
FOR THE THREE MONTHS ENDED MARCH 31, 2023 (UNAUDITED)
 
 
  
Class A
Ordinary Shares
 
  
Class B
Ordinary Shares
 
  
Additional
Paid-in

Capital
 
  
Accumulated
Deficit
 
 
Total
Shareholders’
(Deficit)
 
 
  
Shares
 
  
Amount
 
  
Shares
 
  
Amount
 
Balance at December 31, 2022
  
 
  
 
  
$
  
 
  
 
18,750,000
 
  
$
1,875
 
  
$
  
 
  
$
(26,325,732
 
$
(26,323,857
Accretion of Class A ordinary shares subject to possible redemption
     —          —          —          —          —          (8,079,826     (8,079,826
Net income
     —          —          —          —          —          8,008,646       8,008,646  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
Balance at March 31, 2023
  
 
  
 
  
$
  
 
  
 
18,750,000
 
  
$
1,875
 
  
$
  
 
  
$
(26,396,912
)
 
 
$
(26,395,037
)
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
 
FOR THE THREE MONTHS ENDED MARCH 31, 2022 (UNAUDITED)
 
 
  
Class A
Ordinary Shares
 
  
Class B
Ordinary Shares
 
 
Additional
Paid-in

Capital
 
 
Accumulated
Deficit
 
 
Total
Shareholders’
Equity (Deficit)
 
 
  
Shares
 
  
Amount
 
  
Shares
 
 
Amount
 
Balance at December 31, 2021
  
 
  
 
  
$
  
 
  
 
21,562,500
 
 
$
2,156
 
 
$
22,844
 
 
$
(5,000
 
$
20,000
 
Forfeiture of Class B shares
(1)
     —          —          (2,812,500     (281     281       —         —    
Cash received in excess of fair value of private
warrants
     —          —          —         —         117,334       —         117,334  
Fair value of public warrants at issuance
     —          —          —         —         36,750,000       —         36,750,000  
Accretion of Class A ordinary shares subject to possible redemption
     —          —          —         —         (36,890,459     (41,969,575     (78,860,034
Net income
     —          —          —         —         —         9,876,745       9,876,745  
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance at March 31, 2022
  
 
  
 
  
$
  
 
  
 
18,750,000
 
 
$
1,875
 
 
$
 
 
$
(32,097,830
)
 
 
$
(32,095,955
)
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(
1
)   Reflects the surrender of 2,812,500 Class B ordinary shares for no consideration on February 19, 2022 (see Note 5).
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
3
SCREAMING EAGLE ACQUISITION CORP.
CONDENSED STATEMENT
S
 OF CASH FLOWS (UNAUDITED)

 
  
For the three
months ended
March 31, 2023
 
 
For the three
months ended
March 31, 2022
 
Cash flows from operating activities:
 
Net income
   $ 8,008,646     $ 9,876,745  
Adjustments to reconcile net income to net cash used in operating activities:
                
Interest income from investments held in Trust Account
     (8,079,826     (136,279
Change in fair value of warrant liability
     (469,333     (10,208,000
Warrant issuance transaction costs
              20,182  
Changes in operating assets and liabilities:
                
Prepaid expenses
     82,583       (1,011,780
Accounts payable and accrued expenses
     162,754       880,023  
    
 
 
   
 
 
 
Net cash used in operating activities
     (295,176     (579,109
    
 
 
   
 
 
 
Cash flows from investing activities:
 
Principal deposited in Trust Account
     —         (750,000,000
Cash withdrawn from Trust Account for working capital
     250,000           
    
 
 
   
 
 
 
Net cash provided by (used in) investing activities
     250,000       (750,000,000
    
 
 
   
 
 
 
Cash flows from financing activities:
 
Proceeds from private placement of warrants
              17,600,000  
Proceeds from sale of units in initial public offering
              750,000,000  
Payment of underwriters’ discount
              (15,000,000
Payment of offering costs
              (540,679
Repayment of advances from Sponsor
              (14,537
Repayment of promissory note—related party
              (300,000
    
 
 
   
 
 
 
Net cash provided by financing activities
              751,744,784  
    
 
 
   
 
 
 
Net change in cash
     (45,176     1,165,675  
Cash at beginning of period
     117,696        

  
 
 
 
 
 
 
 
Cash at end of period
  
$
72,520
 
 
$
1,165,675
 
    
 
 
   
 
 
 
Supplemental disclosure of
non-cash
investing and financing activities:
                
Deferred underwriting fee payable
   $        $ 26,250,000  
    
 
 
   
 
 
 
Deferred offering costs included in accrued expenses
   $ —       $ 5,000  
    
 
 
   
 
 
 
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
4

SCREAMING EAGLE ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2023
Note
1-Organization
and Plan of Business Operations
Screaming Eagle Acquisition Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on November 3, 2021. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (“Business Combination”).
Although the Company is not limited to a particular industry or geographic region for purposes of completing a Business Combination, the Company intends to capitalize on the ability of its management team to identify and combine with a business or businesses that can benefit from its management team’s established global relationships and operating experience. The Company is an early stage company and, as such, the Company is subject to all of the risks associated with early stage companies.
As of March 31, 2023, the Company had not commenced any operations. All activity for the period from November 3, 2021 (inception) through March 31, 2023 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below and activities related to pursuing merger opportunities. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates
non-operating
income in the form of interest income on the proceeds derived from the Initial Public Offering.
The registration statement for the Company’s Initial Public Offering was declared effective on January 5, 2022. On January 10, 2022, the Company consummated its Initial Public Offering of 75,000,000 units (the “Units”). Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A ordinary shares”), and
one-third
of one redeemable warrant of the Company (each whole warrant, a “Warrant”), with each Warrant entitling the holder thereof to purchase one Class A ordinary share for $11.50 per share, subject to adjustment. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $750,000,000.
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 11,733,333 (the “private placement warrants”) at a price of $1.50 per private placement warrant to the Company’s Sponsor, generating gross proceeds of $17,600,000, which is described in Note 4.
Transaction costs amounted to $42,130,216, consisting of $15,000,000 of underwriting fees, $26,250,000 of deferred underwriting fees and $880,216 of other offering costs.
Following the closing of the Initial Public Offering and the Private Placement, $750,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and certain proceeds from the sale of the private placement warrants was placed in a trust account (the “Trust Account”). The proceeds held in the Trust Account are invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule
2a-7
under the Investment Company Act of 1940, as amended (the “Investment Company Act”), which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below.
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the private placement warrants, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company must complete one or more Business Combinations with having an aggregate fair market value equal to at least 80% of
 
the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and
taxes
payable on the income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act.
There is no assurance that the Company will be able to successfully effect
a
Business Combination. Upon the closing of the Initial Public Offering, management has agreed that $10.00 per Unit sold in the Initial Public Offering, including proceeds of the sale of the private placement warrants, will be held in the Trust Account and invested in U.S. government securities, in any open-ended investment company that holds itself out as a money market fund meeting certain conditions of Rule
2a-7
of the Investment Company Act, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below.
 
5

The Company will provide its shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) without a shareholder vote by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The shareholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account (initially $10.00 per share), calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the
 
Trust Account and not previously released to the Company (less taxes payable and up to $100,000 of interest to pay dissolution expenses)
. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Class A ordinary shares will be recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” If the Company seeks shareholder approval, the Company will complete a Business Combination only if it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the Company’s ordinary shares which are represented in person or by proxy and are voted at a general meeting of the Company. If a shareholder vote is not required under applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased in or after the Initial Public Offering in favor of approving a Business Combination and to waive its redemption rights with respect to any such shares in connection with a shareholder vote to approve a Business Combination. However, in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. In such case, the Company would not proceed with the redemption of its Public Shares and the related Business Combination, and instead may search for an alternate Business Combination. Additionally, each public shareholder may elect to redeem its Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination.
Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% of the Public Shares without the Company’s prior written consent.
The Sponsor and the Company’s officers and directors have agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Completion Window (as defined below) or (ii) with respect to any other provision relating to shareholders’ rights or
pre-initial
business combination activity, unless the Company provides the public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment and (iii) to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination.
The Company has 24 months from the closing of the Initial Public Offering or January 10, 2024, or 27 months from the closing of the Initial Public Offering or April 10, 2024 if the Company has executed a definitive agreement for its initial Business Combination within 24 months from the closing of the Initial Public Offering (the “Completion Window”), to complete a Business Combination. If the Company is unable to complete a Business Combination within the Completion Window, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than 10 business days thereafter, redeem 100% of the outstanding Public Shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (less taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject in each case to its obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
The Sponsor and the Company’s officers and directors have agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Completion Window. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Completion Window. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7)
 
6

held in the Trust Account in the event the Company does not complete a Business Combination within the Completion Window and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).
The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a third party for services rendered or products sold to the Company, or by a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.00 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of trust assets, less taxes payable. This liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Liquidity and capital resources
As of March 31, 2023, the Company had an unrestricted cash balance of $72,520, cash and investments held in the Trust Account of $767,542,768 and a working capital deficiency of $428,238. The Company’s working capital needs will be satisfied through the funds, held outside of the Trust Account, from the Public Offering. In addition, the Company is permitted to withdraw interest earned on the Trust Account to fund the Company’s working capital requirements (subject to an aggregate maximum release of $3,000,000).
 
As of March 31, 2023, the Company has withdrawn $500,000 from the Trust Account for working capital.
 
Further, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. Up to $1,500,000 of such loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants. The terms of such loans have not been determined and no written agreements exist with respect to such loans.
Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or the scheduled liquidation date of January 10, 2024. Over this time period, the Company will be using the funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.
The Company is a Special Purpose Acquisition Corporation with a scheduled liquidation date of January 10, 2024. Although the Company plans to complete the transaction before the scheduled liquidation date, there can be no assurance that the Company will be able to consummate a business combination by January 10, 2024. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”)
2014-15,
“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that since the mandatory liquidation deadline is less than 12 months away, there is substantial doubt that the Company will operate as a going concern.
No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after January 10, 2024. Management plans to consummate a Business Combination prior to January 10, 2024, however there can be no assurance that one will be completed.
Note
2-Summary
of Significant Accounting Policies
Basis of presentation
The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected through December 31, 2023 or any future periods.
 
7

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form
10-K
filed by the Company with the SEC on March 1, 2023.
Use of estimates
The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. Cash and cash equivalents in the Trust Account are considered to be investments. As of March 31, 2023 and December 31, 2022, cash and cash equivalents consist of cash and money market funds.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation limit of $250,000, and investments held in Trust
 
Account. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations and cash flows.
Investment Held in Trust Account
The Company’s portfolio of investments is comprised solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company classifies its U.S. Treasury and equivalent securities as
held-to-maturity
in accordance with ASC Topic 320 “Investments—Debt and Equity Securities.”
Held-to-maturity
securities are those securities which the Company has the ability and intent to hold until maturity.
Held-to-maturity
treasury securities are recorded at amortized cost on the accompanying balance sheets and adjusted for the amortization or accretion of premiums or discounts. Money market funds are presented at fair value at the end of each reporting period.
 
8

Offering costs
Offering costs consisted of underwriting, legal, accounting and other expenses incurred directly related to the Initial Public Offering. Upon completion of the Initial Public Offering, offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liability were charged to operations. Offering costs allocated to Class A Ordinary Shares were initially charged to temporary equity and then accreted to ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. Offering costs amounted to $42,130,216, of which $42,110,034 was charged to temporary equity upon the completion of the Initial Public Offering and $20,182 was expensed to the
una
ud
ited
condensed statements of operations.
Class A Ordinary Shares subject to possible redemption
The Company accounts for its Class A Ordinary Shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Class A Ordinary Shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2023 and December 31, 2022, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ (deficit) section of the Company’s condensed balance sheets.
The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of Class A ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional
paid-in
capital and accumulated deficit.
As of March 31, 2023 and December 31, 2022, the Class A ordinary shares reflected on the condensed balance sheets are reconciled in the following table:
 
Gross proceeds
  
$
750,000,000
 
Less
  
Fair value of Public Warrants at issuance
  
 
(36,750,000
Class A ordinary share issuance costs
  
 
(42,110,034
Plus:
  
Accretion of carrying value to redemption value
  
 
85,722,976
 
  
 
 
 
Class A ordinary shares subject to possible redemption, December 31, 2022
  
 
756,862,942
 
Accretion of carrying value to redemption value
  
 
8,079,826
 
  
 
 
 
Class A ordinary shares subject to possible redemption, March 31, 2023
  
$
764,942,768
 
  
 
 
 
Derivative financial instruments
The Company accounts for derivative financial instruments in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value upon issuance and remeasured at each reporting date, with changes in the fair value reported in the
unaudited
condensed statements of operations. The classification of derivative financial instruments is evaluated at the end of each reporting period.
 
9

Income taxes
The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”), which prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not
to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
There is currently no taxation imposed on income by the government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Fair value of financial instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature, except for the warrant liability (see Note 10).
Warrant liability
The Company accounts for the private placement warrants as liabilities at fair value on the condensed balance sheets. The private placement warrants are subject to remeasurement at each balance sheet date and any change in fair value is recognized as a component of other income (expense), net on the condensed statements of operations. The Company will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of the private placement warrants. At that time, the portion of the warrant liability related to the private placement warrants will be reclassified to additional
paid-in
capital.
Net Income Per Ordinary Share
The Company has two classes of shares, Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share”. Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. Accretion associated with the redeemable shares of Class A ordinary share is excluded from earnings per share as the redemption value approximates fair value.
The calculation of diluted income per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 36,733,333 Class A ordinary share in the aggregate. As of March 31, 2023 and
March
 31, 2022, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary share and then share in the earnings of the Company. As a result, diluted net income per share of ordinary share is the same as basic net income per share of ordinary share for the periods presented.
The following table reflects the calculation of basic and diluted net income
 
per ordinary share for the three months ended March 31, 2023 and 2022:
 
    
Three Months Ended March 31,
2023
    
Three Months Ended March 31,
2022
 
    
Class A
    
Class B
    
Class A
    
Class B
 
Basic and diluted net income (loss) per ordinary
                                   
Numerator:
                                   
Allocation of net income
   $ 6,406,917      $ 1,601,729      $ 7,729,627      $ 2,147,118  
Denominator:
                                   
Basic and diluted weighted average shares outstanding
     75,000,000        18,750,000        67,500,000        18,750,000  
Basic and diluted net income per ordinary share
   $ 0.09      $ 0.09      $ 0.11      $
0. 11
 
 
10

Fair value of financial instruments
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
   
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
   
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
   
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Recently issued accounting standards
Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.
Note
3-Initial
Public Offering
The Company consummated the Initial Public Offering of 75,000,000 units at $10.00 per unit. Each unit consisted of one Class A ordinary share and
one-third
of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitled the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 9).
Note
4-Private
Placement
The Sponsor purchased an aggregate of 11,733,333 private placement warrants at a price of $1.50 per private placement warrant, for an aggregate purchase price of $17,600,000, from the Company in a private placement that closed simultaneously with the closing of the Initial Public Offering. Each private placement warrant entitles the holder to purchase one Class A ordinary share at $11.50 per share, subject to adjustment (see Note 9). The proceeds from the sale of the private placement warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Completion Window, the proceeds from the sale of the private placement warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the private placement warrants will expire worthless.
Note
5-Related
Party Transactions
Founder Shares
On November 5, 2021, the Sponsor paid an aggregate of $25,000 to cover certain offering and formation costs of the Company in consideration for 17,250,000 of the Company’s Class B ordinary shares (the “Founder Shares”). On December 13, 2021, the Company effected a share recapitalization with respect to the Class B ordinary shares whereby the Company issued one and
one-quarter
Class B ordinary shares in respect of each outstanding Class B ordinary share, resulting in the Sponsor owning 21,562,500 Founder Shares.
 
11

The Founder Shares include an aggregate of up to 2,812,500 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the number of Founder Shares will collectively represent 20% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering. On February 19, 2022, 2,812,500 Founder Shares were forfeited because the underwriters did not exercise their over-allotment option, resulting in the Company’s Sponsor holding 18,750,000 Founder Shares.
The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of (A) one year after the completion of a Business Combination; and (B) subsequent to a Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share
sub-divisions,
share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-trading
day period, provided such release shall not occur earlier than 180 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property.
Promissory Note
On November 5, 2021, the Company issued the promissory note to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000 (the “Promissory Note”). The Promissory Note is
non-interest
bearing and payable on the earlier of (i) December 31, 2022 or (ii) the completion of the Initial Public Offering. As of December 31, 2021, there was $300,000 outstanding under the Promissory Note. On January 11, 2022, the amount outstanding under the Promissory Note was repaid in full, and borrowings under the Promissory Note are no longer available.
Due to Sponsor
As of December 31, 2021, the amount due to Sponsor was $14,537. The amounts were unpaid reimbursements of offering costs paid by the Sponsor on behalf of the Company. On January 11, 2022, the amount outstanding due to Sponsor was repaid in full.
Administrative Services Agreement
Commencing on the effective date of the Initial Public Offering, the Company entered into an agreement pursuant to which it will pay an affiliate of the Sponsor $15,000 per month for office space, utilities, secretarial and administrative support services. Upon completion of a Business Combination or its liquidation, the Company will cease paying these monthly fees. During the three months ended March 31, 2023 and 2022, the Company incurred $45,000 and $45,000, respectively, in expenses for services provided by the Sponsor in connection with the aforementioned agreement. As of March 31, 2023 and December 31, 2022, $45,000 and $45,000 is included in accounts payable and accrued expenses in the accompanying condensed balance sheets.
In addition, the Company has agreed that it will indemnify the Sponsor from any claims arising out of or relating to this offering or the Company’s operations or conduct of the Company’s business or any claim against the Sponsor alleging any expressed or implied management or endorsement by the Sponsor of any of the Company’s activities or any express or implied association between the Sponsor and the Company or any of its affiliates, which agreement will provide that the indemnified parties cannot access the funds held in the Trust Account.
Related Party Loans
In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, such loans may be converted upon completion of a Business Combination into warrants of the post Business Combination entity at a price of $1.50 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. There have been no borrowings under this arrangement to date.
Note
6-Trust
Account
A total of $750,000,000, which includes $735,000,000 of the net proceeds from the Public Offering and $15,000,000 from the sale of the private placement warrants, has been placed in the Trust Account.
 
 
12

As of March 31, 2023, investment securities in the Company’s Trust Account consisted of $767,542,768 in money market fund. As of December 31, 2022, investment securities in the Company’s Trust Account consisted of $759,271,905 in United States Treasury Bills and $441,037 held in money market fund. The Company classifies its Treasury Instruments and equivalent securities as held to maturity in accordance with FASB ASC 320, “Investments-Debt and Equity Securities”.
Held-to-maturity
securities are those securities which the Company has the ability and intent to hold until maturity.
Held-to-maturity
treasury securities are recorded at amortized cost on the accompanying balance sheets and adjusted for the amortization or accretion of premiums or discounts. The following table presents fair value information as of March 31, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. In addition, the table presents the carrying value (held to maturity), excluding accrued interest income and gross unrealized holding loss. Since all of the Company’s permitted investments consist of U.S. government treasury bills and cash, fair values of its investments are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active markets for identical assets as follows:
 
    
Amortized
Cost
    
Gross
Holding
Gain
    
Quoted Prices
in
Active Markets
(Level 1)
 
U.S. Government Treasury Securities as of December 31, 2022
   $  759,271,905      $  161,421      $  759,433,326  
Money market fund as of December 31, 2022
     N/A        N/A      $ 441,037  
Money market fund as of March 31, 2023
     N/A        N/A      $ 767,542,768  
Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. There were no transfers between levels for the three months ended March 31, 2023 and March 31, 2022.
Level 1 instruments consist of investments in U.S. Treasury securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.
Note
7-Commitments
and Contingencies
Registration Rights
The holders of the Founder Shares, private placement warrants and warrants that may be issued upon conversion of the Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the private placement warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) w
ould
be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Initial Public Offering requiring the Company to register a sale of any of the securities held by them, including any other securities of the Company acquired by them prior to the consummation of the Company’s initial Business Combination. The holders of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Risks and Uncertainties
In February 2022, the Russian
Federation and Belarus commenced a military action within the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these condensed financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these
unaudited
condensed financial statements.
Underwriting Agreement
The Company had granted the underwriters a
45-day
option to purchase up to 11,250,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. On February 19, 2022, the option lapsed because the underwriters did not exercise their over-allotment option.
In addition, the underwriters are entitled to a deferred fee of $0.35 per Unit, or $26,250,000
in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. 
 
13

Note
8-Shareholders’
Equity (Deficit)
Preference Shares
-The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share. The Company’s board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. The board of directors will be able to, without shareholder approval, issue preference shares with voting and other rights that could adversely affect the voting power and other rights of the holders of the ordinary shares and could have anti-takeover effects. At March 31, 2023 and December 31, 2022, there were no preference shares issued or outstanding.
Class
 A Ordinary Shares
-The Company is authorized to issue 400,000,000 Class A ordinary shares, with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. At March 31, 2023 and December 31, 2022, there were 75,000,000 Class A ordinary shares issued and outstanding subject to possible redemption. At March 31, 2023 and December 31, 2022, there were no Class A ordinary shares issued or outstanding.
Class
 B Ordinary Shares
-The Company is authorized to issue 80,000,000 Founder Shares, with a par value of $0.0001 per share. Holders of the Founder Shares are entitled to one vote for each share. On November 5, 2021, the Sponsor paid an aggregate of $25,000 to cover certain offering and formation costs of the Company in consideration for 17,250,000 of the Company’s Class B ordinary shares (the “Founder Shares”). On December 13, 2021, the Company effected a share recapitalization with respect to the Founder Shares whereby the Company issued one and
one-quarter
Founder Shares in respect of each outstanding Founder Share, resulting in the Sponsor owning 21,562,500 Founder Shares. The Founder Shares included an aggregate of up to 2,812,500 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the number of Founder Shares would collectively represent 20% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering. On February 19, 2022, 2,812,500 Founder Shares were forfeited because the underwriters did not exercise their over-allotment option, resulting in the Sponsor holding 18,750,000 Founder Shares.
Holders of the Founder Shares will be entitled to vote on the appointment and removal of directors or continuing the Company in a jurisdiction outside the Cayman Islands (including any special resolution required to amend the constitutional documents of the Company or to adopt new constitutional documents of the Company, in each case, as a result of the Company approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands). On any other matter submitted to a vote of the shareholders prior to or in connection with the completion of the initial Business Combination, holders of the Founder Shares and holders of the Class A ordinary shares will vote together as a single class, except as required by law.
The Founder Shares will automatically convert into Class A ordinary shares concurrently with or immediately following the completion of a Business Combination on a
one-for-one
basis, subject to adjustment. In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with a Business Combination, the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the total number of Class A ordinary shares outstanding after such conversion (after giving effect to any redemptions of Class A ordinary shares by public shareholders), including the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of a Business Combination, excluding any Class A ordinary shares or equity- linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in a Business Combination and any private placement warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than
one-for-one
basis.
Note
9-Warrants
As of March 31, 2023 and December 31, 2022, the Company has 25,000,000 Public Warrants and 11,733,333 private placement warrants outstanding. The Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination. The Public Warrants will expire five years from the completion of a Business Combination, or earlier upon redemption or liquidation.
The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue a Class A ordinary share upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.
 
14

The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement of which the Form
10-K
forms a part or a new registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption.
In addition, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of the Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company elects to do so, the Company will not be required to file or maintain in effect a registration statement, but it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants:
 
(1)
in whole and not in part;
 
(2)
at a price of $0.01 per Public Warrant;
 
(3)
upon not less than 30 days’ prior written notice of redemption to each warrant holder; and
 
(4)
if, and only if, the reported closing price of the ordinary shares equals or exceeds $18.00 per share (as adjusted for share
sub-divisions,
share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a
30-trading
day period ending three business days before the Company send to the notice of redemption to the warrant holders.
If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
If the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Completion Window and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.
The private placement warrants will be identical to the public warrants underlying the Units being sold in the Initial Public Offering, except that (i) the private placement warrants will not be redeemable by the Company, (ii) the private placement warrants and the Class A ordinary shares issuable upon the exercise of the private placement warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (iii) the private placement warrants will be exercisable on a cashless basis, (iv) will use a different Black-Scholes Warrant Model for purposes of calculating the Black-Scholes Warrant Value (as defined in the Warrant Agreement) and (v) the private placement warrants and the Class A ordinary shares issuable upon exercise of the private placement warrants will be entitled to registration rights. If the private placement warrants are held by someone other than the initial purchasers or their permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
Note
10-
Recurring
Fair Value Measurements
As of March 31, 2023, investment securities in the Company’s Trust Account consisted of $767,542,768 in money market fund. As of December 31, 2022, investment securities in the Company’s Trust Account consisted of $759,271,905 in United States Treasury Bills and $441,037 held in money market fund. See Note 6 for fair value information for the Trust Account.
 
15

The fair value of private placement warrants was initially and subsequently measured at fair value using a Black-Scholes Option Pricing Model. For the three months ended March 31, 2023 and 2022, the Company recognized a gain resulting from a decrease in the fair value of the private placement warrants of $469,333 and $10,208,000, respectively, presented as change in fair value of warrant liability in the accompanying
unaudited
condensed statements of operations.
The following table sets forth by level within the fair value hierarchy the Company’s liability that was accounted for at fair value on a recurring basis:
 
    
(Level 1)
    
(Level 2)
    
(Level 3)
 
Private placement warrants as of March 31, 2023
   $ —        $ —        $ 2,816,000  
Private placement warrants as of December 31, 2022
   $ —        $ —        $ 3,285,333  
The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:
                 
    
March 31,
2023
   
December 31,
2022
 
Ordinary share price
   $ 10.16     $ 9.94  
Exercise price
   $ 11.50     $ 11.50  
Volatility
     19.5     31.0
Term
     5.51       5.75  
Risk-free rate
     3.59     3.98
Dividend yield
     0     0
Probability of completing Business Combination
(1)
     11     9
 
(1)
Estimates of 11% and 9% based on public trading of
rights
for SPACs and their implied business combination probabilities as of March 31, 2023 and December 31, 2022, respectively. 
 
16

The change in the fair value of the warrant liabilities for the three months ended March 31, 2023 and 2022 is summarized as follows:
 
Level 3 Derivative warrant liability at December 31, 2022
   $ 3,285,333  
Change in fair value of derivative warrant liability
     (469,333
    
 
 
 
Level 3 Derivative warrant liability at March 31, 2023
   $ 2,816,000  
 
  
 
 
 
 
 
 
 
 
Level 3 Derivative warrant liability at December 31, 2021
   $     
Issuance of Private Warrants on January 10, 2022
     17,482,666  
Change in fair value of derivative warrant liability
     (10,208,000
    
 
 
 
Level 3 Derivative warrant liability at March 31, 2022
   $ 7,274,666  
    
 
 
 
Note
11-Subsequent
Events
The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to, the date that these condensed financial statements were available to be issued. Based upon this review, other than as noted below, the Company did not identify any subsequent events, that have occurred that would require adjustments to the disclosures in the financial statements.
Subsequent to March 31, 2023, the Company withdrew $250,000 of interest earned on the Trust Account for working capital.
 
17


ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Screaming Eagle Acquisition Corp. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Eagle Equity Partners V, LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward- looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward- looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual Report on Form 10-K filed with the SEC on March 1, 2023. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a blank check company incorporated on November 3, 2021 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Our efforts to identify a prospective initial business combination target will not be limited to a particular industry, sector or geographic region. While we may pursue an initial business combination opportunity in any industry or sector, we intend to capitalize on the ability of our management team to identify and combine with a business or businesses that can benefit from our management team’s established global relationships and operating experience.

We intend to effectuate our initial business combination using cash from the proceeds of the Initial Public Offering and the private placement of the private placement warrants, the proceeds of the sale of our shares in connection with our initial business combination (pursuant to forward purchase agreements or backstop agreements we may enter into following the consummation of the Initial Public Offering or otherwise), shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, other securities issuances, or a combination of the foregoing.

The issuance of additional shares in connection with a business combination to the owners of the target or other investors:

 

   

may significantly dilute the equity interest of investors in the Initial Public Offering, which dilution would increase if the anti-dilution provisions in the founder shares resulted in the issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion of the founder shares;

 

   

may subordinate the rights of holders of Class A ordinary shares if preferred shares are issued with rights senior to those afforded our Class A ordinary shares;

 

   

could cause a change in control if a substantial number of our Class A ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors;

 

   

may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; and

 

   

may adversely affect prevailing market prices for our Class A ordinary shares and/or warrants.

 

18


Similarly, if we issue debt securities or otherwise incur significant debt to bank or other lenders or the owners of a target, it could result in:

 

   

default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations;

 

   

acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;

 

   

our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand;

 

   

our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding;

 

   

our inability to pay dividends on our Class A ordinary shares;

 

   

using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A ordinary shares if declared, expenses, capital expenditures, acquisitions and other general corporate purposes;

 

   

limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;

 

   

increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and

 

   

limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt.

As indicated in the accompanying financial statements, at March 31, 2023, we had an unrestricted cash balance of $72,520 as well as cash and investments held in the Trust Account of $767,542,768. Further, we expect to incur significant costs in the pursuit of our initial business combination. We cannot assure you that our plans to complete our initial business combination will be successful.

Results of Operations

We have neither engaged in any operations nor generated any revenues to date. Our only activities since inception have been organizational activities and those necessary to prepare for the Initial Public Offering. We will not generate any operating revenues until after completion of our initial business combination. We have generated non-operating income in the form of interest income on cash and cash equivalents after the Initial Public Offering. There has been no significant change in our financial or trading position and no material adverse change has occurred since the date of our audited financial statements. We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

For the three months ended March 31, 2023, we had a net income of $8,008,646, a loss from operations of $540,513, comprised of general and administrative expenses, and non-operating income of $8,549,159, comprised of a change in fair value of warrant liability of $469,333, and interest earned in the Trust Account of $8,079,826. For the three months ended March 31, 2022, we had a net income of $9,876,745, a loss from operations of $447,352, comprised of general and administrative expenses, and non-operating income of $10,324,097, comprised of a change in fair value of warrant liability of $10,208,000, and interest earned in the Trust Account of $136,279 offset by warrant issuance costs of $20,182.

Through March 31, 2023 our efforts have been limited to organizational activities, activities relating to the Public Offering, activities relating to identifying and evaluating prospective acquisition candidates and activities relating to general corporate matters. We have not generated any revenue, other than interest income earned on the proceeds held in the Trust Account.

Liquidity and Capital Resources

As of March 31, 2023, we had an unrestricted cash balance of $72,520 as well as cash and investments held in the Trust Account of $767,542,768. Our liquidity needs had been satisfied prior to the completion of the Initial Public Offering through receipt of a $25,000 capital contribution from our Sponsor in exchange for the issuance of the founder shares and $300,000 loan from our Sponsor, which was paid in full on January 11, 2022, and borrowings under the Promissory Note are no longer available.

 

19


On January 10, 2022, the Company consummated the Initial Public Offering of 75,000,000 units at $10.00 per unit and a private sale of 11,733,333 private placement warrants at a purchase price of $1.50 per warrant. A total of $750,000,000 comprised of $735,000,000 of the proceeds from the Initial Public Offering (which amount includes $26,250,000 of the underwriters’ deferred discount) and $15,000,000 of the proceeds of the sale of the private placement warrants was placed in the trust account. The proceeds are invested only in U.S. government treasury obligations with a maturity of 185 days of less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations.

We intend to use substantially all of the funds held in the trust account, including any amounts representing interest earned on the trust account (excluding deferred underwriting commissions) to complete our initial business combination. We may withdraw interest to pay our taxes, if any. Our annual income tax obligations will depend on the amount of interest and other income earned on the amounts held in the trust account. We expect the interest earned on the amount in the trust account will be sufficient to pay our income taxes. To the extent that our equity or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the trust account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

We will use the funds held outside the trust account to primarily identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a business combination.

The Company’s liquidity needs had been satisfied prior to the completion of the initial public offering through receipt of a $25,000 capital contribution from our Sponsor in exchange for the issuance of the Founder Shares and a $300,000 loan from the Sponsor, which was paid in full on January 11, 2022. The Company’s working capital needs will be satisfied through the funds held outside of the Trust Account, from the Public Offering. In addition, the Company is permitted to withdraw interest earned on the Trust Account to fund the Company’s working capital requirements (subject to an aggregate maximum release of $3,000,000) and to pay taxes. In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial business combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we would repay such loaned amounts. In the event that our initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Such loans may be convertible into private placement warrants of the post business combination entity at a price of $1.50 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants. The terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. Prior to the completion of our initial business combination, we do not expect to seek loans from parties other than our Sponsor or an affiliate of our Sponsor as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.

Moreover, we may need to obtain additional financing to complete our initial business combination, either because the transaction requires more cash than is available from the proceeds held in our trust account or because we become obligated to redeem a significant number of our public shares upon completion of the business combination, in which case we may issue additional securities or incur debt in connection with such business combination. In addition, we intend to target businesses with enterprise values that are greater than we could acquire with the net proceeds of the Initial Public Offering and the sale of the private placement units, and, as a result, if the cash portion of the purchase price exceeds the amount available from the trust account, net of amounts needed to satisfy any redemptions by public shareholders, we may be required to seek additional financing to complete such proposed initial business combination. We may also obtain financing prior to the closing of our initial business combination to fund our working capital needs and transaction costs in connection with our search for and completion of our initial business combination. There is no limitation on our ability to raise funds through the issuance of equity or equity-linked securities or through loans, advances or other indebtedness in connection with our initial business combination, including pursuant to forward purchase agreements or backstop agreements we may enter into following consummation of the Initial Public Offering. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our initial business combination. If we are unable to complete our initial business combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account. In addition, following our initial business combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.

Going Concern

The Company is a Special Purpose Acquisition Corporation with a scheduled liquidation date of January 10, 2024, unless a definitive agreement has been executed, in which case the scheduled liquidation date is April 10, 2024. Although the Company plans to complete the transaction before the scheduled liquidation date, there can be no assurance that the Company will be able to consummate a business combination by January 10, 2024 or April 10, 2024. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that since the mandatory liquidation deadline is less than 12 months away, there is substantial doubt that the Company will operate as a going concern.

No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after January 10, 2024 or April 10, 2024. Management plans to consummate a business combination prior to January 10, 2024 or April 10, 2024, however there can be no assurance that one will be completed.

 

20


Commitments and Contractual Obligations; Quarterly Results

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities. No unaudited quarterly operating data is included in this Quarterly Report as we have not conducted any operations to date.

Administrative Services and Indemnification Fee

On January 5, 2022, the Company entered into an Administrative Services and Indemnification Agreement. We agreed to pay an affiliate of our Sponsor $15,000 per month for office space, utilities, secretarial and administrative support services and to provide indemnification to the Sponsor from any claims arising out of or relating to the Initial Public Offering or the Company’s operations or conduct of the Company’s business (including its initial business combination) or any claim against the Sponsor alleging any expressed or implied management or endorsement by the Sponsor of any of the Company’s activities or any express or implied association between the Sponsor and the Company or any of its affiliates. Upon completion of a business combination or the Company’s liquidation, we will cease paying these monthly fees. For the three months ended March 31, 2023 and March 31, 2022, the Company incurred $45,000 and $45,000, respectively, in administrative services expenses under the arrangement. As of March 31, 2023 and December 31, 2022, $45,000 and $45,000 is included in accounts payable and accrued expenses in the accompanying condensed balance sheets.

Underwriting Agreement

On January 5, 2022, the Company entered into an Underwriting Agreement. The underwriters were paid a cash underwriting discount of two percent (2.0%) of the gross proceeds of the Initial Public Offering, or $15,000,000. Additionally, the underwriters will be entitled to a deferred underwriting commission of 3.5% or $26,250,000 of the gross proceeds of the Initial Public Offering held in the Trust Account upon the completion of the Company’s initial business combination subject to the terms of the underwriting agreement.

 

21


The deferred underwriting commissions will become payable to the underwriters from the amounts held in the trust account solely in the event that the Company completes an initial business combination, subject to the terms of the underwriting agreement.

Registration Rights Agreement

The holders of the founder shares, private placement warrants, warrants that may be issued upon conversion of working capital loans (and any Class A ordinary shares issuable upon the exercise of the private placement warrants and warrants that may be issued upon conversion of working capital loans and upon conversion of the founder shares) will be entitled to registration rights pursuant to a registration rights agreement signed on the effective date of the initial public offering, requiring us to register such securities and any of our other securities they hold or acquire prior to the consummation of our initial business combination for resale. The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to our completion of our initial business combination. We will bear the expenses incurred in connection with the filing of any such registration statements.

Critical Accounting Estimates

The preparation of financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and expenses during the period reported. We have identified the following critical accounting policies that require us to use judgments, often as a result of the need to make estimates and assumptions regarding matters that are inherently uncertain, and actual results could differ from these estimates.

Warrant liability

The Company accounts for the private placement warrants as liabilities at fair value on the balance sheets. The private placement warrants are subject to remeasurement at each balance sheet date and any change in fair value is recognized as a component of other income (expense), net on the statements of operations. The Company will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of the private placement warrants. At that time, the portion of the warrant liability related to the private placement warrants will be reclassified to additional paid-in capital.

 

22


ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Quarterly Report, is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Our management evaluated, with the participation of our current chief executive officer and vice president of finance (our “Certifying Officers”), the effectiveness of our disclosure controls and procedures as of March 31, 2023, pursuant to Rule 13a-15(b) under the Exchange Act. Based upon that evaluation, our Certifying Officers concluded that, as of March 31, 2023, our disclosure controls and procedures were effective.

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II—OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

We are not currently subject to any material legal proceedings, nor, to our knowledge, is any material legal proceeding threatened against us or any of our officers or directors in their corporate capacity.

ITEM 1A. RISK FACTORS.

Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in our Annual Report on Form 10-K filed with the SEC on March 1, 2023. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations.

As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in Annual Report on Form 10-K filed with the SEC on March 1, 2023.

 

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None.

 

23


ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5. OTHER INFORMATION.

None.

ITEM 6. EXHIBITS

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q

 

No.

  

Description of Exhibit

  31.1*    Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
  31.2*    Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
  32.1**    Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
  32.2**    Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*    Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.CAL*    Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*    Inline XBRL Taxonomy Extension Schema Document
101.DEF*    Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*    Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*    Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

*

Filed herewith.

 

24


PART III

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: May 10, 2023

 

SCREAMING EAGLE ACQUISITION CORP.
 

/s/ Eli Baker

Name:

Title:

 

Eli Baker

Chief Executive Officer
(Principal Executive Officer)

 

/s/ Ryan O’Connor

Name:

Title:

 

Ryan O’Connor

Vice President of Finance
(Principal Financial and Accounting Officer)

 

 

25

EX-31.1 2 d457148dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, Eli Baker, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of Screaming Eagle Acquisition Corp.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

  a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 10, 2023

 

By:  

/s/ Eli Baker

Name:   Eli Baker
Title:  

Chief Executive Officer

(Principal Executive Officer)

 

EX-31.2 3 d457148dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Ryan O’Connor, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of Screaming Eagle Acquisition Corp.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

  a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 10, 2023

 

By:  

/s/ Ryan O’Connor

Name:   Ryan O’Connor
Title:  

Vice President of Finance

(Principal Financial and Accounting Officer)

 

EX-32.1 4 d457148dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADDED BY

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Screaming Eagle Acquisition Corp. (the “Company”) for the quarterly period ended March 31, 2023, as filed with the Securities and Exchange Commission (the “Report”), I, Eli Baker, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted by §906 of the Sarbanes-Oxley Act of 2002, that:

 

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.

To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

Date: May 10, 2023

 

By:  

/s/ Eli Baker

Name:   Eli Baker
Title:  

Chief Executive Officer

(Principal Executive Officer)

 

EX-32.2 5 d457148dex322.htm EX-32.2 EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADDED BY

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Screaming Eagle Acquisition Corp. (the “Company”) for the quarterly period ended March 31, 2023, as filed with the Securities and Exchange Commission (the “Report”), I, Ryan O’Connor, Vice President of Finance of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted by §906 of the Sarbanes-Oxley Act of 2002, that:

 

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.

To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

Date: May 10, 2023

 

By:  

/s/ Ryan O’Connor

Name:   Ryan O’Connor
Title:  

Vice President of Finance

(Principal Financial and Accounting Officer)

EX-101.SCH 6 scrm-20230331.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Condensed Balance Sheets link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Condensed Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Condensed Statements Of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Condensed Statements Of Operations (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Condensed Statements Of Changes In Shareholders' Equity (Deficit) link:presentationLink link:definitionLink link:calculationLink 1007 - Statement - Condensed Statements Of Changes In Shareholders' Equity (Deficit) (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1008 - Statement - Condensed Statements of Cash Flow link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - Organization and Plan of Business Operations link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Initial Public Offering link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Private Placement link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Trust Account link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Shareholders' Equity (Deficit) link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Warrants link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Recurring Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Trust Account (Tables) link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - Recurring Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - Organization Consolidation And Presentation Of Financial Statements (Detail) link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - Summary of Significant Accounting Policies - Summary of Reconciliation of Proceeds from Temporary Equity to Outstanding Value (Detail) link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Detail) link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - Initial Public Offering - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - Private Placement - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - Related Party Transactions - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - Trust Account - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - Trust Account - Summary of Available-for-sale Securities Reconciliation (Detail) link:presentationLink link:definitionLink link:calculationLink 1033 - Disclosure - Commitments and Contingencies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1034 - Disclosure - Shareholders' Equity (Deficit) - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1035 - Disclosure - Warrants - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1036 - Disclosure - Recurring Fair Value Measurements - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1037 - Disclosure - Recurring Fair Value Measurements - Schedule of Fair Value Hierarchy the Company's Liabilities that were Accounted for at Fair Value on a Recurring Basis (Detail) link:presentationLink link:definitionLink link:calculationLink 1038 - Disclosure - Recurring Fair Value Measurements - Summary of quantitative information regarding Level 3 fair value measurements inputs as their measurement dates (Detail) link:presentationLink link:definitionLink link:calculationLink 1039 - Disclosure - Recurring Fair Value Measurements - Summary of quantitative information regarding Level 3 fair value measurements inputs as their measurement dates (Parenthetical) (Detail) link:presentationLink link:definitionLink link:calculationLink 1040 - Disclosure - Recurring Fair Value Measurements - Summary of The change in the fair value of the warrant liabilities (Detail) link:presentationLink link:definitionLink link:calculationLink 1041 - Disclosure - Subsequent Events - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 scrm-20230331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 scrm-20230331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 scrm-20230331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 10 scrm-20230331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover Page - shares
3 Months Ended
Mar. 31, 2023
May 10, 2023
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2023  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q1  
Entity Registrant Name SCREAMING EAGLE ACQUISITION CORP.  
Entity Central Index Key 0001893325  
Current Fiscal Year End Date --12-31  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company true  
Title of 12(b) Security Class A ordinary shares, 0.0001 par value  
Trading Symbol SCRM  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Tax Identification Number 00-0000000  
Entity File Number 001-41203  
Entity Address, Address Line One 955 Fifth Avenue  
Entity Address, City or Town New York  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10075  
City Area Code 310  
Local Phone Number 209-7280  
Entity Incorporation, State or Country Code E9  
Common Class A [Member]    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   75,000,000
Common Class B [Member]    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   18,750,000
Capital Units [Member]    
Document Information [Line Items]    
Title of 12(b) Security Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-third of one redeemable warrant  
Trading Symbol SCRMU  
Security Exchange Name NASDAQ  
Warrant [Member]    
Document Information [Line Items]    
Title of 12(b) Security Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share  
Trading Symbol SCRMW  
Security Exchange Name NASDAQ  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash $ 72,520 $ 117,696
Prepaid expenses 499,201 581,784
Total current assets 571,721 699,480
Cash and investments held in Trust Account 767,542,768 759,712,942
Total assets 768,114,489 760,412,422
Current liabilities:    
Accounts payable and accrued expenses 500,758 338,004
Total current liabilities 500,758 338,004
Warrant liability 2,816,000 3,285,333
Deferred underwriting compensation 26,250,000 26,250,000
Total liabilities 29,566,758 29,873,337
Commitments and contingencies
Class A ordinary shares subject to possible redemption; 75,000,000 and 75,000,000 shares at $10.20 and $10.09 redemption value at March 31, 2023 and December 31, 2022, respectively 764,942,768 756,862,942
Shareholders' (deficit):    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding 0 0
Additional paid-in capital 0 0
Accumulated deficit (26,396,912) (26,325,732)
Total shareholders' (deficit) (26,395,037) (26,323,857)
Total liabilities and shareholders' (deficit) 768,114,489 760,412,422
Common Class A [Member]    
Shareholders' (deficit):    
Common Stock 0 0
Common Class B [Member]    
Shareholders' (deficit):    
Common Stock $ 1,875 $ 1,875
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Balance Sheets (Parenthetical) - $ / shares
Mar. 31, 2023
Dec. 31, 2022
Nov. 05, 2021
Temporary Equity, Shares Outstanding 75,000,000 75,000,000  
Temporary Equity, Redemption Price Per Share $ 10.2 $ 10.09  
Preferred Stock, Par or Stated Value Per Share $ 0.0001    
Preferred Stock, Shares Authorized 1,000,000    
Preferred Stock, Shares Issued 0 0  
Preferred Stock, Shares Outstanding 0 0  
Common Stock, Shares, Outstanding 0 0  
Common Class A [Member]      
Temporary Equity, Shares Outstanding 75,000,000 75,000,000  
Temporary Equity, Redemption Price Per Share $ 10    
Preferred Stock, Par or Stated Value Per Share $ 0.0001    
Preferred Stock, Shares Authorized 1,000,000    
Preferred Stock, Shares Issued 0    
Preferred Stock, Shares Outstanding 0    
Common Stock, Par or Stated Value Per Share $ 0.0001    
Common Stock, Shares Authorized 400,000,000    
Common Stock, Shares, Issued 0 0  
Common Stock, Shares, Outstanding 0    
Common Class B [Member]      
Common Stock, Par or Stated Value Per Share $ 0.0001    
Common Stock, Shares Authorized 80,000,000    
Common Stock, Shares, Issued 18,750,000 18,750,000 17,250,000
Common Stock, Shares, Outstanding 18,750,000 18,750,000 17,250,000
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Statements Of Operations - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating costs $ 540,513 $ 447,352
Loss from operations (540,513) (447,352)
Other income (expense):    
Interest from investments held in Trust Account 8,079,826 136,279
Allocation of offering costs to warrant liability 0 (20,182)
Change in fair value of warrant liability 469,333 10,208,000
Net income $ 8,008,646 $ 9,876,745
Basic net income per ordinary share   $ 0.11
Common Class A [Member]    
Other income (expense):    
Weighted average number of ordinary shares 75,000,000 67,500,000
Basic net income per ordinary share $ 0.09 $ 0.11
Diluted net income per ordinary share $ 0.09 $ 0.11
Common Class B [Member]    
Other income (expense):    
Weighted average number of ordinary shares [1] 18,750,000 18,750,000
Basic net income per ordinary share $ 0.09 $ 0.11
Diluted net income per ordinary share $ 0.09 $ 0.11
[1] Retroactively adjusted for the three months ended March 31, 2022 to reflect the surrender of 2,812,500 Class B ordinary shares for no consideration on February 19, 2022 (see Note 5).
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Statements Of Operations (Parenthetical) - Common Class B [Member]
Feb. 19, 2022
USD ($)
shares
Common Stock, Shares, surrender | shares 2,812,500
Common Stock, shares surrender, value | $ $ 0
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Statements Of Changes In Shareholders' Equity (Deficit) - USD ($)
Total
Ordinary Shares [Member]
Common Class A [Member]
Ordinary Shares [Member]
Common Class B [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Beginning balance, Shares at Dec. 31, 2021   0 21,562,500    
Beginning balance, Amount at Dec. 31, 2021 $ 20,000 $ 0 $ 2,156 $ 22,844 $ (5,000)
Forfeiture of Class B shares, Shares [1]     (2,812,500)    
Forfeiture of Class B shares, Amount [1]     $ (281) 281  
Cash received in excess of fair value of private warrants 117,334     117,334  
Fair value of public warrants at issuance 36,750,000     36,750,000  
Accretion of Class A ordinary shares subject to possible redemption (78,860,034)     (36,890,459) (41,969,575)
Net income 9,876,745       9,876,745
Ending balance, Shares at Mar. 31, 2022   0 18,750,000    
Ending balance, Amount at Mar. 31, 2022 (32,095,955) $ 0 $ 1,875 0 (32,097,830)
Beginning balance, Shares at Dec. 31, 2022   0 18,750,000    
Beginning balance, Amount at Dec. 31, 2022 (26,323,857) $ 0 $ 1,875 0 (26,325,732)
Accretion of Class A ordinary shares subject to possible redemption (8,079,826)       (8,079,826)
Net income 8,008,646       8,008,646
Ending balance, Shares at Mar. 31, 2023   0 18,750,000    
Ending balance, Amount at Mar. 31, 2023 $ (26,395,037) $ 0 $ 1,875 $ 0 $ (26,396,912)
[1] Reflects the surrender of 2,812,500 Class B ordinary shares for no consideration on February 19, 2022 (see Note 5).
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Statements Of Changes In Shareholders' Equity (Deficit) (Parenthetical) - Common Class B [Member]
Feb. 19, 2022
USD ($)
shares
Common Stock, Shares, surrender | shares 2,812,500
Common Stock, shares surrender, value | $ $ 0
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Statements of Cash Flow - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net Income $ 8,008,646 $ 9,876,745
Adjustments to reconcile net income to net cash used in operating activities:    
Interest income from investments held in Trust Account (8,079,826) (136,279)
Change in fair value of warrant liability (469,333) (10,208,000)
Warrant issuance transaction costs 0 20,182
Changes in operating assets and liabilities:    
Prepaid expenses 82,583 (1,011,780)
Accounts payable and accrued expenses 162,754 880,023
Net cash used in operating activities (295,176) (579,109)
Cash flows from investing activities:    
Principal deposited in Trust Account   (750,000,000)
Cash withdrawn from Trust Account for working capital 250,000 0
Net cash provided by (used in) investing activities 250,000 (750,000,000)
Cash flows from financing activities:    
Proceeds from private placement of warrants 0 17,600,000
Proceeds from sale of units in initial public offering 0 750,000,000
Payment of underwriters' discount 0 (15,000,000)
Payment of offering costs 0 (540,679)
Repayment of advances from Sponsor 0 (14,537)
Repayment of promissory note—related party 0 (300,000)
Net cash provided by financing activities 0 751,744,784
Net change in cash (45,176) 1,165,675
Cash at beginning of period 117,696  
Cash at end of period 72,520 1,165,675
Supplemental disclosure of non-cash investing and financing activities:    
Deferred underwriting fee payable $ 0 26,250,000
Deferred offering costs included in accrued expenses   $ 5,000
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Organization and Plan of Business Operations
3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Plan of Business Operations
Note
1-Organization
and Plan of Business Operations
Screaming Eagle Acquisition Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on November 3, 2021. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (“Business Combination”).
Although the Company is not limited to a particular industry or geographic region for purposes of completing a Business Combination, the Company intends to capitalize on the ability of its management team to identify and combine with a business or businesses that can benefit from its management team’s established global relationships and operating experience. The Company is an early stage company and, as such, the Company is subject to all of the risks associated with early stage companies.
As of March 31, 2023, the Company had not commenced any operations. All activity for the period from November 3, 2021 (inception) through March 31, 2023 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below and activities related to pursuing merger opportunities. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates
non-operating
income in the form of interest income on the proceeds derived from the Initial Public Offering.
The registration statement for the Company’s Initial Public Offering was declared effective on January 5, 2022. On January 10, 2022, the Company consummated its Initial Public Offering of 75,000,000 units (the “Units”). Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A ordinary shares”), and
one-third
of one redeemable warrant of the Company (each whole warrant, a “Warrant”), with each Warrant entitling the holder thereof to purchase one Class A ordinary share for $11.50 per share, subject to adjustment. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $750,000,000.
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 11,733,333 (the “private placement warrants”) at a price of $1.50 per private placement warrant to the Company’s Sponsor, generating gross proceeds of $17,600,000, which is described in Note 4.
Transaction costs amounted to $42,130,216, consisting of $15,000,000 of underwriting fees, $26,250,000 of deferred underwriting fees and $880,216 of other offering costs.
Following the closing of the Initial Public Offering and the Private Placement, $750,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and certain proceeds from the sale of the private placement warrants was placed in a trust account (the “Trust Account”). The proceeds held in the Trust Account are invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule
2a-7
under the Investment Company Act of 1940, as amended (the “Investment Company Act”), which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below.
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the private placement warrants, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company must complete one or more Business Combinations with having an aggregate fair market value equal to at least 80% of
 
the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and
taxes
payable on the income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act.
There is no assurance that the Company will be able to successfully effect
a
Business Combination. Upon the closing of the Initial Public Offering, management has agreed that $10.00 per Unit sold in the Initial Public Offering, including proceeds of the sale of the private placement warrants, will be held in the Trust Account and invested in U.S. government securities, in any open-ended investment company that holds itself out as a money market fund meeting certain conditions of Rule
2a-7
of the Investment Company Act, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below.
 
The Company will provide its shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) without a shareholder vote by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The shareholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account (initially $10.00 per share), calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the
 
Trust Account and not previously released to the Company (less taxes payable and up to $100,000 of interest to pay dissolution expenses)
. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Class A ordinary shares will be recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” If the Company seeks shareholder approval, the Company will complete a Business Combination only if it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the Company’s ordinary shares which are represented in person or by proxy and are voted at a general meeting of the Company. If a shareholder vote is not required under applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased in or after the Initial Public Offering in favor of approving a Business Combination and to waive its redemption rights with respect to any such shares in connection with a shareholder vote to approve a Business Combination. However, in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. In such case, the Company would not proceed with the redemption of its Public Shares and the related Business Combination, and instead may search for an alternate Business Combination. Additionally, each public shareholder may elect to redeem its Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination.
Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% of the Public Shares without the Company’s prior written consent.
The Sponsor and the Company’s officers and directors have agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Completion Window (as defined below) or (ii) with respect to any other provision relating to shareholders’ rights or
pre-initial
business combination activity, unless the Company provides the public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment and (iii) to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination.
The Company has 24 months from the closing of the Initial Public Offering or January 10, 2024, or 27 months from the closing of the Initial Public Offering or April 10, 2024 if the Company has executed a definitive agreement for its initial Business Combination within 24 months from the closing of the Initial Public Offering (the “Completion Window”), to complete a Business Combination. If the Company is unable to complete a Business Combination within the Completion Window, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than 10 business days thereafter, redeem 100% of the outstanding Public Shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (less taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject in each case to its obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
The Sponsor and the Company’s officers and directors have agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Completion Window. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Completion Window. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7)
 
held in the Trust Account in the event the Company does not complete a Business Combination within the Completion Window and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).
The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a third party for services rendered or products sold to the Company, or by a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.00 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of trust assets, less taxes payable. This liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Liquidity and capital resources
As of March 31, 2023, the Company had an unrestricted cash balance of $72,520, cash and investments held in the Trust Account of $767,542,768 and a working capital deficiency of $428,238. The Company’s working capital needs will be satisfied through the funds, held outside of the Trust Account, from the Public Offering. In addition, the Company is permitted to withdraw interest earned on the Trust Account to fund the Company’s working capital requirements (subject to an aggregate maximum release of $3,000,000).
 
As of March 31, 2023, the Company has withdrawn $500,000 from the Trust Account for working capital.
 
Further, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. Up to $1,500,000 of such loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants. The terms of such loans have not been determined and no written agreements exist with respect to such loans.
Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or the scheduled liquidation date of January 10, 2024. Over this time period, the Company will be using the funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.
The Company is a Special Purpose Acquisition Corporation with a scheduled liquidation date of January 10, 2024. Although the Company plans to complete the transaction before the scheduled liquidation date, there can be no assurance that the Company will be able to consummate a business combination by January 10, 2024. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”)
2014-15,
“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that since the mandatory liquidation deadline is less than 12 months away, there is substantial doubt that the Company will operate as a going concern.
No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after January 10, 2024. Management plans to consummate a Business Combination prior to January 10, 2024, however there can be no assurance that one will be completed.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Significant Accounting Policies
Note
2-Summary
of Significant Accounting Policies
Basis of presentation
The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected through December 31, 2023 or any future periods.
 
The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form
10-K
filed by the Company with the SEC on March 1, 2023.
Use of estimates
The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. Cash and cash equivalents in the Trust Account are considered to be investments. As of March 31, 2023 and December 31, 2022, cash and cash equivalents consist of cash and money market funds.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation limit of $250,000, and investments held in Trust
 
Account. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations and cash flows.
Investment Held in Trust Account
The Company’s portfolio of investments is comprised solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company classifies its U.S. Treasury and equivalent securities as
held-to-maturity
in accordance with ASC Topic 320 “Investments—Debt and Equity Securities.”
Held-to-maturity
securities are those securities which the Company has the ability and intent to hold until maturity.
Held-to-maturity
treasury securities are recorded at amortized cost on the accompanying balance sheets and adjusted for the amortization or accretion of premiums or discounts. Money market funds are presented at fair value at the end of each reporting period.
 
Offering costs
Offering costs consisted of underwriting, legal, accounting and other expenses incurred directly related to the Initial Public Offering. Upon completion of the Initial Public Offering, offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liability were charged to operations. Offering costs allocated to Class A Ordinary Shares were initially charged to temporary equity and then accreted to ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. Offering costs amounted to $42,130,216, of which $42,110,034 was charged to temporary equity upon the completion of the Initial Public Offering and $20,182 was expensed to the
una
ud
ited
condensed statements of operations.
Class A Ordinary Shares subject to possible redemption
The Company accounts for its Class A Ordinary Shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Class A Ordinary Shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2023 and December 31, 2022, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ (deficit) section of the Company’s condensed balance sheets.
The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of Class A ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional
paid-in
capital and accumulated deficit.
As of March 31, 2023 and December 31, 2022, the Class A ordinary shares reflected on the condensed balance sheets are reconciled in the following table:
 
Gross proceeds
  
$
750,000,000
 
Less
  
Fair value of Public Warrants at issuance
  
 
(36,750,000
Class A ordinary share issuance costs
  
 
(42,110,034
Plus:
  
Accretion of carrying value to redemption value
  
 
85,722,976
 
  
 
 
 
Class A ordinary shares subject to possible redemption, December 31, 2022
  
 
756,862,942
 
Accretion of carrying value to redemption value
  
 
8,079,826
 
  
 
 
 
Class A ordinary shares subject to possible redemption, March 31, 2023
  
$
764,942,768
 
  
 
 
 
Derivative financial instruments
The Company accounts for derivative financial instruments in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value upon issuance and remeasured at each reporting date, with changes in the fair value reported in the
unaudited
condensed statements of operations. The classification of derivative financial instruments is evaluated at the end of each reporting period.
 
Income taxes
The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”), which prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not
to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
There is currently no taxation imposed on income by the government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Fair value of financial instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature, except for the warrant liability (see Note 10).
Warrant liability
The Company accounts for the private placement warrants as liabilities at fair value on the condensed balance sheets. The private placement warrants are subject to remeasurement at each balance sheet date and any change in fair value is recognized as a component of other income (expense), net on the condensed statements of operations. The Company will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of the private placement warrants. At that time, the portion of the warrant liability related to the private placement warrants will be reclassified to additional
paid-in
capital.
Net Income Per Ordinary Share
The Company has two classes of shares, Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share”. Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. Accretion associated with the redeemable shares of Class A ordinary share is excluded from earnings per share as the redemption value approximates fair value.
The calculation of diluted income per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 36,733,333 Class A ordinary share in the aggregate. As of March 31, 2023 and
March
 31, 2022, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary share and then share in the earnings of the Company. As a result, diluted net income per share of ordinary share is the same as basic net income per share of ordinary share for the periods presented.
The following table reflects the calculation of basic and diluted net income
 
per ordinary share for the three months ended March 31, 2023 and 2022:
 
    
Three Months Ended March 31,
2023
    
Three Months Ended March 31,
2022
 
    
Class A
    
Class B
    
Class A
    
Class B
 
Basic and diluted net income (loss) per ordinary
                                   
Numerator:
                                   
Allocation of net income
   $ 6,406,917      $ 1,601,729      $ 7,729,627      $ 2,147,118  
Denominator:
                                   
Basic and diluted weighted average shares outstanding
     75,000,000        18,750,000        67,500,000        18,750,000  
Basic and diluted net income per ordinary share
   $ 0.09      $ 0.09      $ 0.11      $
0. 11
 
 
Fair value of financial instruments
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
   
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
   
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
   
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Recently issued accounting standards
Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Initial Public Offering
3 Months Ended
Mar. 31, 2023
Initial Public Offer [Abstract]  
Initial Public Offering
Note
3-Initial
Public Offering
The Company consummated the Initial Public Offering of 75,000,000 units at $10.00 per unit. Each unit consisted of one Class A ordinary share and
one-third
of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitled the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 9).
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Private Placement
3 Months Ended
Mar. 31, 2023
Private Placement [Abstract]  
Private Placement
Note
4-Private
Placement
The Sponsor purchased an aggregate of 11,733,333 private placement warrants at a price of $1.50 per private placement warrant, for an aggregate purchase price of $17,600,000, from the Company in a private placement that closed simultaneously with the closing of the Initial Public Offering. Each private placement warrant entitles the holder to purchase one Class A ordinary share at $11.50 per share, subject to adjustment (see Note 9). The proceeds from the sale of the private placement warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Completion Window, the proceeds from the sale of the private placement warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the private placement warrants will expire worthless.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions
3 Months Ended
Mar. 31, 2023
Related Party Transactions [Abstract]  
Related Party Transactions
Note
5-Related
Party Transactions
Founder Shares
On November 5, 2021, the Sponsor paid an aggregate of $25,000 to cover certain offering and formation costs of the Company in consideration for 17,250,000 of the Company’s Class B ordinary shares (the “Founder Shares”). On December 13, 2021, the Company effected a share recapitalization with respect to the Class B ordinary shares whereby the Company issued one and
one-quarter
Class B ordinary shares in respect of each outstanding Class B ordinary share, resulting in the Sponsor owning 21,562,500 Founder Shares.
 
The Founder Shares include an aggregate of up to 2,812,500 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the number of Founder Shares will collectively represent 20% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering. On February 19, 2022, 2,812,500 Founder Shares were forfeited because the underwriters did not exercise their over-allotment option, resulting in the Company’s Sponsor holding 18,750,000 Founder Shares.
The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of (A) one year after the completion of a Business Combination; and (B) subsequent to a Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share
sub-divisions,
share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-trading
day period, provided such release shall not occur earlier than 180 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property.
Promissory Note
On November 5, 2021, the Company issued the promissory note to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000 (the “Promissory Note”). The Promissory Note is
non-interest
bearing and payable on the earlier of (i) December 31, 2022 or (ii) the completion of the Initial Public Offering. As of December 31, 2021, there was $300,000 outstanding under the Promissory Note. On January 11, 2022, the amount outstanding under the Promissory Note was repaid in full, and borrowings under the Promissory Note are no longer available.
Due to Sponsor
As of December 31, 2021, the amount due to Sponsor was $14,537. The amounts were unpaid reimbursements of offering costs paid by the Sponsor on behalf of the Company. On January 11, 2022, the amount outstanding due to Sponsor was repaid in full.
Administrative Services Agreement
Commencing on the effective date of the Initial Public Offering, the Company entered into an agreement pursuant to which it will pay an affiliate of the Sponsor $15,000 per month for office space, utilities, secretarial and administrative support services. Upon completion of a Business Combination or its liquidation, the Company will cease paying these monthly fees. During the three months ended March 31, 2023 and 2022, the Company incurred $45,000 and $45,000, respectively, in expenses for services provided by the Sponsor in connection with the aforementioned agreement. As of March 31, 2023 and December 31, 2022, $45,000 and $45,000 is included in accounts payable and accrued expenses in the accompanying condensed balance sheets.
In addition, the Company has agreed that it will indemnify the Sponsor from any claims arising out of or relating to this offering or the Company’s operations or conduct of the Company’s business or any claim against the Sponsor alleging any expressed or implied management or endorsement by the Sponsor of any of the Company’s activities or any express or implied association between the Sponsor and the Company or any of its affiliates, which agreement will provide that the indemnified parties cannot access the funds held in the Trust Account.
Related Party Loans
In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, such loans may be converted upon completion of a Business Combination into warrants of the post Business Combination entity at a price of $1.50 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. There have been no borrowings under this arrangement to date.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Trust Account
3 Months Ended
Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]  
Trust Account
Note
6-Trust
Account
A total of $750,000,000, which includes $735,000,000 of the net proceeds from the Public Offering and $15,000,000 from the sale of the private placement warrants, has been placed in the Trust Account.
 
As of March 31, 2023, investment securities in the Company’s Trust Account consisted of $767,542,768 in money market fund. As of December 31, 2022, investment securities in the Company’s Trust Account consisted of $759,271,905 in United States Treasury Bills and $441,037 held in money market fund. The Company classifies its Treasury Instruments and equivalent securities as held to maturity in accordance with FASB ASC 320, “Investments-Debt and Equity Securities”.
Held-to-maturity
securities are those securities which the Company has the ability and intent to hold until maturity.
Held-to-maturity
treasury securities are recorded at amortized cost on the accompanying balance sheets and adjusted for the amortization or accretion of premiums or discounts. The following table presents fair value information as of March 31, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. In addition, the table presents the carrying value (held to maturity), excluding accrued interest income and gross unrealized holding loss. Since all of the Company’s permitted investments consist of U.S. government treasury bills and cash, fair values of its investments are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active markets for identical assets as follows:
 
    
Amortized
Cost
    
Gross
Holding
Gain
    
Quoted Prices
in
Active Markets
(Level 1)
 
U.S. Government Treasury Securities as of December 31, 2022
   $  759,271,905      $  161,421      $  759,433,326  
Money market fund as of December 31, 2022
     N/A        N/A      $ 441,037  
Money market fund as of March 31, 2023
     N/A        N/A      $ 767,542,768  
Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. There were no transfers between levels for the three months ended March 31, 2023 and March 31, 2022.
Level 1 instruments consist of investments in U.S. Treasury securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Note
7-Commitments
and Contingencies
Registration Rights
The holders of the Founder Shares, private placement warrants and warrants that may be issued upon conversion of the Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the private placement warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) w
ould
be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Initial Public Offering requiring the Company to register a sale of any of the securities held by them, including any other securities of the Company acquired by them prior to the consummation of the Company’s initial Business Combination. The holders of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Risks and Uncertainties
In February 2022, the Russian
Federation and Belarus commenced a military action within the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these condensed financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these
unaudited
condensed financial statements.
Underwriting Agreement
The Company had granted the underwriters a
45-day
option to purchase up to 11,250,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. On February 19, 2022, the option lapsed because the underwriters did not exercise their over-allotment option.
In addition, the underwriters are entitled to a deferred fee of $0.35 per Unit, or $26,250,000
in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. 
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Shareholders' Equity (Deficit)
3 Months Ended
Mar. 31, 2023
Stockholders' Equity Note [Abstract]  
Shareholders' Equity (Deficit)
Note
8-Shareholders’
Equity (Deficit)
Preference Shares
-The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share. The Company’s board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. The board of directors will be able to, without shareholder approval, issue preference shares with voting and other rights that could adversely affect the voting power and other rights of the holders of the ordinary shares and could have anti-takeover effects. At March 31, 2023 and December 31, 2022, there were no preference shares issued or outstanding.
Class
 A Ordinary Shares
-The Company is authorized to issue 400,000,000 Class A ordinary shares, with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. At March 31, 2023 and December 31, 2022, there were 75,000,000 Class A ordinary shares issued and outstanding subject to possible redemption. At March 31, 2023 and December 31, 2022, there were no Class A ordinary shares issued or outstanding.
Class
 B Ordinary Shares
-The Company is authorized to issue 80,000,000 Founder Shares, with a par value of $0.0001 per share. Holders of the Founder Shares are entitled to one vote for each share. On November 5, 2021, the Sponsor paid an aggregate of $25,000 to cover certain offering and formation costs of the Company in consideration for 17,250,000 of the Company’s Class B ordinary shares (the “Founder Shares”). On December 13, 2021, the Company effected a share recapitalization with respect to the Founder Shares whereby the Company issued one and
one-quarter
Founder Shares in respect of each outstanding Founder Share, resulting in the Sponsor owning 21,562,500 Founder Shares. The Founder Shares included an aggregate of up to 2,812,500 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the number of Founder Shares would collectively represent 20% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering. On February 19, 2022, 2,812,500 Founder Shares were forfeited because the underwriters did not exercise their over-allotment option, resulting in the Sponsor holding 18,750,000 Founder Shares.
Holders of the Founder Shares will be entitled to vote on the appointment and removal of directors or continuing the Company in a jurisdiction outside the Cayman Islands (including any special resolution required to amend the constitutional documents of the Company or to adopt new constitutional documents of the Company, in each case, as a result of the Company approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands). On any other matter submitted to a vote of the shareholders prior to or in connection with the completion of the initial Business Combination, holders of the Founder Shares and holders of the Class A ordinary shares will vote together as a single class, except as required by law.
The Founder Shares will automatically convert into Class A ordinary shares concurrently with or immediately following the completion of a Business Combination on a
one-for-one
basis, subject to adjustment. In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with a Business Combination, the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the total number of Class A ordinary shares outstanding after such conversion (after giving effect to any redemptions of Class A ordinary shares by public shareholders), including the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of a Business Combination, excluding any Class A ordinary shares or equity- linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in a Business Combination and any private placement warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than
one-for-one
basis.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Warrants
3 Months Ended
Mar. 31, 2023
Warrants and Rights Note Disclosure [Abstract]  
Warrants
Note
9-Warrants
As of March 31, 2023 and December 31, 2022, the Company has 25,000,000 Public Warrants and 11,733,333 private placement warrants outstanding. The Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination. The Public Warrants will expire five years from the completion of a Business Combination, or earlier upon redemption or liquidation.
The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue a Class A ordinary share upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.
 
The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement of which the Form
10-K
forms a part or a new registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption.
In addition, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of the Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company elects to do so, the Company will not be required to file or maintain in effect a registration statement, but it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants:
 
(1)
in whole and not in part;
 
(2)
at a price of $0.01 per Public Warrant;
 
(3)
upon not less than 30 days’ prior written notice of redemption to each warrant holder; and
 
(4)
if, and only if, the reported closing price of the ordinary shares equals or exceeds $18.00 per share (as adjusted for share
sub-divisions,
share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a
30-trading
day period ending three business days before the Company send to the notice of redemption to the warrant holders.
If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
If the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Completion Window and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.
The private placement warrants will be identical to the public warrants underlying the Units being sold in the Initial Public Offering, except that (i) the private placement warrants will not be redeemable by the Company, (ii) the private placement warrants and the Class A ordinary shares issuable upon the exercise of the private placement warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (iii) the private placement warrants will be exercisable on a cashless basis, (iv) will use a different Black-Scholes Warrant Model for purposes of calculating the Black-Scholes Warrant Value (as defined in the Warrant Agreement) and (v) the private placement warrants and the Class A ordinary shares issuable upon exercise of the private placement warrants will be entitled to registration rights. If the private placement warrants are held by someone other than the initial purchasers or their permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Recurring Fair Value Measurements
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Recurring Fair Value Measurements
Note
10-
Recurring
Fair Value Measurements
As of March 31, 2023, investment securities in the Company’s Trust Account consisted of $767,542,768 in money market fund. As of December 31, 2022, investment securities in the Company’s Trust Account consisted of $759,271,905 in United States Treasury Bills and $441,037 held in money market fund. See Note 6 for fair value information for the Trust Account.
 
The fair value of private placement warrants was initially and subsequently measured at fair value using a Black-Scholes Option Pricing Model. For the three months ended March 31, 2023 and 2022, the Company recognized a gain resulting from a decrease in the fair value of the private placement warrants of $469,333 and $10,208,000, respectively, presented as change in fair value of warrant liability in the accompanying
unaudited
condensed statements of operations.
The following table sets forth by level within the fair value hierarchy the Company’s liability that was accounted for at fair value on a recurring basis:
 
    
(Level 1)
    
(Level 2)
    
(Level 3)
 
Private placement warrants as of March 31, 2023
   $ —        $ —        $ 2,816,000  
Private placement warrants as of December 31, 2022
   $ —        $ —        $ 3,285,333  
The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:
                 
    
March 31,
2023
   
December 31,
2022
 
Ordinary share price
   $ 10.16     $ 9.94  
Exercise price
   $ 11.50     $ 11.50  
Volatility
     19.5     31.0
Term
     5.51       5.75  
Risk-free rate
     3.59     3.98
Dividend yield
     0     0
Probability of completing Business Combination
(1)
     11     9
 
(1)
Estimates of 11% and 9% based on public trading of
rights
for SPACs and their implied business combination probabilities as of March 31, 2023 and December 31, 2022, respectively. 
 
The change in the fair value of the warrant liabilities for the three months ended March 31, 2023 and 2022 is summarized as follows:
 
Level 3 Derivative warrant liability at December 31, 2022
   $ 3,285,333  
Change in fair value of derivative warrant liability
     (469,333
    
 
 
 
Level 3 Derivative warrant liability at March 31, 2023
   $ 2,816,000  
 
  
 
 
 
 
 
 
 
 
Level 3 Derivative warrant liability at December 31, 2021
   $ —    
Issuance of Private Warrants on January 10, 2022
     17,482,666  
Change in fair value of derivative warrant liability
     (10,208,000
    
 
 
 
Level 3 Derivative warrant liability at March 31, 2022
   $ 7,274,666  
    
 
 
 
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events
3 Months Ended
Mar. 31, 2023
Subsequent Events [Abstract]  
Subsequent Events
Note
11-Subsequent
Events
The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to, the date that these condensed financial statements were available to be issued. Based upon this review, other than as noted below, the Company did not identify any subsequent events, that have occurred that would require adjustments to the disclosures in the financial statements.
Subsequent to March 31, 2023, the Company withdrew $250,000 of interest earned on the Trust Account for working capital.
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Basis of presentation
Basis of presentation
The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected through December 31, 2023 or any future periods.
 
The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form
10-K
filed by the Company with the SEC on March 1, 2023.
Use of estimates
Use of estimates
The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash equivalents
Cash equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. Cash and cash equivalents in the Trust Account are considered to be investments. As of March 31, 2023 and December 31, 2022, cash and cash equivalents consist of cash and money market funds.
Concentration of Credit Risk
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation limit of $250,000, and investments held in Trust
 
Account. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations and cash flows.
Investment Held in Trust Account
Investment Held in Trust Account
The Company’s portfolio of investments is comprised solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company classifies its U.S. Treasury and equivalent securities as
held-to-maturity
in accordance with ASC Topic 320 “Investments—Debt and Equity Securities.”
Held-to-maturity
securities are those securities which the Company has the ability and intent to hold until maturity.
Held-to-maturity
treasury securities are recorded at amortized cost on the accompanying balance sheets and adjusted for the amortization or accretion of premiums or discounts. Money market funds are presented at fair value at the end of each reporting period.
Offering costs
Offering costs
Offering costs consisted of underwriting, legal, accounting and other expenses incurred directly related to the Initial Public Offering. Upon completion of the Initial Public Offering, offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liability were charged to operations. Offering costs allocated to Class A Ordinary Shares were initially charged to temporary equity and then accreted to ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. Offering costs amounted to $42,130,216, of which $42,110,034 was charged to temporary equity upon the completion of the Initial Public Offering and $20,182 was expensed to the
una
ud
ited
condensed statements of operations.
Class A Ordinary Shares subject to possible redemption
Class A Ordinary Shares subject to possible redemption
The Company accounts for its Class A Ordinary Shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Class A Ordinary Shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2023 and December 31, 2022, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ (deficit) section of the Company’s condensed balance sheets.
The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of Class A ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional
paid-in
capital and accumulated deficit.
As of March 31, 2023 and December 31, 2022, the Class A ordinary shares reflected on the condensed balance sheets are reconciled in the following table:
 
Gross proceeds
  
$
750,000,000
 
Less
  
Fair value of Public Warrants at issuance
  
 
(36,750,000
Class A ordinary share issuance costs
  
 
(42,110,034
Plus:
  
Accretion of carrying value to redemption value
  
 
85,722,976
 
  
 
 
 
Class A ordinary shares subject to possible redemption, December 31, 2022
  
 
756,862,942
 
Accretion of carrying value to redemption value
  
 
8,079,826
 
  
 
 
 
Class A ordinary shares subject to possible redemption, March 31, 2023
  
$
764,942,768
 
  
 
 
 
Derivative financial instruments
Derivative financial instruments
The Company accounts for derivative financial instruments in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value upon issuance and remeasured at each reporting date, with changes in the fair value reported in the
unaudited
condensed statements of operations. The classification of derivative financial instruments is evaluated at the end of each reporting period.
Warrant liability
Warrant liability
The Company accounts for the private placement warrants as liabilities at fair value on the condensed balance sheets. The private placement warrants are subject to remeasurement at each balance sheet date and any change in fair value is recognized as a component of other income (expense), net on the condensed statements of operations. The Company will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of the private placement warrants. At that time, the portion of the warrant liability related to the private placement warrants will be reclassified to additional
paid-in
capital.
Income taxes
Income taxes
The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”), which prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not
to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
There is currently no taxation imposed on income by the government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Fair value of financial instruments
Fair value of financial instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature, except for the warrant liability (see Note 10).
Fair value of financial instruments
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
   
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
   
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
   
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Net income per ordinary share
Net Income Per Ordinary Share
The Company has two classes of shares, Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share”. Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. Accretion associated with the redeemable shares of Class A ordinary share is excluded from earnings per share as the redemption value approximates fair value.
The calculation of diluted income per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 36,733,333 Class A ordinary share in the aggregate. As of March 31, 2023 and
March
 31, 2022, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary share and then share in the earnings of the Company. As a result, diluted net income per share of ordinary share is the same as basic net income per share of ordinary share for the periods presented.
The following table reflects the calculation of basic and diluted net income
 
per ordinary share for the three months ended March 31, 2023 and 2022:
 
    
Three Months Ended March 31,
2023
    
Three Months Ended March 31,
2022
 
    
Class A
    
Class B
    
Class A
    
Class B
 
Basic and diluted net income (loss) per ordinary
                                   
Numerator:
                                   
Allocation of net income
   $ 6,406,917      $ 1,601,729      $ 7,729,627      $ 2,147,118  
Denominator:
                                   
Basic and diluted weighted average shares outstanding
     75,000,000        18,750,000        67,500,000        18,750,000  
Basic and diluted net income per ordinary share
   $ 0.09      $ 0.09      $ 0.11      $
0. 11
 
Recently issued accounting standards
Recently issued accounting standards
Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Summary of Reconciliation Of Proceeds From Temporary Equity To Outstanding Value (Detail)
As of March 31, 2023 and December 31, 2022, the Class A ordinary shares reflected on the condensed balance sheets are reconciled in the following table:
 
Gross proceeds
  
$
750,000,000
 
Less
  
Fair value of Public Warrants at issuance
  
 
(36,750,000
Class A ordinary share issuance costs
  
 
(42,110,034
Plus:
  
Accretion of carrying value to redemption value
  
 
85,722,976
 
  
 
 
 
Class A ordinary shares subject to possible redemption, December 31, 2022
  
 
756,862,942
 
Accretion of carrying value to redemption value
  
 
8,079,826
 
  
 
 
 
Class A ordinary shares subject to possible redemption, March 31, 2023
  
$
764,942,768
 
  
 
 
 
Schedule of Earnings Per Share, Basic and Diluted As a result, diluted net income per share of ordinary share is the same as basic net income per share of ordinary share for the periods presented.
The following table reflects the calculation of basic and diluted net income
 
per ordinary share for the three months ended March 31, 2023 and 2022:
 
    
Three Months Ended March 31,
2023
    
Three Months Ended March 31,
2022
 
    
Class A
    
Class B
    
Class A
    
Class B
 
Basic and diluted net income (loss) per ordinary
                                   
Numerator:
                                   
Allocation of net income
   $ 6,406,917      $ 1,601,729      $ 7,729,627      $ 2,147,118  
Denominator:
                                   
Basic and diluted weighted average shares outstanding
     75,000,000        18,750,000        67,500,000        18,750,000  
Basic and diluted net income per ordinary share
   $ 0.09      $ 0.09      $ 0.11      $
0. 11
 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Trust Account (Tables)
3 Months Ended
Mar. 31, 2023
Debt Securities, Available-for-Sale and Held-to-Maturity, after Allowance for Credit Loss [Abstract]  
Summary of Available-for-sale Securities Reconciliation Since all of the Company’s permitted investments consist of U.S. government treasury bills and cash, fair values of its investments are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active markets for identical assets as follows:
 
    
Amortized
Cost
    
Gross
Holding
Gain
    
Quoted Prices
in
Active Markets
(Level 1)
 
U.S. Government Treasury Securities as of December 31, 2022
   $  759,271,905      $  161,421      $  759,433,326  
Money market fund as of December 31, 2022
     N/A        N/A      $ 441,037  
Money market fund as of March 31, 2023
     N/A        N/A      $ 767,542,768  
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Recurring Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following table sets forth by level within the fair value hierarchy the Company’s liability that was accounted for at fair value on a recurring basis:
 
    
(Level 1)
    
(Level 2)
    
(Level 3)
 
Private placement warrants as of March 31, 2023
   $ —        $ —        $ 2,816,000  
Private placement warrants as of December 31, 2022
   $ —        $ —        $ 3,285,333  
Summary of quantitative information regarding Level 3 fair value measurements inputs as their measurement dates
The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:
                 
    
March 31,
2023
   
December 31,
2022
 
Ordinary share price
   $ 10.16     $ 9.94  
Exercise price
   $ 11.50     $ 11.50  
Volatility
     19.5     31.0
Term
     5.51       5.75  
Risk-free rate
     3.59     3.98
Dividend yield
     0     0
Probability of completing Business Combination
(1)
     11     9
 
(1)
Estimates of 11% and 9% based on public trading of
rights
for SPACs and their implied business combination probabilities as of March 31, 2023 and December 31, 2022, respectively. 
Summary of The change in the fair value of the warrant liabilities
The change in the fair value of the warrant liabilities for the three months ended March 31, 2023 and 2022 is summarized as follows:
 
Level 3 Derivative warrant liability at December 31, 2022
   $ 3,285,333  
Change in fair value of derivative warrant liability
     (469,333
    
 
 
 
Level 3 Derivative warrant liability at March 31, 2023
   $ 2,816,000  
 
  
 
 
 
 
 
 
 
 
Level 3 Derivative warrant liability at December 31, 2021
   $ —    
Issuance of Private Warrants on January 10, 2022
     17,482,666  
Change in fair value of derivative warrant liability
     (10,208,000
    
 
 
 
Level 3 Derivative warrant liability at March 31, 2022
   $ 7,274,666  
    
 
 
 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Organization Consolidation And Presentation Of Financial Statements (Detail) - USD ($)
3 Months Ended
Jan. 10, 2022
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Organization And Plan Of Operation [Line Items]        
Proceeds from initial public offer   $ 0 $ 750,000,000  
Proceeds from the issuance of warrants   0 17,600,000  
Deferred underwriting commission non current.   $ 26,250,000    
Payments to Acquire Restricted Investments $ 750,000,000   $ 750,000,000  
Per share value of restricted investments $ 10      
Term of restricted investments   185 days    
Minimum percentage of net assets of the acquire   80.00%    
Temporary equity, redemption price per share   $ 10.2   $ 10.09
Minimum networth needed to consummate business combination   $ 5,000,001    
Minimum percentage of public shares that can be transferred without restriction   20.00%    
Percentage of public shares to be redeemed in case business combination is not consummated   100.00%    
Time limit for the consummation of business combination one.   24 months    
Date before which business combination shall be consummated one.   Jan. 10, 2024    
Time limit for the consummation of business combination two.   27 months    
Date before which business combination shall be consummated two.   Apr. 10, 2024    
Number of days after the the cut off date within which public shareholders shall be redeemed in case business combination is not consummated   10 days    
Liquidation basis of accounting, accrued costs to dispose of assets and liabilities   $ 100,000    
Cash   72,520   $ 117,696
Assets held-in-trust, noncurrent   767,542,768   $ 759,712,942
Maximum release permitted to be withdrawn   3,000,000    
Working capital deficiency   428,238    
Proceeds From Trust Account For Working Capital Purposes   500,000    
Working Capital Loans [Member] | Sponsor [Member]        
Organization And Plan Of Operation [Line Items]        
Working capital loans convertible into equity warrants   $ 1,500,000    
Debt instrument, convertible, conversion price   $ 1.5    
Maximum [Member]        
Organization And Plan Of Operation [Line Items]        
Per share to be maintained in the trust account   10    
Minimum [Member]        
Organization And Plan Of Operation [Line Items]        
Per share to be maintained in the trust account   $ 10    
Private Placement Warrants [Member]        
Organization And Plan Of Operation [Line Items]        
Proceeds from the issuance of warrants   $ 17,600,000    
Common Class A [Member]        
Organization And Plan Of Operation [Line Items]        
Common Stock, Par or Stated Value Per Share   $ 0.0001    
Temporary equity, redemption price per share   $ 10    
IPO [Member]        
Organization And Plan Of Operation [Line Items]        
Proceeds from initial public offer $ 750,000,000 $ 735,000,000    
IPO [Member] | Common Class A [Member]        
Organization And Plan Of Operation [Line Items]        
Stock issued during the period shares new issues 75,000,000      
Common Stock, Par or Stated Value Per Share $ 0.0001      
Class of warrants or rights exercise price per warrant 11.5      
Sale of stock issue price per share $ 10      
Transaction costs share issue   42,130,216    
Underwriting fees   15,000,000    
Other offering costs   880,216    
Private Placement [Member] | Private Placement Warrants [Member]        
Organization And Plan Of Operation [Line Items]        
Class of warrants or rights issued during the period units 11,733,333      
Class of warrants or rights issue price per unit $ 1.5      
Private Placement [Member] | Common Class A [Member] | Private Placement Warrants [Member]        
Organization And Plan Of Operation [Line Items]        
Class of warrants or rights exercise price per warrant $ 11.5      
Class of warrants or rights issued during the period units 11,733,333      
Class of warrants or rights issue price per unit $ 1.5      
Proceeds from the issuance of warrants   $ 17,600,000    
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies - Additional Information (Detail)
3 Months Ended
Mar. 31, 2023
USD ($)
shares
Accounting Policies [Line Items]  
Accrued interest and penalties on unrecognized tax benefits $ 0
Cash insured with federal insurance corporation $ 250,000
Common Class A [Member]  
Accounting Policies [Line Items]  
Class of warrants or rights number of securities covered by the warrants or rights | shares 36,733,333
IPO [Member] | Common Class A [Member]  
Accounting Policies [Line Items]  
Transaction costs share issue $ 42,130,216
Offering costs charged to temporary equity 42,110,034
Offering costs expensed $ 20,182
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies - Summary of Reconciliation of Proceeds from Temporary Equity to Outstanding Value (Detail) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Accounting Policies [Abstract]    
Gross proceeds   $ 750,000,000
Fair value Of Public Warrants At Issuance   (36,750,000)
Class A ordinary share issuance costs   (42,110,034)
Accretion of carrying value to redemption value $ 8,079,826 85,722,976
Class A ordinary shares subject to possible redemption $ 764,942,768 $ 756,862,942
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Detail) - USD ($)
2 Months Ended 3 Months Ended
Dec. 31, 2021
Mar. 31, 2023
Mar. 31, 2022
Numerator:      
Allocation of net income (loss)   $ 8,008,646 $ 9,876,745
Denominator:      
Basic net income per share     $ 0.11
Common Class A [Member]      
Denominator:      
Basic net income per share   $ 0.09 0.11
Diluted net income per share   0.09 0.11
Common Class B [Member]      
Denominator:      
Basic net income per share   0.09 0.11
Diluted net income per share   $ 0.09 $ 0.11
Non Redeemable Common Stock [Member] | Common Class A [Member]      
Denominator:      
Basic weighted average shares outstanding   75,000,000 67,500,000
Diluted weighted average shares outstanding   75,000,000 67,500,000
Non Redeemable Common Stock [Member] | Common Class B [Member]      
Numerator:      
Allocation of net income (loss) $ 2,147,118 $ 1,601,729  
Denominator:      
Basic weighted average shares outstanding   18,750,000 18,750,000
Diluted weighted average shares outstanding   18,750,000 18,750,000
Basic net income per share   $ 0.09 $ 0.11
Diluted net income per share   $ 0.09  
Redeemable Common Stock [Member] | Common Class A [Member]      
Numerator:      
Allocation of net income (loss) $ 7,729,627 $ 6,406,917  
Denominator:      
Basic net income per share   $ 0.09 0.11
Diluted net income per share   $ 0.09 $ 0.11
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Initial Public Offering - Additional Information (Detail) - IPO [Member] - Common Class A [Member]
Jan. 10, 2022
$ / shares
shares
Initial Public Offer [Line Items]  
Stock issued during the period shares new issues | shares 75,000,000
Sale of stock issue price per share $ 10
Class of warrants or rights exercise price per warrant 11.5
Public Warrants [Member]  
Initial Public Offer [Line Items]  
Class of warrants or rights exercise price per warrant $ 11.5
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Private Placement - Additional Information (Detail) - USD ($)
3 Months Ended
Jan. 10, 2022
Mar. 31, 2023
Mar. 31, 2022
Private Placement [Line Items]      
Proceeds from the issuance of warrants   $ 0 $ 17,600,000
Private Placement Warrants [Member]      
Private Placement [Line Items]      
Proceeds from the issuance of warrants   17,600,000  
Private Placement [Member] | Private Placement Warrants [Member]      
Private Placement [Line Items]      
Class of warrants or rights issued during the period units 11,733,333    
Class of warrants or rights issue price per unit $ 1.5    
Private Placement [Member] | Private Placement Warrants [Member] | Common Class A [Member]      
Private Placement [Line Items]      
Class of warrants or rights issued during the period units 11,733,333    
Class of warrants or rights issue price per unit $ 1.5    
Class of warrants or rights exercise price per share $ 11.5    
Proceeds from the issuance of warrants   $ 17,600,000  
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions - Additional Information (Detail) - USD ($)
3 Months Ended
Feb. 19, 2022
Dec. 13, 2021
Nov. 05, 2021
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Related Party Transactions [Line Items]              
Common stock, shares, outstanding       0   0  
Notes payable to related party current             $ 300,000
Due to affiliate current   $ 14,537          
Administrative Services Agreement [Member]              
Related Party Transactions [Line Items]              
Accounts payable and accrued expenses       $ 45,000   $ 45,000  
Sponsor [Member] | Promissory Note Issued To The Sponsor [Member]              
Related Party Transactions [Line Items]              
Debt instrument face value     $ 300,000        
Sponsor [Member] | Administrative Services Agreement [Member]              
Related Party Transactions [Line Items]              
Related party transaction expenses payable per month   $ 15,000          
Expenses from transactions with related party       $ 45,000 $ 45,000    
Sponsor [Member] | Working Capital Loans [Member]              
Related Party Transactions [Line Items]              
Debt instrument conversion price per share       $ 1.5      
Common Class B [Member]              
Related Party Transactions [Line Items]              
Stock issued during the period shares for services     25,000        
Stock issued durig the period value for services     $ 17,250,000        
Common stock, shares, outstanding     17,250,000 18,750,000   18,750,000  
Stock forfeited during the period shares 2,812,500 2,812,500          
Common Class B [Member] | Sponsor [Member]              
Related Party Transactions [Line Items]              
Common stock, shares, outstanding   21,562,500          
Stock forfeited during the period shares     2,812,500        
Percentage of common stock issued and outstanding       20.00%      
Common stock shares lock in period     1 year        
Share price     $ 12        
Number of trading days for determining the share price     20 days        
Total number of trading days for determining the share price     30 days        
Common stock shares lock in period one     180 days        
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Trust Account - Additional Information (Detail) - USD ($)
3 Months Ended
Jan. 10, 2022
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
United States Treasury Bills [Line Items]        
Proceeds from Issuance or Sale of Equity   $ 750,000,000    
Proceeds from Issuance Initial Public Offering   0 $ 750,000,000  
Cash   767,542,768   $ 441,037
Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net   0 $ 0  
IPO [Member]        
United States Treasury Bills [Line Items]        
Proceeds from Issuance Initial Public Offering $ 750,000,000 735,000,000    
Private Placement [Member]        
United States Treasury Bills [Line Items]        
Proceeds from Issuance of Private Placement   15,000,000    
US Treasury Bills [Member]        
United States Treasury Bills [Line Items]        
Debt securities, held-to-maturity   $ 767,542,768   $ 759,271,905
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Trust Account - Summary of Available-for-sale Securities Reconciliation (Detail) - Fair Value, Inputs, Level 1 [Member] - USD ($)
Mar. 31, 2023
Dec. 31, 2022
U.S. Government Treasury Securities [Member]    
Trust Account [Line Items]    
Amortized Cost   $ 759,271,905
Gross Holding Gain   161,421
Quoted Prices in Active Markets (Level 1)   759,433,326
Money Market Funds [Member]    
Trust Account [Line Items]    
Quoted Prices in Active Markets (Level 1) $ 767,542,768 $ 441,037
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies - Additional Information (Detail)
3 Months Ended
Mar. 31, 2023
USD ($)
$ / shares
shares
Commitments and Contingencies [Line Items]  
Deferred underwriting commission per unit, shares | $ / shares $ 0.35
Deferred underwriting commissions noncurrent | $ $ 26,250,000
Over-Allotment Option [Member]  
Commitments and Contingencies [Line Items]  
Over allotment option period 45 days
Stock issued during period shares | shares 11,250,000
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Shareholders' Equity (Deficit) - Additional Information (Detail) - USD ($)
3 Months Ended
Feb. 19, 2022
Dec. 13, 2021
Nov. 05, 2021
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Shareholders Deficit [Line Items]            
Preferred Stock, Shares Authorized       1,000,000    
Preferred Stock, Par or Stated Value Per Share       $ 0.0001    
Preferred Stock, Shares Issued       0   0
Preferred Stock, Shares Outstanding       0   0
Temporary Equity, Shares Outstanding       75,000,000   75,000,000
Common Stock, Shares, Outstanding       0   0
Offering and formation cost       $ 540,513 $ 447,352  
Founder Shares [Member]            
Shareholders Deficit [Line Items]            
Stock Conversion Basis       one vote    
Stockholders' Equity Note, Stock Split   one and one-quarter        
Founder Shares [Member] | Sponsor [Member]            
Shareholders Deficit [Line Items]            
Common Stock, Shares, Outstanding 18,750,000          
Common Class A [Member]            
Shareholders Deficit [Line Items]            
Preferred Stock, Shares Authorized       1,000,000    
Preferred Stock, Par or Stated Value Per Share       $ 0.0001    
Preferred Stock, Shares Issued       0    
Preferred Stock, Shares Outstanding       0    
Common Stock, Shares Authorized       400,000,000    
Common Stock, Par or Stated Value Per Share       $ 0.0001    
Stock Conversion Basis       one vote    
Temporary Equity, Shares Outstanding       75,000,000   75,000,000
Temporary Equity, Shares Issued       75,000,000    
Percentage of ownership held by initial shareholders 20.00%          
Common Stock, Shares, Issued       0   0
Common Stock, Shares, Outstanding       0    
Common Class B [Member]            
Shareholders Deficit [Line Items]            
Common Stock, Shares Authorized       80,000,000    
Common Stock, Par or Stated Value Per Share       $ 0.0001    
Percentage of ownership held by initial shareholders   20.00%        
Shares Issued, Shares, Share-based Payment Arrangement, Forfeited 2,812,500 2,812,500        
Common Stock, Shares, Issued     17,250,000 18,750,000   18,750,000
Common Stock, Shares, Outstanding     17,250,000 18,750,000   18,750,000
Offering and formation cost     $ 25,000      
Common Class B [Member] | Sponsor [Member]            
Shareholders Deficit [Line Items]            
Shares Issued, Shares, Share-based Payment Arrangement, Forfeited     2,812,500      
Common Stock, Shares, Outstanding   21,562,500        
Common Class B [Member] | Founder Shares [Member]            
Shareholders Deficit [Line Items]            
Common Stock, Shares Authorized       80,000,000    
Common Stock, Par or Stated Value Per Share       $ 0.0001    
Shares Issued, Shares, Share-based Payment Arrangement, Forfeited   21,562,500        
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Warrants - Additional Information (Detail)
3 Months Ended
Mar. 31, 2023
$ / shares
shares
Warrants [Line Items]  
Minimum lock In period for transfer, assign or sell warrants after completion of IPO 30 days
Public Warrants [Member]  
Warrants [Line Items]  
Number of warrants or rights outstanding 25,000,000
Warrants exercisable term from the date of completion of business combination 20 days
Private Placement Warrants [Member]  
Warrants [Line Items]  
Number of warrants or rights outstanding 11,733,333
Redemption of warrants [Member] | Share Price Equal or Exceeds Eighteen Rupees per dollar [Member] | Common Class A [Member]  
Warrants [Line Items]  
Class of warrants, redemption price per unit 0.01%
Class of warrants, redemption notice period 30 days
Share price | $ / shares $ 18
Number of consecutive trading days for determining share price 20 days
Number of trading days for determining share price 30 days
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Recurring Fair Value Measurements - Additional Information (Detail) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Cash $ 767,542,768   $ 441,037
Private Placement Warrants [Member]      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Fair Value Adjustment of Warrants $ 469,333 $ 10,208,000  
United States Treasury Bills [Member]      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Debt Securities, Held-to-Maturity     $ 759,271,905
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Recurring Fair Value Measurements - Schedule of Fair Value Hierarchy the Company's Liabilities that were Accounted for at Fair Value on a Recurring Basis (Detail) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Level 3 [Member] | Private placement warrants [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrants and Rights Outstanding $ 2,816,000 $ 3,285,333
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Recurring Fair Value Measurements - Summary of quantitative information regarding Level 3 fair value measurements inputs as their measurement dates (Detail) - Fair Value, Inputs, Level 3 [Member]
Mar. 31, 2023
yr
$ / shares
Dec. 31, 2022
$ / shares
yr
Ordinary share stock price    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input 10.16 9.94
Exercise price    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input 11.5 11.5
Volatility    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input 19.5 31
Term    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input | yr 5.51 5.75
Risk-free rate    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input 3.59 3.98
Dividend yield    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input 0 0
Probability of completing Business Combination    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input [1] 11 9
[1] Estimates of 11% and 9% based on public trading of rights for SPACs and their implied business combination probabilities as of March 31, 2023 and December 31, 2022, respectively.
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Recurring Fair Value Measurements - Summary of quantitative information regarding Level 3 fair value measurements inputs as their measurement dates (Parenthetical) (Detail)
Mar. 31, 2023
Dec. 31, 2022
Measurement Input Probability Rate [Member] | SPAC Market Data Published By Third Party [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants and Rights Outstanding, Measurement Input 11 9
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Recurring Fair Value Measurements - Summary of The change in the fair value of the warrant liabilities (Detail) - Warrant Liability [Member] - Fair Value, Inputs, Level 3 [Member] - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Level 3 Derivative warrant liability Beginning Balance $ 3,285,333 $ 0
Issuance of Private Warrants on January 10, 2022   17,482,666
Change in fair value of derivative warrant liability (469,333) (10,208,000)
Level 3 Derivative warrant liability Ending Balance $ 2,816,000 $ 7,274,666
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events - Additional Information (Detail) - USD ($)
3 Months Ended
Apr. 01, 2023
Mar. 31, 2023
Subsequent Event [Line Items]    
Proceeds from Trust Account for Working Capital Purposes   $ 500,000
Subsequent Event [Member]    
Subsequent Event [Line Items]    
Proceeds from Trust Account for Working Capital Purposes $ 250,000  
XML 52 d457148d10q_htm.xml IDEA: XBRL DOCUMENT 0001893325 2023-01-01 2023-03-31 0001893325 2022-12-31 0001893325 2023-03-31 0001893325 2022-01-01 2022-03-31 0001893325 2022-01-10 2022-01-10 0001893325 2022-01-10 0001893325 2021-12-31 0001893325 2021-12-13 0001893325 2022-03-31 0001893325 us-gaap:CommonClassBMember 2023-03-31 0001893325 us-gaap:CommonClassAMember 2023-03-31 0001893325 scrm:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001893325 srt:MinimumMember 2023-03-31 0001893325 srt:MaximumMember 2023-03-31 0001893325 scrm:PrivatePlacementWarrantsMember 2023-03-31 0001893325 scrm:PublicWarrantsMember 2023-03-31 0001893325 scrm:WorkingCapitalLoansMember scrm:SponsorMember 2023-03-31 0001893325 scrm:RedemptionOfWarrantsMember us-gaap:CommonClassAMember scrm:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember 2023-03-31 0001893325 scrm:UnitedStatesTreasuryBillsMember 2023-03-31 0001893325 scrm:SponsorMember us-gaap:CommonClassBMember 2023-03-31 0001893325 scrm:AdministrativeServicesAgreementMember 2023-03-31 0001893325 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2023-03-31 0001893325 us-gaap:CommonClassBMember scrm:FounderSharesMember 2023-03-31 0001893325 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputSharePriceMember 2023-03-31 0001893325 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExercisePriceMember 2023-03-31 0001893325 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2023-03-31 0001893325 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember 2023-03-31 0001893325 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-03-31 0001893325 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember 2023-03-31 0001893325 us-gaap:FairValueInputsLevel3Member scrm:MeasurementInputProbabilityRateMember 2023-03-31 0001893325 scrm:MeasurementInputProbabilityRateMember scrm:SpacMarketDataPublishedByThirdPartyMember 2023-03-31 0001893325 scrm:PrivatePlacementWarrantsMember 2023-01-01 2023-03-31 0001893325 us-gaap:CommonClassAMember us-gaap:IPOMember 2023-01-01 2023-03-31 0001893325 scrm:PublicWarrantsMember 2023-01-01 2023-03-31 0001893325 scrm:PrivatePlacementWarrantsMember us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2023-01-01 2023-03-31 0001893325 scrm:RedemptionOfWarrantsMember us-gaap:CommonClassAMember scrm:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember 2023-01-01 2023-03-31 0001893325 us-gaap:CommonClassAMember 2023-01-01 2023-03-31 0001893325 us-gaap:CommonClassBMember 2023-01-01 2023-03-31 0001893325 us-gaap:CommonClassAMember scrm:RedeemableCommonStockMember 2023-01-01 2023-03-31 0001893325 us-gaap:CommonClassBMember scrm:NonRedeemableCommonStockMember 2023-01-01 2023-03-31 0001893325 us-gaap:CommonClassAMember scrm:NonRedeemableCommonStockMember 2023-01-01 2023-03-31 0001893325 us-gaap:OverAllotmentOptionMember 2023-01-01 2023-03-31 0001893325 us-gaap:IPOMember 2023-01-01 2023-03-31 0001893325 us-gaap:PrivatePlacementMember 2023-01-01 2023-03-31 0001893325 scrm:AdministrativeServicesAgreementMember scrm:SponsorMember 2023-01-01 2023-03-31 0001893325 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001893325 scrm:FounderSharesMember 2023-01-01 2023-03-31 0001893325 us-gaap:CapitalUnitsMember 2023-01-01 2023-03-31 0001893325 us-gaap:WarrantMember 2023-01-01 2023-03-31 0001893325 us-gaap:FairValueInputsLevel3Member scrm:WarrantLiabilityMember 2023-01-01 2023-03-31 0001893325 scrm:PrivatePlacementWarrantsMember 2022-01-01 2022-03-31 0001893325 us-gaap:CommonClassAMember 2022-01-01 2022-03-31 0001893325 us-gaap:CommonClassBMember 2022-01-01 2022-03-31 0001893325 us-gaap:CommonClassAMember scrm:NonRedeemableCommonStockMember 2022-01-01 2022-03-31 0001893325 us-gaap:CommonClassBMember scrm:NonRedeemableCommonStockMember 2022-01-01 2022-03-31 0001893325 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001893325 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001893325 scrm:AdministrativeServicesAgreementMember scrm:SponsorMember 2022-01-01 2022-03-31 0001893325 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001893325 us-gaap:FairValueInputsLevel3Member scrm:WarrantLiabilityMember 2022-01-01 2022-03-31 0001893325 us-gaap:CommonClassAMember scrm:RedeemableCommonStockMember 2022-01-01 2022-03-31 0001893325 us-gaap:CommonClassAMember us-gaap:IPOMember 2022-01-10 2022-01-10 0001893325 us-gaap:IPOMember 2022-01-10 2022-01-10 0001893325 scrm:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2022-01-10 2022-01-10 0001893325 scrm:PrivatePlacementWarrantsMember us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2022-01-10 2022-01-10 0001893325 us-gaap:CommonClassAMember us-gaap:IPOMember 2022-01-10 0001893325 scrm:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2022-01-10 0001893325 scrm:PublicWarrantsMember us-gaap:CommonClassAMember us-gaap:IPOMember 2022-01-10 0001893325 scrm:PrivatePlacementWarrantsMember us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2022-01-10 0001893325 us-gaap:CommonClassAMember 2022-12-31 0001893325 us-gaap:CommonClassBMember 2022-12-31 0001893325 scrm:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001893325 scrm:UnitedStatesTreasuryBillsMember 2022-12-31 0001893325 scrm:AdministrativeServicesAgreementMember 2022-12-31 0001893325 us-gaap:FairValueInputsLevel1Member scrm:U.s.GovernmentTreasurySecuritiesMember 2022-12-31 0001893325 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2022-12-31 0001893325 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputSharePriceMember 2022-12-31 0001893325 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExercisePriceMember 2022-12-31 0001893325 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001893325 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember 2022-12-31 0001893325 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001893325 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember 2022-12-31 0001893325 us-gaap:FairValueInputsLevel3Member scrm:MeasurementInputProbabilityRateMember 2022-12-31 0001893325 scrm:UnitedStatesTreasuryBillsMember 2022-12-31 0001893325 scrm:MeasurementInputProbabilityRateMember scrm:SpacMarketDataPublishedByThirdPartyMember 2022-12-31 0001893325 us-gaap:CommonClassAMember scrm:RedeemableCommonStockMember 2021-11-03 2021-12-31 0001893325 us-gaap:CommonClassBMember scrm:NonRedeemableCommonStockMember 2021-11-03 2021-12-31 0001893325 us-gaap:CommonClassBMember 2021-11-05 2021-11-05 0001893325 scrm:SponsorMember us-gaap:CommonClassBMember 2021-11-05 2021-11-05 0001893325 scrm:SponsorMember us-gaap:CommonClassBMember 2021-12-13 0001893325 scrm:AdministrativeServicesAgreementMember scrm:SponsorMember 2021-12-13 0001893325 us-gaap:CommonClassBMember 2021-12-13 0001893325 scrm:SponsorMember us-gaap:CommonClassBMember 2021-11-05 0001893325 scrm:PromissoryNoteIssuedToTheSponsorMember scrm:SponsorMember 2021-11-05 0001893325 us-gaap:CommonClassBMember 2021-11-05 0001893325 us-gaap:CommonClassBMember 2021-12-13 2021-12-13 0001893325 us-gaap:CommonClassBMember scrm:FounderSharesMember 2021-12-13 2021-12-13 0001893325 scrm:FounderSharesMember 2021-12-13 2021-12-13 0001893325 us-gaap:CommonClassBMember 2022-02-19 2022-02-19 0001893325 us-gaap:CommonClassBMember 2022-02-19 0001893325 us-gaap:CommonClassAMember 2022-02-19 0001893325 scrm:SponsorMember scrm:FounderSharesMember 2022-02-19 0001893325 us-gaap:SubsequentEventMember 2023-04-01 2023-04-01 0001893325 us-gaap:CommonClassAMember 2023-05-10 0001893325 us-gaap:CommonClassBMember 2023-05-10 0001893325 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-12-31 0001893325 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-12-31 0001893325 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001893325 us-gaap:RetainedEarningsMember 2022-12-31 0001893325 us-gaap:FairValueInputsLevel3Member scrm:WarrantLiabilityMember 2022-12-31 0001893325 us-gaap:FairValueInputsLevel3Member scrm:WarrantLiabilityMember 2023-03-31 0001893325 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-03-31 0001893325 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-03-31 0001893325 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001893325 us-gaap:RetainedEarningsMember 2023-03-31 0001893325 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001893325 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001893325 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001893325 us-gaap:RetainedEarningsMember 2021-12-31 0001893325 us-gaap:FairValueInputsLevel3Member scrm:WarrantLiabilityMember 2021-12-31 0001893325 us-gaap:FairValueInputsLevel3Member scrm:WarrantLiabilityMember 2022-03-31 0001893325 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001893325 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-03-31 0001893325 us-gaap:RetainedEarningsMember 2022-03-31 0001893325 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 iso4217:USD shares utr:Day pure utr:Month utr:Year iso4217:USD shares utr:Y false Q1 0001893325 --12-31 00-0000000 10-Q true 2023-03-31 2023 false 001-41203 SCREAMING EAGLE ACQUISITION CORP. E9 955 Fifth Avenue New York NY 10075 310 209-7280 Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-third of one redeemable warrant SCRMU NASDAQ Class A ordinary shares, 0.0001 par value SCRM NASDAQ Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share SCRMW NASDAQ Yes Yes Large Accelerated Filer false false true 75000000 18750000 0.11 0.11 72520 117696 499201 581784 571721 699480 767542768 759712942 768114489 760412422 500758 338004 500758 338004 2816000 3285333 26250000 26250000 29566758 29873337 75000000 75000000 10.2 10.09 764942768 756862942 0.0001 1000000 0 0 0 0 0.0001 400000000 0 0 75000000 0 0 0.0001 80000000 18750000 18750000 18750000 18750000 1875 1875 0 0 -26396912 -26325732 -26395037 -26323857 768114489 760412422 540513 447352 -540513 -447352 8079826 136279 0 20182 469333 10208000 8008646 9876745 75000000 67500000 0.09 0.09 0.11 0.11 18750000 18750000 0.09 0.09 0.11 0.11 2812500 0 0 0 18750000 1875 0 -26325732 -26323857 8079826 8079826 8008646 8008646 0 0 18750000 1875 0 -26396912 -26395037 0 0 21562500 2156 22844 -5000 20000 -2812500 -281 281 117334 117334 36750000 36750000 36890459 41969575 78860034 9876745 9876745 0 0 18750000 1875 0 -32097830 -32095955 2812500 0 8008646 9876745 8079826 136279 469333 10208000 0 20182 -82583 1011780 162754 880023 -295176 -579109 750000000 250000 0 250000 -750000000 0 17600000 0 750000000 0 15000000 0 540679 0 14537 0 300000 0 751744784 -45176 1165675 117696 72520 1165675 0 26250000 5000 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Note <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1-Organization</div> and Plan of Business Operations </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Screaming Eagle Acquisition Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on November 3, 2021. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (“Business Combination”). </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Although the Company is not limited to a particular industry or geographic region for purposes of completing a Business Combination, the Company intends to capitalize on the ability of its management team to identify and combine with a business or businesses that can benefit from its management team’s established global relationships and operating experience. The Company is an early stage company and, as such, the Company is subject to all of the risks associated with early stage companies. </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">As of March 31, 2023, the Company had not commenced any operations. All activity for the period from November 3, 2021 (inception) through March 31, 2023 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below and activities related to pursuing merger opportunities. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-operating</div> income in the form of interest income on the proceeds derived from the Initial Public Offering. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The registration statement for the Company’s Initial Public Offering was declared effective on January 5, 2022. On January 10, 2022, the Company consummated its Initial Public Offering of 75,000,000 units (the “Units”). Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A ordinary shares”), and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-third</div> of one redeemable warrant of the Company (each whole warrant, a “Warrant”), with each Warrant entitling the holder thereof to purchase one Class A ordinary share for $11.50 per share, subject to adjustment. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $750,000,000. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 11,733,333 (the “private placement warrants”) at a price of $1.50 per private placement warrant to the Company’s Sponsor, generating gross proceeds of $17,600,000, which is described in Note 4. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Transaction costs amounted to $42,130,216, consisting of $15,000,000 of underwriting fees, $26,250,000 of deferred underwriting fees and $880,216 of other offering costs. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Following the closing of the Initial Public Offering and the Private Placement, $750,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and certain proceeds from the sale of the private placement warrants was placed in a trust account (the “Trust Account”). The proceeds held in the Trust Account are invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-7</div> under the Investment Company Act of 1940, as amended (the “Investment Company Act”), which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the private placement warrants, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company must complete one or more Business Combinations with having an aggregate fair market value equal to at least 80% of<div style="display:inline;"> </div><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and <div style="display:inline;">taxes</div> payable on the income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. </div></div></div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is no assurance that the Company will be able to successfully effect <div style="display:inline;">a </div>Business Combination. Upon the closing of the Initial Public Offering, management has agreed that $10.00 per Unit sold in the Initial Public Offering, including proceeds of the sale of the private placement warrants, will be held in the Trust Account and invested in U.S. government securities, in any open-ended investment company that holds itself out as a money market fund meeting certain conditions of Rule <div style="white-space:nowrap;display:inline;">2a-7</div> of the Investment Company Act, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below. </div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center;text-indent: 0px;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company will provide its shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) without a shareholder vote by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The shareholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account (initially $10.00 per share), calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Trust Account and not previously released to the Company (less taxes payable and up to $100,000 of interest to pay dissolution expenses)</div></div>. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Class A ordinary shares will be recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” If the Company seeks shareholder approval, the Company will complete a Business Combination only if it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the Company’s ordinary shares which are represented in person or by proxy and are voted at a general meeting of the Company. If a shareholder vote is not required under applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased in or after the Initial Public Offering in favor of approving a Business Combination and to waive its redemption rights with respect to any such shares in connection with a shareholder vote to approve a Business Combination. However, in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. In such case, the Company would not proceed with the redemption of its Public Shares and the related Business Combination, and instead may search for an alternate Business Combination. Additionally, each public shareholder may elect to redeem its Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% of the Public Shares without the Company’s prior written consent. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Sponsor and the Company’s officers and directors have agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Completion Window (as defined below) or (ii) with respect to any other provision relating to shareholders’ rights or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-initial</div> business combination activity, unless the Company provides the public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment and (iii) to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has 24 months from the closing of the Initial Public Offering or January 10, 2024, or 27 months from the closing of the Initial Public Offering or April 10, 2024 if the Company has executed a definitive agreement for its initial Business Combination within 24 months from the closing of the Initial Public Offering (the “Completion Window”), to complete a Business Combination. If the Company is unable to complete a Business Combination within the Completion Window, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than 10 business days thereafter, redeem 100% of the outstanding Public Shares, at a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-share</div> price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (less taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject in each case to its obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Sponsor and the Company’s officers and directors have agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Completion Window. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Completion Window. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7) </div></div></div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">held in the Trust Account in the event the Company does not complete a Business Combination within the Completion Window and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a third party for services rendered or products sold to the Company, or by a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.00 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of trust assets, less taxes payable. This liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Liquidity and capital resources </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">As of March 31, 2023, the Company had an unrestricted cash balance of $72,520, cash and investments held in the Trust Account of $767,542,768 and a working capital deficiency of $428,238. The Company’s working capital needs will be satisfied through the funds, held outside of the Trust Account, from the Public Offering. In addition, the Company is permitted to withdraw interest earned on the Trust Account to fund the Company’s working capital requirements (subject to an aggregate maximum release of $3,000,000).<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">As of March 31, 2023, the Company has withdrawn $500,000 from the Trust Account for working capital.<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div>Further, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. Up to $1,500,000 of such loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants. The terms of such loans have not been determined and no written agreements exist with respect to such loans. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or the scheduled liquidation date of January 10, 2024. Over this time period, the Company will be using the funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company is a Special Purpose Acquisition Corporation with a scheduled liquidation date of January 10, 2024. Although the Company plans to complete the transaction before the scheduled liquidation date, there can be no assurance that the Company will be able to consummate a business combination by January 10, 2024. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2014-15,</div> “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that since the mandatory liquidation deadline is less than 12 months away, there is substantial doubt that the Company will operate as a going concern. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after January 10, 2024. Management plans to consummate a Business Combination prior to January 10, 2024, however there can be no assurance that one will be completed. </div> 75000000 0.0001 11.5 10 750000000 11733333 1.5 17600000 42130216 15000000 26250000 880216 750000000 10 P185D 0.80 10 100000 5000001 0.20 1 P24M 2024-01-10 P27M 2024-04-10 P10D 100000 10 10 72520 767542768 428238 3000000 500000 1500000 1.5 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Note <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2-Summary</div> of Significant Accounting Policies </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of presentation </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected through December 31, 2023 or any future periods. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center;text-indent: 0px;"/> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> filed by the Company with the SEC on March 1, 2023. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of estimates </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash equivalents </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. Cash and cash equivalents in the Trust Account are considered to be investments. As of March 31, 2023 and December 31, 2022, cash and cash equivalents consist of cash and money market funds. </div></div></div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation limit of $250,000, and investments held in Trust<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Account. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations and cash flows. </div></div></div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Investment Held in Trust Account </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company’s portfolio of investments is comprised solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company classifies its U.S. Treasury and equivalent securities as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">held-to-maturity</div></div> in accordance with ASC Topic 320 “Investments—Debt and Equity Securities.” <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Held-to-maturity</div></div> securities are those securities which the Company has the ability and intent to hold until maturity. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Held-to-maturity</div></div> treasury securities are recorded at amortized cost on the accompanying balance sheets and adjusted for the amortization or accretion of premiums or discounts. Money market funds are presented at fair value at the end of each reporting period. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Offering costs </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Offering costs consisted of underwriting, legal, accounting and other expenses incurred directly related to the Initial Public Offering. Upon completion of the Initial Public Offering, offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liability were charged to operations. Offering costs allocated to Class A Ordinary Shares were initially charged to temporary equity and then accreted to ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. Offering costs amounted to $42,130,216, of which $42,110,034 was charged to temporary equity upon the completion of the Initial Public Offering and $20,182 was expensed to the <div style="letter-spacing: 0px; top: 0px;;display:inline;">una<div style="letter-spacing: 0px; top: 0px;;display:inline;">ud<div style="letter-spacing: 0px; top: 0px;;display:inline;">ited </div></div></div>condensed statements of operations. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class A Ordinary Shares subject to possible redemption </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its Class A Ordinary Shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Class A Ordinary Shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2023 and December 31, 2022, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ (deficit) section of the Company’s condensed balance sheets. </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of Class A ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital and accumulated deficit. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of March 31, 2023 and December 31, 2022, the Class A ordinary shares reflected on the condensed balance sheets are reconciled in the following table: </div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 83%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Gross proceeds</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;">750,000,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="display:inline;"/></td> <td style="vertical-align: bottom;"><div style="display:inline;"/></td> <td style="vertical-align: bottom;"><div style="display:inline;"/></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value of Public Warrants at issuance</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;">(36,750,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;">) </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary share issuance costs</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;">(42,110,034</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;">) </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Plus:</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="display:inline;"/></td> <td style="vertical-align: bottom;"><div style="display:inline;"/></td> <td style="vertical-align: bottom;"><div style="display:inline;"/></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accretion of carrying value to redemption value</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;">85,722,976</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"><div style="display:inline;"/></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary shares subject to possible redemption, December 31, 2022</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;">756,862,942</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accretion of carrying value to redemption value</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;">8,079,826</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"><div style="display:inline;"/></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary shares subject to possible redemption, March 31, 2023</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;">764,942,768</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"><div style="display:inline;"/></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="display:inline;"> </div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"/> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivative financial instruments </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for derivative financial instruments in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value upon issuance and remeasured at each reporting date, with changes in the fair value reported in the <div style="letter-spacing: 0px; top: 0px;;display:inline;">unaudited </div>condensed statements of operations. The classification of derivative financial instruments is evaluated at the end of each reporting period. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income taxes </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”), which prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">more-likely-than-not</div> to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is currently no taxation imposed on income by the government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair value of financial instruments </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature, except for the warrant liability (see Note 10). </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Warrant liability </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for the private placement warrants as liabilities at fair value on the condensed balance sheets. The private placement warrants are subject to remeasurement at each balance sheet date and any change in fair value is recognized as a component of other income (expense), net on the condensed statements of operations. The Company will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of the private placement warrants. At that time, the portion of the warrant liability related to the private placement warrants will be reclassified to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Net Income Per Ordinary Share </div></div></div></div></div><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has two classes of shares, Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share”. Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. Accretion associated with the redeemable shares of Class A ordinary share is excluded from earnings per share as the redemption value approximates fair value. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The calculation of diluted income per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 36,733,333 Class A ordinary share in the aggregate. As of March 31, 2023 and <div style="letter-spacing: 0px; top: 0px;;display:inline;">March</div> 31, 2022, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary share and then share in the earnings of the Company. As a result, diluted net income per share of ordinary share is the same as basic net income per share of ordinary share for the periods presented.</div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table reflects the calculation of basic and diluted net income<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>per ordinary share for the three months ended March 31, 2023 and 2022: </div></div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:52%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basic and diluted net income (loss) per ordinary</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Numerator:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;">Allocation of net income </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,406,917</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,601,729</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,729,627</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,147,118</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Denominator:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted weighted average shares outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,750,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">67,500,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,750,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Basic and diluted net income per ordinary share</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.09</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.09</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.11</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><span style="-sec-ix-hidden:hidden78885200">0</span>. <span style="-sec-ix-hidden:hidden78885201">11</span></div></div></div></td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair value of financial instruments </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recently issued accounting standards </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements. </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of presentation </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected through December 31, 2023 or any future periods. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center;text-indent: 0px;"/> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> filed by the Company with the SEC on March 1, 2023. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of estimates </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash equivalents </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. Cash and cash equivalents in the Trust Account are considered to be investments. As of March 31, 2023 and December 31, 2022, cash and cash equivalents consist of cash and money market funds. </div></div></div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation limit of $250,000, and investments held in Trust<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Account. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations and cash flows. </div></div></div> 250000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Investment Held in Trust Account </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company’s portfolio of investments is comprised solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company classifies its U.S. Treasury and equivalent securities as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">held-to-maturity</div></div> in accordance with ASC Topic 320 “Investments—Debt and Equity Securities.” <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Held-to-maturity</div></div> securities are those securities which the Company has the ability and intent to hold until maturity. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Held-to-maturity</div></div> treasury securities are recorded at amortized cost on the accompanying balance sheets and adjusted for the amortization or accretion of premiums or discounts. Money market funds are presented at fair value at the end of each reporting period. </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Offering costs </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Offering costs consisted of underwriting, legal, accounting and other expenses incurred directly related to the Initial Public Offering. Upon completion of the Initial Public Offering, offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liability were charged to operations. Offering costs allocated to Class A Ordinary Shares were initially charged to temporary equity and then accreted to ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. Offering costs amounted to $42,130,216, of which $42,110,034 was charged to temporary equity upon the completion of the Initial Public Offering and $20,182 was expensed to the <div style="letter-spacing: 0px; top: 0px;;display:inline;">una<div style="letter-spacing: 0px; top: 0px;;display:inline;">ud<div style="letter-spacing: 0px; top: 0px;;display:inline;">ited </div></div></div>condensed statements of operations. </div> 42130216 42110034 20182 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class A Ordinary Shares subject to possible redemption </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its Class A Ordinary Shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Class A Ordinary Shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2023 and December 31, 2022, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ (deficit) section of the Company’s condensed balance sheets. </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of Class A ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital and accumulated deficit. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of March 31, 2023 and December 31, 2022, the Class A ordinary shares reflected on the condensed balance sheets are reconciled in the following table: </div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 83%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Gross proceeds</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;">750,000,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="display:inline;"/></td> <td style="vertical-align: bottom;"><div style="display:inline;"/></td> <td style="vertical-align: bottom;"><div style="display:inline;"/></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value of Public Warrants at issuance</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;">(36,750,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;">) </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary share issuance costs</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;">(42,110,034</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;">) </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Plus:</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="display:inline;"/></td> <td style="vertical-align: bottom;"><div style="display:inline;"/></td> <td style="vertical-align: bottom;"><div style="display:inline;"/></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accretion of carrying value to redemption value</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;">85,722,976</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"><div style="display:inline;"/></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary shares subject to possible redemption, December 31, 2022</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;">756,862,942</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accretion of carrying value to redemption value</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;">8,079,826</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"><div style="display:inline;"/></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary shares subject to possible redemption, March 31, 2023</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;">764,942,768</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"><div style="display:inline;"/></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="display:inline;"> </div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"/> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of March 31, 2023 and December 31, 2022, the Class A ordinary shares reflected on the condensed balance sheets are reconciled in the following table: </div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 83%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Gross proceeds</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;">750,000,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="display:inline;"/></td> <td style="vertical-align: bottom;"><div style="display:inline;"/></td> <td style="vertical-align: bottom;"><div style="display:inline;"/></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value of Public Warrants at issuance</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;">(36,750,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;">) </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary share issuance costs</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;">(42,110,034</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;">) </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Plus:</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="display:inline;"/></td> <td style="vertical-align: bottom;"><div style="display:inline;"/></td> <td style="vertical-align: bottom;"><div style="display:inline;"/></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accretion of carrying value to redemption value</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;">85,722,976</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"><div style="display:inline;"/></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary shares subject to possible redemption, December 31, 2022</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;">756,862,942</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accretion of carrying value to redemption value</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;">8,079,826</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"><div style="display:inline;"/></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary shares subject to possible redemption, March 31, 2023</div></div></div></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;">764,942,768</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"><div style="display:inline;"/></td> <td style="vertical-align: bottom;"><div style="display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="display:inline;"> </div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"/> 750000000 -36750000 -42110034 85722976 756862942 8079826 764942768 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivative financial instruments </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for derivative financial instruments in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value upon issuance and remeasured at each reporting date, with changes in the fair value reported in the <div style="letter-spacing: 0px; top: 0px;;display:inline;">unaudited </div>condensed statements of operations. The classification of derivative financial instruments is evaluated at the end of each reporting period. </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income taxes </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”), which prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">more-likely-than-not</div> to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is currently no taxation imposed on income by the government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. </div> 0 0 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair value of financial instruments </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature, except for the warrant liability (see Note 10). </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair value of financial instruments </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. </div></div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Warrant liability </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for the private placement warrants as liabilities at fair value on the condensed balance sheets. The private placement warrants are subject to remeasurement at each balance sheet date and any change in fair value is recognized as a component of other income (expense), net on the condensed statements of operations. The Company will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of the private placement warrants. At that time, the portion of the warrant liability related to the private placement warrants will be reclassified to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Net Income Per Ordinary Share </div></div></div></div></div><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has two classes of shares, Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share”. Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. Accretion associated with the redeemable shares of Class A ordinary share is excluded from earnings per share as the redemption value approximates fair value. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The calculation of diluted income per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 36,733,333 Class A ordinary share in the aggregate. As of March 31, 2023 and <div style="letter-spacing: 0px; top: 0px;;display:inline;">March</div> 31, 2022, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary share and then share in the earnings of the Company. As a result, diluted net income per share of ordinary share is the same as basic net income per share of ordinary share for the periods presented.</div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table reflects the calculation of basic and diluted net income<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>per ordinary share for the three months ended March 31, 2023 and 2022: </div></div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:52%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basic and diluted net income (loss) per ordinary</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Numerator:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;">Allocation of net income </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,406,917</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,601,729</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,729,627</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,147,118</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Denominator:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted weighted average shares outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,750,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">67,500,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,750,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Basic and diluted net income per ordinary share</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.09</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.09</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.11</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><span style="-sec-ix-hidden:hidden78885200">0</span>. <span style="-sec-ix-hidden:hidden78885201">11</span></div></div></div></td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> 36733333 As a result, diluted net income per share of ordinary share is the same as basic net income per share of ordinary share for the periods presented.<div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table reflects the calculation of basic and diluted net income<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>per ordinary share for the three months ended March 31, 2023 and 2022: </div></div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:52%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basic and diluted net income (loss) per ordinary</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Numerator:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;">Allocation of net income </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,406,917</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,601,729</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,729,627</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,147,118</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Denominator:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted weighted average shares outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,750,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">67,500,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,750,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Basic and diluted net income per ordinary share</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.09</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.09</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.11</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><span style="-sec-ix-hidden:hidden78885200">0</span>. <span style="-sec-ix-hidden:hidden78885201">11</span></div></div></div></td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> 6406917 1601729 7729627 2147118 75000000 75000000 18750000 18750000 67500000 67500000 18750000 18750000 0.09 0.09 0.09 0.09 0.11 0.11 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recently issued accounting standards </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;">Note <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">3-Initial</div> Public Offering </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company consummated the Initial Public Offering of 75,000,000 units at $10.00 per unit. Each unit consisted of one Class A ordinary share and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-third</div> of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitled the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 9). </div> 75000000 10 11.5 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;">Note <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">4-Private</div> Placement </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Sponsor purchased an aggregate of 11,733,333 private placement warrants at a price of $1.50 per private placement warrant, for an aggregate purchase price of $17,600,000, from the Company in a private placement that closed simultaneously with the closing of the Initial Public Offering. Each private placement warrant entitles the holder to purchase one Class A ordinary share at $11.50 per share, subject to adjustment (see Note 9). The proceeds from the sale of the private placement warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Completion Window, the proceeds from the sale of the private placement warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the private placement warrants will expire worthless. </div></div> 11733333 1.5 17600000 11.5 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;">Note <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">5-Related</div> Party Transactions </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Founder Shares </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On November 5, 2021, the Sponsor paid an aggregate of $25,000 to cover certain offering and formation costs of the Company in consideration for 17,250,000 of the Company’s Class B ordinary shares (the “Founder Shares”). On December 13, 2021, the Company effected a share recapitalization with respect to the Class B ordinary shares whereby the Company issued one and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-quarter</div> Class B ordinary shares in respect of each outstanding Class B ordinary share, resulting in the Sponsor owning 21,562,500 Founder Shares. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Founder Shares include an aggregate of up to 2,812,500 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the number of Founder Shares will collectively represent 20% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering. On February 19, 2022, 2,812,500 Founder Shares were forfeited because the underwriters did not exercise their over-allotment option, resulting in the Company’s Sponsor holding 18,750,000 Founder Shares. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of (A) one year after the completion of a Business Combination; and (B) subsequent to a Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sub-divisions,</div> share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period, provided such release shall not occur earlier than 180 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Promissory Note </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On November 5, 2021, the Company issued the promissory note to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000 (the “Promissory Note”). The Promissory Note is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-interest</div> bearing and payable on the earlier of (i) December 31, 2022 or (ii) the completion of the Initial Public Offering. As of December 31, 2021, there was $300,000 outstanding under the Promissory Note. On January 11, 2022, the amount outstanding under the Promissory Note was repaid in full, and borrowings under the Promissory Note are no longer available. </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Due to Sponsor </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2021, the amount due to Sponsor was $14,537. The amounts were unpaid reimbursements of offering costs paid by the Sponsor on behalf of the Company. On January 11, 2022, the amount outstanding due to Sponsor was repaid in full. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Administrative Services Agreement </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Commencing on the effective date of the Initial Public Offering, the Company entered into an agreement pursuant to which it will pay an affiliate of the Sponsor $15,000 per month for office space, utilities, secretarial and administrative support services. Upon completion of a Business Combination or its liquidation, the Company will cease paying these monthly fees. During the three months ended March 31, 2023 and 2022, the Company incurred $45,000 and $45,000, respectively, in expenses for services provided by the Sponsor in connection with the aforementioned agreement. As of March 31, 2023 and December 31, 2022, $45,000 and $45,000 is included in accounts payable and accrued expenses in the accompanying condensed balance sheets. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, the Company has agreed that it will indemnify the Sponsor from any claims arising out of or relating to this offering or the Company’s operations or conduct of the Company’s business or any claim against the Sponsor alleging any expressed or implied management or endorsement by the Sponsor of any of the Company’s activities or any express or implied association between the Sponsor and the Company or any of its affiliates, which agreement will provide that the indemnified parties cannot access the funds held in the Trust Account. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Related Party Loans </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, such loans may be converted upon completion of a Business Combination into warrants of the post Business Combination entity at a price of $1.50 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. There have been no borrowings under this arrangement to date. </div></div> 25000 17250000 21562500 2812500 0.20 18750000 P1Y 12 P20D P30D P180D 300000 300000 14537 15000 45000 45000 45000 45000 1.5 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;">Note <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">6-Trust</div> Account </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A total of $750,000,000, which includes $735,000,000 of the net proceeds from the Public Offering and $15,000,000 from the sale of the private placement warrants, has been placed in the Trust Account. </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">As of March 31, 2023, investment securities in the Company’s Trust Account consisted of $767,542,768 in money market fund. As of December 31, 2022, investment securities in the Company’s Trust Account consisted of $759,271,905 in United States Treasury Bills and $441,037 held in money market fund. The Company classifies its Treasury Instruments and equivalent securities as held to maturity in accordance with FASB ASC 320, “Investments-Debt and Equity Securities”. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Held-to-maturity</div></div> securities are those securities which the Company has the ability and intent to hold until maturity. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Held-to-maturity</div></div> treasury securities are recorded at amortized cost on the accompanying balance sheets and adjusted for the amortization or accretion of premiums or discounts. The following table presents fair value information as of March 31, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. In addition, the table presents the carrying value (held to maturity), excluding accrued interest income and gross unrealized holding loss. Since all of the Company’s permitted investments consist of U.S. government treasury bills and cash, fair values of its investments are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active markets for identical assets as follows: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 61%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortized<br/> Cost</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross<br/> Holding<br/> Gain</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted Prices<br/> in<br/> Active Markets<br/> (Level 1)</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">U.S. Government Treasury Securities as of December 31, 2022 </div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 759,271,905</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 161,421</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 759,433,326</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Money market fund as of December 31, 2022</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">441,037</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Money market fund as of March 31, 2023</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">767,542,768</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. There were no transfers between levels for the three months ended March 31, 2023 and March 31, 2022. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 1 instruments consist of investments in U.S. Treasury securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. </div></div> 750000000 735000000 15000000 767542768 759271905 441037 Since all of the Company’s permitted investments consist of U.S. government treasury bills and cash, fair values of its investments are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active markets for identical assets as follows: <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 61%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortized<br/> Cost</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross<br/> Holding<br/> Gain</div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted Prices<br/> in<br/> Active Markets<br/> (Level 1)</div></div></td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">U.S. Government Treasury Securities as of December 31, 2022 </div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 759,271,905</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 161,421</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 759,433,326</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Money market fund as of December 31, 2022</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">441,037</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Money market fund as of March 31, 2023</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">767,542,768</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> 759271905 161421 759433326 441037 767542768 0 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;">Note <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">7-Commitments</div> and Contingencies </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Registration Rights </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The holders of the Founder Shares, private placement warrants and warrants that may be issued upon conversion of the Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the private placement warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) w<div style="display:inline;">ould</div> be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Initial Public Offering requiring the Company to register a sale of any of the securities held by them, including any other securities of the Company acquired by them prior to the consummation of the Company’s initial Business Combination. The holders of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Risks and Uncertainties </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In February 2022, the Russian </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> Federation and Belarus commenced a military action within the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these condensed financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these <div style="display:inline;">unaudited </div>condensed financial statements. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Underwriting Agreement </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company had granted the underwriters a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">45-day</div> option to purchase up to 11,250,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. On February 19, 2022, the option lapsed because the underwriters did not exercise their over-allotment option. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">In addition, the underwriters are entitled to a deferred fee of $0.35 per Unit, or $26,250,000 <div style="letter-spacing: 0px; top: 0px;;display:inline;">in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. </div> </div></div> P45D 11250000 0.35 26250000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;">Note <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-Shareholders’</div> Equity (Deficit) </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Preference Shares</div></div></div></div>-The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share. The Company’s board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. The board of directors will be able to, without shareholder approval, issue preference shares with voting and other rights that could adversely affect the voting power and other rights of the holders of the ordinary shares and could have anti-takeover effects. At March 31, 2023 and December 31, 2022, there were no preference shares issued or outstanding. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> A Ordinary Shares</div></div></div></div>-The Company is authorized to issue 400,000,000 Class A ordinary shares, with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. At March 31, 2023 and December 31, 2022, there were 75,000,000 Class A ordinary shares issued and outstanding subject to possible redemption. At March 31, 2023 and December 31, 2022, there were no Class A ordinary shares issued or outstanding. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> B Ordinary Shares</div></div></div></div>-The Company is authorized to issue 80,000,000 Founder Shares, with a par value of $0.0001 per share. Holders of the Founder Shares are entitled to one vote for each share. On November 5, 2021, the Sponsor paid an aggregate of $25,000 to cover certain offering and formation costs of the Company in consideration for 17,250,000 of the Company’s Class B ordinary shares (the “Founder Shares”). On December 13, 2021, the Company effected a share recapitalization with respect to the Founder Shares whereby the Company issued one and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-quarter</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/> Founder Shares in respect of each outstanding Founder Share, resulting in the Sponsor owning 21,562,500 Founder Shares. The Founder Shares included an aggregate of up to 2,812,500 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the number of Founder Shares would collectively represent 20% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering. On February 19, 2022, 2,812,500 Founder Shares were forfeited because the underwriters did not exercise their over-allotment option, resulting in the Sponsor holding 18,750,000 Founder Shares. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Holders of the Founder Shares will be entitled to vote on the appointment and removal of directors or continuing the Company in a jurisdiction outside the Cayman Islands (including any special resolution required to amend the constitutional documents of the Company or to adopt new constitutional documents of the Company, in each case, as a result of the Company approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands). On any other matter submitted to a vote of the shareholders prior to or in connection with the completion of the initial Business Combination, holders of the Founder Shares and holders of the Class A ordinary shares will vote together as a single class, except as required by law. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Founder Shares will automatically convert into Class A ordinary shares concurrently with or immediately following the completion of a Business Combination on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis, subject to adjustment. In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with a Business Combination, the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the total number of Class A ordinary shares outstanding after such conversion (after giving effect to any redemptions of Class A ordinary shares by public shareholders), including the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of a Business Combination, excluding any Class A ordinary shares or equity- linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in a Business Combination and any private placement warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis. </div> 1000000 0.0001 0 0 0 0 400000000 0.0001 one vote 75000000 75000000 0 0 0 0 80000000 0.0001 one vote 25000 17250000 17250000 one and one-quarter 21562500 2812500 0.20 2812500 18750000 0.20 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;">Note <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">9-Warrants</div> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of March 31, 2023 and December 31, 2022, the Company has 25,000,000 Public Warrants and 11,733,333 private placement warrants outstanding. The Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination. The Public Warrants will expire five years from the completion of a Business Combination, or earlier upon redemption or liquidation. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue a Class A ordinary share upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement of which the Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> forms a part or a new registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of the Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company elects to do so, the Company will not be required to file or maintain in effect a registration statement, but it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(2)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at a price of $0.01 per Public Warrant; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(3)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">upon not less than 30 days’ prior written notice of redemption to each warrant holder; and </div></div></td></tr></table><div style="clear: both; max-height: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(4)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">if, and only if, the reported closing price of the ordinary shares equals or exceeds $18.00 per share (as adjusted for share <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sub-divisions,</div> share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period ending three business days before the Company send to the notice of redemption to the warrant holders. </div></td></tr></table><div style="clear: both; max-height: 0px;"/><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Completion Window and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The private placement warrants will be identical to the public warrants underlying the Units being sold in the Initial Public Offering, except that (i) the private placement warrants will not be redeemable by the Company, (ii) the private placement warrants and the Class A ordinary shares issuable upon the exercise of the private placement warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (iii) the private placement warrants will be exercisable on a cashless basis, (iv) will use a different Black-Scholes Warrant Model for purposes of calculating the Black-Scholes Warrant Value (as defined in the Warrant Agreement) and (v) the private placement warrants and the Class A ordinary shares issuable upon exercise of the private placement warrants will be entitled to registration rights. If the private placement warrants are held by someone other than the initial purchasers or their permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. </div></div> 25000000 11733333 P20D 0.0001 P30D 18 P20D P30D P30D <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;">Note <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Recurring</div> Fair Value Measurements </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of March 31, 2023, investment securities in the Company’s Trust Account consisted of $767,542,768 in money market fund. As of December 31, 2022, investment securities in the Company’s Trust Account consisted of $759,271,905 in United States Treasury Bills and $441,037 held in money market fund. See Note 6 for fair value information for the Trust Account. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of private placement warrants was initially and subsequently measured at fair value using a Black-Scholes Option Pricing Model. For the three months ended March 31, 2023 and 2022, the Company recognized a gain resulting from a decrease in the fair value of the private placement warrants of $469,333 and $10,208,000, respectively, presented as change in fair value of warrant liability in the accompanying <div style="display:inline;">unaudited </div>condensed statements of operations. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table sets forth by level within the fair value hierarchy the Company’s liability that was accounted for at fair value on a recurring basis: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 70%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Level 1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Level 2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Level 3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Private placement warrants as of March 31, 2023</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,816,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Private placement warrants as of December 31, 2022</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,285,333</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"/> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr> <td style="width:75%"> </td> <td style="vertical-align:bottom;width:9%"> </td> <td> </td> <td> </td> <td> </td> <td style="vertical-align:bottom;width:8%"> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="font-weight:bold;display:inline;">March 31,<br/> 2023</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ordinary share price</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.16</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.94</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise price</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.50</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.50</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">31.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Term</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.51</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.75</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.59</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.98</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Probability of completing Business Combination<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">Estimates of 11% and 9% based on public trading of <div style="letter-spacing: 0px; top: 0px;;display:inline;">rights </div>for SPACs and their implied business combination probabilities as of March 31, 2023 and December 31, 2022, respectively.  </div></div></td></tr></table> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The change in the fair value of the warrant liabilities for the three months ended March 31, 2023 and 2022 is summarized as follows: </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 83%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td colspan="4" style="vertical-align: top; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3 Derivative warrant liability at December 31, 2022</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,285,333</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value of derivative warrant liability</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(469,333</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3 Derivative warrant liability at March 31, 2023</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,816,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0pt; background-color: rgba(255, 255, 255, 0); line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 0pt; font-size: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 0pt; font-size: 0pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; line-height: 0pt;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 0pt; font-size: 0pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; line-height: 0pt;;display:inline;"> </div></div></div> </td> <td style="background-color: rgba(255, 255, 255, 0); line-height: 0pt; font-size: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0px; margin-bottom: 0px; margin-left: 1em; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3 Derivative warrant liability at December 31, 2021</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance of Private Warrants on January 10, 2022</div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">17,482,666</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value of derivative warrant liability</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">(10,208,000</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Level 3 Derivative warrant liability at March 31, 2022</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">7,274,666</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> </tr> </table> 767542768 759271905 441037 469333 10208000 <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table sets forth by level within the fair value hierarchy the Company’s liability that was accounted for at fair value on a recurring basis: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 70%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Level 1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Level 2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Level 3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Private placement warrants as of March 31, 2023</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,816,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Private placement warrants as of December 31, 2022</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,285,333</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr></table> 2816000 3285333 <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"/> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr> <td style="width:75%"> </td> <td style="vertical-align:bottom;width:9%"> </td> <td> </td> <td> </td> <td> </td> <td style="vertical-align:bottom;width:8%"> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="font-weight:bold;display:inline;">March 31,<br/> 2023</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ordinary share price</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.16</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.94</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise price</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.50</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.50</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">31.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Term</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.51</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.75</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.59</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.98</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Probability of completing Business Combination<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">Estimates of 11% and 9% based on public trading of <div style="letter-spacing: 0px; top: 0px;;display:inline;">rights </div>for SPACs and their implied business combination probabilities as of March 31, 2023 and December 31, 2022, respectively.  </div></div></td></tr></table> 10.16 9.94 11.5 11.5 19.5 31 5.51 5.75 3.59 3.98 0 0 11 9 11 9 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The change in the fair value of the warrant liabilities for the three months ended March 31, 2023 and 2022 is summarized as follows: </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 83%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td colspan="4" style="vertical-align: top; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3 Derivative warrant liability at December 31, 2022</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,285,333</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value of derivative warrant liability</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(469,333</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3 Derivative warrant liability at March 31, 2023</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,816,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0pt; background-color: rgba(255, 255, 255, 0); line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 0pt; font-size: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 0pt; font-size: 0pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; line-height: 0pt;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 0pt; font-size: 0pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; line-height: 0pt;;display:inline;"> </div></div></div> </td> <td style="background-color: rgba(255, 255, 255, 0); line-height: 0pt; font-size: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0px; margin-bottom: 0px; margin-left: 1em; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3 Derivative warrant liability at December 31, 2021</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance of Private Warrants on January 10, 2022</div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">17,482,666</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value of derivative warrant liability</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">(10,208,000</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Level 3 Derivative warrant liability at March 31, 2022</div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">7,274,666</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> </tr> </table> 3285333 -469333 2816000 0 17482666 -10208000 7274666 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Note <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">11-Subsequent</div> Events </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to, the date that these condensed financial statements were available to be issued. Based upon this review, other than as noted below, the Company did not identify any subsequent events, that have occurred that would require adjustments to the disclosures in the financial statements. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Subsequent to March 31, 2023, the Company withdrew $250,000 of interest earned on the Trust Account for working capital. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> 250000 Retroactively adjusted for the three months ended March 31, 2022 to reflect the surrender of 2,812,500 Class B ordinary shares for no consideration on February 19, 2022 (see Note 5). Reflects the surrender of 2,812,500 Class B ordinary shares for no consideration on February 19, 2022 (see Note 5). Estimates of 11% and 9% based on public trading of rights for SPACs and their implied business combination probabilities as of March 31, 2023 and December 31, 2022, respectively. EXCEL 53 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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c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end XML 54 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 55 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 56 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 125 202 1 true 39 0 false 8 false false R1.htm 1001 - Document - Cover Page Sheet http://www.screamingeagleacquisitioncorp.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Condensed Balance Sheets Sheet http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets Condensed Balance Sheets Statements 2 false false R3.htm 1003 - Statement - Condensed Balance Sheets (Parenthetical) Sheet http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheetsParenthetical Condensed Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Condensed Statements Of Operations Sheet http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations Condensed Statements Of Operations Statements 4 false false R5.htm 1005 - Statement - Condensed Statements Of Operations (Parenthetical) Sheet http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperationsParenthetical Condensed Statements Of Operations (Parenthetical) Statements 5 false false R6.htm 1006 - Statement - Condensed Statements Of Changes In Shareholders' Equity (Deficit) Sheet http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficit Condensed Statements Of Changes In Shareholders' Equity (Deficit) Statements 6 false false R7.htm 1007 - Statement - Condensed Statements Of Changes In Shareholders' Equity (Deficit) (Parenthetical) Sheet http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficitParenthetical Condensed Statements Of Changes In Shareholders' Equity (Deficit) (Parenthetical) Statements 7 false false R8.htm 1008 - Statement - Condensed Statements of Cash Flow Sheet http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow Condensed Statements of Cash Flow Statements 8 false false R9.htm 1009 - Disclosure - Organization and Plan of Business Operations Sheet http://www.screamingeagleacquisitioncorp.com/role/OrganizationAndPlanOfBusinessOperations Organization and Plan of Business Operations Notes 9 false false R10.htm 1010 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 1011 - Disclosure - Initial Public Offering Sheet http://www.screamingeagleacquisitioncorp.com/role/InitialPublicOffering Initial Public Offering Notes 11 false false R12.htm 1012 - Disclosure - Private Placement Sheet http://www.screamingeagleacquisitioncorp.com/role/PrivatePlacement Private Placement Notes 12 false false R13.htm 1013 - Disclosure - Related Party Transactions Sheet http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactions Related Party Transactions Notes 13 false false R14.htm 1014 - Disclosure - Trust Account Sheet http://www.screamingeagleacquisitioncorp.com/role/TrustAccount Trust Account Notes 14 false false R15.htm 1015 - Disclosure - Commitments and Contingencies Sheet http://www.screamingeagleacquisitioncorp.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 1016 - Disclosure - Shareholders' Equity (Deficit) Sheet http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficit Shareholders' Equity (Deficit) Notes 16 false false R17.htm 1017 - Disclosure - Warrants Sheet http://www.screamingeagleacquisitioncorp.com/role/Warrants Warrants Notes 17 false false R18.htm 1018 - Disclosure - Recurring Fair Value Measurements Sheet http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurements Recurring Fair Value Measurements Notes 18 false false R19.htm 1019 - Disclosure - Subsequent Events Sheet http://www.screamingeagleacquisitioncorp.com/role/SubsequentEvents Subsequent Events Notes 19 false false R20.htm 1020 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPolicies 20 false false R21.htm 1021 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPolicies 21 false false R22.htm 1022 - Disclosure - Trust Account (Tables) Sheet http://www.screamingeagleacquisitioncorp.com/role/TrustAccountTables Trust Account (Tables) Tables http://www.screamingeagleacquisitioncorp.com/role/TrustAccount 22 false false R23.htm 1023 - Disclosure - Recurring Fair Value Measurements (Tables) Sheet http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsTables Recurring Fair Value Measurements (Tables) Tables http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurements 23 false false R24.htm 1024 - Disclosure - Organization Consolidation And Presentation Of Financial Statements (Detail) Sheet http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail Organization Consolidation And Presentation Of Financial Statements (Detail) Details 24 false false R25.htm 1025 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail Summary of Significant Accounting Policies - Additional Information (Detail) Details 25 false false R26.htm 1026 - Disclosure - Summary of Significant Accounting Policies - Summary of Reconciliation of Proceeds from Temporary Equity to Outstanding Value (Detail) Sheet http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfProceedsFromTemporaryEquityToOutstandingValueDetail Summary of Significant Accounting Policies - Summary of Reconciliation of Proceeds from Temporary Equity to Outstanding Value (Detail) Details 26 false false R27.htm 1027 - Disclosure - Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Detail) Sheet http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Detail) Details 27 false false R28.htm 1028 - Disclosure - Initial Public Offering - Additional Information (Detail) Sheet http://www.screamingeagleacquisitioncorp.com/role/InitialPublicOfferingAdditionalInformationDetail Initial Public Offering - Additional Information (Detail) Details 28 false false R29.htm 1029 - Disclosure - Private Placement - Additional Information (Detail) Sheet http://www.screamingeagleacquisitioncorp.com/role/PrivatePlacementAdditionalInformationDetail Private Placement - Additional Information (Detail) Details 29 false false R30.htm 1030 - Disclosure - Related Party Transactions - Additional Information (Detail) Sheet http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail Related Party Transactions - Additional Information (Detail) Details 30 false false R31.htm 1031 - Disclosure - Trust Account - Additional Information (Detail) Sheet http://www.screamingeagleacquisitioncorp.com/role/TrustAccountAdditionalInformationDetail Trust Account - Additional Information (Detail) Details 31 false false R32.htm 1032 - Disclosure - Trust Account - Summary of Available-for-sale Securities Reconciliation (Detail) Sheet http://www.screamingeagleacquisitioncorp.com/role/TrustAccountSummaryOfAvailableForSaleSecuritiesReconciliationDetail Trust Account - Summary of Available-for-sale Securities Reconciliation (Detail) Details 32 false false R33.htm 1033 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.screamingeagleacquisitioncorp.com/role/CommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 33 false false R34.htm 1034 - Disclosure - Shareholders' Equity (Deficit) - Additional Information (Detail) Sheet http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail Shareholders' Equity (Deficit) - Additional Information (Detail) Details http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficit 34 false false R35.htm 1035 - Disclosure - Warrants - Additional Information (Detail) Sheet http://www.screamingeagleacquisitioncorp.com/role/WarrantsAdditionalInformationDetail Warrants - Additional Information (Detail) Details 35 false false R36.htm 1036 - Disclosure - Recurring Fair Value Measurements - Additional Information (Detail) Sheet http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsAdditionalInformationDetail Recurring Fair Value Measurements - Additional Information (Detail) Details 36 false false R37.htm 1037 - Disclosure - Recurring Fair Value Measurements - Schedule of Fair Value Hierarchy the Company's Liabilities that were Accounted for at Fair Value on a Recurring Basis (Detail) Sheet http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsScheduleOfFairValueHierarchyTheCompanySLiabilitiesThatWereAccountedForAtFairValueOnARecurringBasisDetail Recurring Fair Value Measurements - Schedule of Fair Value Hierarchy the Company's Liabilities that were Accounted for at Fair Value on a Recurring Basis (Detail) Details 37 false false R38.htm 1038 - Disclosure - Recurring Fair Value Measurements - Summary of quantitative information regarding Level 3 fair value measurements inputs as their measurement dates (Detail) Sheet http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesDetail Recurring Fair Value Measurements - Summary of quantitative information regarding Level 3 fair value measurements inputs as their measurement dates (Detail) Details 38 false false R39.htm 1039 - Disclosure - Recurring Fair Value Measurements - Summary of quantitative information regarding Level 3 fair value measurements inputs as their measurement dates (Parenthetical) (Detail) Sheet http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesParentheticalDetail Recurring Fair Value Measurements - Summary of quantitative information regarding Level 3 fair value measurements inputs as their measurement dates (Parenthetical) (Detail) Details 39 false false R40.htm 1040 - Disclosure - Recurring Fair Value Measurements - Summary of The change in the fair value of the warrant liabilities (Detail) Sheet http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfTheChangeInTheFairValueOfTheWarrantLiabilitiesDetail Recurring Fair Value Measurements - Summary of The change in the fair value of the warrant liabilities (Detail) Details 40 false false R41.htm 1041 - Disclosure - Subsequent Events - Additional Information (Detail) Sheet http://www.screamingeagleacquisitioncorp.com/role/SubsequentEventsAdditionalInformationDetail Subsequent Events - Additional Information (Detail) Details 41 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept NotesPayableRelatedPartiesClassifiedCurrent in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d457148d10q.htm 2147 [dq-0542-Deprecated-Concept] Concept DueToAffiliateCurrent in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d457148d10q.htm 2147 [dq-0542-Deprecated-Concept] Concept RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d457148d10q.htm 2147 [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:EarningsPerShareBasic - d457148d10q.htm 316 d457148d10q.htm d457148dex311.htm d457148dex312.htm d457148dex321.htm d457148dex322.htm scrm-20230331.xsd scrm-20230331_cal.xml scrm-20230331_def.xml scrm-20230331_lab.xml scrm-20230331_pre.xml http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 59 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d457148d10q.htm": { "axisCustom": 3, "axisStandard": 12, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 300, "http://xbrl.sec.gov/dei/2022": 36 }, "contextCount": 125, "dts": { "calculationLink": { "local": [ "scrm-20230331_cal.xml" ] }, "definitionLink": { "local": [ "scrm-20230331_def.xml" ] }, "inline": { "local": [ "d457148d10q.htm" ] }, "labelLink": { "local": [ "scrm-20230331_lab.xml" ] }, "presentationLink": { "local": [ "scrm-20230331_pre.xml" ] }, "schema": { "local": [ "scrm-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 339, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 2, "http://xbrl.sec.gov/dei/2022": 5, "total": 7 }, "keyCustom": 63, "keyStandard": 139, "memberCustom": 16, "memberStandard": 22, "nsprefix": "scrm", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "menuCat": "Cover", "order": "1", "role": "http://www.screamingeagleacquisitioncorp.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1010 - Disclosure - Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "10", "role": "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "scrm:InitialPublicOfferTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1011 - Disclosure - Initial Public Offering", "menuCat": "Notes", "order": "11", "role": "http://www.screamingeagleacquisitioncorp.com/role/InitialPublicOffering", "shortName": "Initial Public Offering", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "scrm:InitialPublicOfferTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "scrm:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1012 - Disclosure - Private Placement", "menuCat": "Notes", "order": "12", "role": "http://www.screamingeagleacquisitioncorp.com/role/PrivatePlacement", "shortName": "Private Placement", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "scrm:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1013 - Disclosure - Related Party Transactions", "menuCat": "Notes", "order": "13", "role": "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "scrm:TrustAccountTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1014 - Disclosure - Trust Account", "menuCat": "Notes", "order": "14", "role": "http://www.screamingeagleacquisitioncorp.com/role/TrustAccount", "shortName": "Trust Account", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "scrm:TrustAccountTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1015 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "15", "role": "http://www.screamingeagleacquisitioncorp.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1016 - Disclosure - Shareholders' Equity (Deficit)", "menuCat": "Notes", "order": "16", "role": "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficit", "shortName": "Shareholders' Equity (Deficit)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "scrm:WarrantsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1017 - Disclosure - Warrants", "menuCat": "Notes", "order": "17", "role": "http://www.screamingeagleacquisitioncorp.com/role/Warrants", "shortName": "Warrants", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "scrm:WarrantsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1018 - Disclosure - Recurring Fair Value Measurements", "menuCat": "Notes", "order": "18", "role": "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurements", "shortName": "Recurring Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1019 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "19", "role": "http://www.screamingeagleacquisitioncorp.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - Condensed Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets", "shortName": "Condensed Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "lang": null, "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1020 - Disclosure - Summary of Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "20", "role": "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "scrm:OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "scrm:DisclosureInTabularFormOfReconciliationOfProceedsFromTemporaryEquityToOutstandingValueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1021 - Disclosure - Summary of Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "21", "role": "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "scrm:OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "scrm:DisclosureInTabularFormOfReconciliationOfProceedsFromTemporaryEquityToOutstandingValueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1022 - Disclosure - Trust Account (Tables)", "menuCat": "Tables", "order": "22", "role": "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountTables", "shortName": "Trust Account (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1023 - Disclosure - Recurring Fair Value Measurements (Tables)", "menuCat": "Tables", "order": "23", "role": "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsTables", "shortName": "Recurring Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1024 - Disclosure - Organization Consolidation And Presentation Of Financial Statements (Detail)", "menuCat": "Details", "order": "24", "role": "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "shortName": "Organization Consolidation And Presentation Of Financial Statements (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:NatureOfOperations", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "lang": null, "name": "scrm:DeferredUnderwritingCommissionNonCurrent.", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "us-gaap:IncomeTaxPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1025 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)", "menuCat": "Details", "order": "25", "role": "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:IncomeTaxPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "scrm:DisclosureInTabularFormOfReconciliationOfProceedsFromTemporaryEquityToOutstandingValueTableTextBlock", "scrm:OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "scrm:CumulativeGrossProceedsFromTemporaryEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1026 - Disclosure - Summary of Significant Accounting Policies - Summary of Reconciliation of Proceeds from Temporary Equity to Outstanding Value (Detail)", "menuCat": "Details", "order": "26", "role": "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfProceedsFromTemporaryEquityToOutstandingValueDetail", "shortName": "Summary of Significant Accounting Policies - Summary of Reconciliation of Proceeds from Temporary Equity to Outstanding Value (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "scrm:DisclosureInTabularFormOfReconciliationOfProceedsFromTemporaryEquityToOutstandingValueTableTextBlock", "scrm:OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "scrm:CumulativeGrossProceedsFromTemporaryEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1027 - Disclosure - Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Detail)", "menuCat": "Details", "order": "27", "role": "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail", "shortName": "Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding", "td", "tr", "table", "ix:continuation", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_NonRedeemableCommonStockMemberSCRMClassificationOfCommonStockBasedOnRedeemabilityAxis", "decimals": "0", "lang": null, "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "us-gaap:NatureOfOperations", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_10_2022To01_10_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1028 - Disclosure - Initial Public Offering - Additional Information (Detail)", "menuCat": "Details", "order": "28", "role": "http://www.screamingeagleacquisitioncorp.com/role/InitialPublicOfferingAdditionalInformationDetail", "shortName": "Initial Public Offering - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "scrm:InitialPublicOfferTextBlock", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn01_10_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "INF", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfWarrants", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1029 - Disclosure - Private Placement - Additional Information (Detail)", "menuCat": "Details", "order": "29", "role": "http://www.screamingeagleacquisitioncorp.com/role/PrivatePlacementAdditionalInformationDetail", "shortName": "Private Placement - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": null }, "R3": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:TemporaryEquitySharesOutstanding", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - Condensed Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheetsParenthetical", "shortName": "Condensed Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockSharesOutstanding", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1030 - Disclosure - Related Party Transactions - Additional Information (Detail)", "menuCat": "Details", "order": "30", "role": "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "shortName": "Related Party Transactions - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn12_31_2021", "decimals": "0", "lang": null, "name": "us-gaap:NotesPayableRelatedPartiesClassifiedCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "div", "scrm:TrustAccountTextBlock", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOrSaleOfEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1031 - Disclosure - Trust Account - Additional Information (Detail)", "menuCat": "Details", "order": "31", "role": "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountAdditionalInformationDetail", "shortName": "Trust Account - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "scrm:TrustAccountTextBlock", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOrSaleOfEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_U.s.GovernmentTreasurySecuritiesMemberusgaapFinancialInstrumentAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtSecuritiesHeldToMaturityExcludingAccruedInterestBeforeAllowanceForCreditLossCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1032 - Disclosure - Trust Account - Summary of Available-for-sale Securities Reconciliation (Detail)", "menuCat": "Details", "order": "32", "role": "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountSummaryOfAvailableForSaleSecuritiesReconciliationDetail", "shortName": "Trust Account - Summary of Available-for-sale Securities Reconciliation (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_U.s.GovernmentTreasurySecuritiesMemberusgaapFinancialInstrumentAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtSecuritiesHeldToMaturityExcludingAccruedInterestBeforeAllowanceForCreditLossCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "2", "first": true, "lang": null, "name": "scrm:DeferredUnderwritingCommissionPerUnit", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1033 - Disclosure - Commitments and Contingencies - Additional Information (Detail)", "menuCat": "Details", "order": "33", "role": "http://www.screamingeagleacquisitioncorp.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "shortName": "Commitments and Contingencies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "2", "first": true, "lang": null, "name": "scrm:DeferredUnderwritingCommissionPerUnit", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1034 - Disclosure - Shareholders' Equity (Deficit) - Additional Information (Detail)", "menuCat": "Details", "order": "34", "role": "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail", "shortName": "Shareholders' Equity (Deficit) - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023_FounderSharesMemberusgaapStatementEquityComponentsAxis", "decimals": null, "lang": "en-US", "name": "us-gaap:CommonStockConversionBasis", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "scrm:MinimumLockInPeriodforTransferAssignOrSellWarrantsAfterCompletionOfIpo", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1035 - Disclosure - Warrants - Additional Information (Detail)", "menuCat": "Details", "order": "35", "role": "http://www.screamingeagleacquisitioncorp.com/role/WarrantsAdditionalInformationDetail", "shortName": "Warrants - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "scrm:MinimumLockInPeriodforTransferAssignOrSellWarrantsAfterCompletionOfIpo", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1036 - Disclosure - Recurring Fair Value Measurements - Additional Information (Detail)", "menuCat": "Details", "order": "36", "role": "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsAdditionalInformationDetail", "shortName": "Recurring Fair Value Measurements - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "0", "lang": null, "name": "us-gaap:FairValueAdjustmentOfWarrants", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn03_31_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1037 - Disclosure - Recurring Fair Value Measurements - Schedule of Fair Value Hierarchy the Company's Liabilities that were Accounted for at Fair Value on a Recurring Basis (Detail)", "menuCat": "Details", "order": "37", "role": "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsScheduleOfFairValueHierarchyTheCompanySLiabilitiesThatWereAccountedForAtFairValueOnARecurringBasisDetail", "shortName": "Recurring Fair Value Measurements - Schedule of Fair Value Hierarchy the Company's Liabilities that were Accounted for at Fair Value on a Recurring Basis (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn03_31_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn03_31_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1038 - Disclosure - Recurring Fair Value Measurements - Summary of quantitative information regarding Level 3 fair value measurements inputs as their measurement dates (Detail)", "menuCat": "Details", "order": "38", "role": "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesDetail", "shortName": "Recurring Fair Value Measurements - Summary of quantitative information regarding Level 3 fair value measurements inputs as their measurement dates (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn03_31_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn03_31_2023_MeasurementInputProbabilityRateMemberusgaapMeasurementInputTypeAxis_SpacMarketDataPublishedByThirdPartyMemberSCRMBasisOfMeasurementInputAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1039 - Disclosure - Recurring Fair Value Measurements - Summary of quantitative information regarding Level 3 fair value measurements inputs as their measurement dates (Parenthetical) (Detail)", "menuCat": "Details", "order": "39", "role": "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesParentheticalDetail", "shortName": "Recurring Fair Value Measurements - Summary of quantitative information regarding Level 3 fair value measurements inputs as their measurement dates (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn03_31_2023_MeasurementInputProbabilityRateMemberusgaapMeasurementInputTypeAxis_SpacMarketDataPublishedByThirdPartyMemberSCRMBasisOfMeasurementInputAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingExpenses", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - Condensed Statements Of Operations", "menuCat": "Statements", "order": "4", "role": "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations", "shortName": "Condensed Statements Of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "0", "lang": null, "name": "us-gaap:OperatingIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_WarrantLiabilityMemberusgaapFinancialInstrumentAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1040 - Disclosure - Recurring Fair Value Measurements - Summary of The change in the fair value of the warrant liabilities (Detail)", "menuCat": "Details", "order": "40", "role": "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfTheChangeInTheFairValueOfTheWarrantLiabilitiesDetail", "shortName": "Recurring Fair Value Measurements - Summary of The change in the fair value of the warrant liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_WarrantLiabilityMemberusgaapFinancialInstrumentAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "div", "div", "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "scrm:ProceedsFromTrustAccountForWorkingCapitalPurposes", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1041 - Disclosure - Subsequent Events - Additional Information (Detail)", "menuCat": "Details", "order": "41", "role": "http://www.screamingeagleacquisitioncorp.com/role/SubsequentEventsAdditionalInformationDetail", "shortName": "Subsequent Events - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "us-gaap:SubsequentEventsTextBlock", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P04_01_2023To04_01_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis", "decimals": "0", "lang": null, "name": "scrm:ProceedsFromTrustAccountForWorkingCapitalPurposes", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn02_19_2022_CommonClassBMemberusgaapStatementClassOfStockAxis", "decimals": "INF", "first": true, "lang": null, "name": "scrm:CommonStockSharesSurrender", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - Condensed Statements Of Operations (Parenthetical)", "menuCat": "Statements", "order": "5", "role": "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperationsParenthetical", "shortName": "Condensed Statements Of Operations (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R6": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - Condensed Statements Of Changes In Shareholders' Equity (Deficit)", "menuCat": "Statements", "order": "6", "role": "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficit", "shortName": "Condensed Statements Of Changes In Shareholders' Equity (Deficit)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "PAsOn02_19_2022_CommonClassBMemberusgaapStatementClassOfStockAxis", "decimals": "INF", "first": true, "lang": null, "name": "scrm:CommonStockSharesSurrender", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1007 - Statement - Condensed Statements Of Changes In Shareholders' Equity (Deficit) (Parenthetical)", "menuCat": "Statements", "order": "7", "role": "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficitParenthetical", "shortName": "Condensed Statements Of Changes In Shareholders' Equity (Deficit) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1008 - Statement - Condensed Statements of Cash Flow", "menuCat": "Statements", "order": "8", "role": "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow", "shortName": "Condensed Statements of Cash Flow", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "0", "lang": null, "name": "scrm:WarrantIssuanceTransactionCosts", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1009 - Disclosure - Organization and Plan of Business Operations", "menuCat": "Notes", "order": "9", "role": "http://www.screamingeagleacquisitioncorp.com/role/OrganizationAndPlanOfBusinessOperations", "shortName": "Organization and Plan of Business Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d457148d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 39, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r339" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r339" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r339" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r343" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r339" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r339" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r339" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r339" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r340" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "scrm_AccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounting Policies", "label": "Accounting Policies [Line Items]" } } }, "localname": "AccountingPoliciesLineItems", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "scrm_AccountingPoliciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounting Policies [Table]", "label": "Accounting Policies [Table]" } } }, "localname": "AccountingPoliciesTable", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "scrm_AdministrativeServicesAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Administrative Services Agreement", "label": "Administrative Services Agreement [Member]" } } }, "localname": "AdministrativeServicesAgreementMember", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "scrm_AllocationOfOfferingCostsToWarrantLiability": { "auth_ref": [], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Allocation of offering costs to warrant liability.", "label": "Allocation Of Offering Costs To Warrant Liability", "negatedLabel": "Allocation of offering costs to warrant liability" } } }, "localname": "AllocationOfOfferingCostsToWarrantLiability", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "scrm_BasisOfMeasurementInputAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basis of Measurement Input [Axis]" } } }, "localname": "BasisOfMeasurementInputAxis", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesParentheticalDetail" ], "xbrltype": "stringItemType" }, "scrm_BasisOfMeasurementInputDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basis of Measurement Input [Domain]" } } }, "localname": "BasisOfMeasurementInputDomain", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesParentheticalDetail" ], "xbrltype": "domainItemType" }, "scrm_CashReceivedInExcessOfFairValueOfPrivateWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash received in excess of fair value of private warrants.", "label": "Cash received in excess of fair value of private warrants", "terseLabel": "Cash received in excess of fair value of private warrants" } } }, "localname": "CashReceivedInExcessOfFairValueOfPrivateWarrants", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "scrm_CashWithdrawnFromTrustAccountForWorkingCapital": { "auth_ref": [], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash withdrawn from trust account for working capital.", "label": "Cash Withdrawn From Trust Account For Working Capital", "verboseLabel": "Cash withdrawn from Trust Account for working capital" } } }, "localname": "CashWithdrawnFromTrustAccountForWorkingCapital", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "scrm_ChangeInFairValueOfWarrantLiability": { "auth_ref": [], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Change in fair value of warrant liability.", "label": "Change In Fair Value Of Warrant Liability", "negatedLabel": "Change in fair value of warrant liability", "terseLabel": "Change in fair value of warrant liability" } } }, "localname": "ChangeInFairValueOfWarrantLiability", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "scrm_ClassOfWarrantsOrRightsIssuePricePerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrants Or Rights Issue Price Per Unit", "label": "Class Of Warrants Or Rights Issue Price Per Unit", "terseLabel": "Class of warrants or rights issue price per unit" } } }, "localname": "ClassOfWarrantsOrRightsIssuePricePerUnit", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "scrm_ClassOfWarrantsOrRightsIssuedDuringThePeriodUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrants Or Rights Issued During The Period Units.", "label": "Class Of Warrants Or Rights Issued During The Period Units", "terseLabel": "Class of warrants or rights issued during the period units", "verboseLabel": "Class of warrants or rights issued during the period units" } } }, "localname": "ClassOfWarrantsOrRightsIssuedDuringThePeriodUnits", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "scrm_ClassOfWarrantsRedemptionNoticePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants, redemption notice period.", "label": "Class Of Warrants, Redemption Notice Period", "terseLabel": "Class of warrants, redemption notice period" } } }, "localname": "ClassOfWarrantsRedemptionNoticePeriod", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "scrm_ClassOfWarrantsRedemptionPricePerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants, redemption price per unit.", "label": "Class Of Warrants, Redemption Price Per Unit", "terseLabel": "Class of warrants, redemption price per unit" } } }, "localname": "ClassOfWarrantsRedemptionPricePerUnit", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "scrm_ClassificationOfCommonStockBasedOnRedeemabilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification Of Common Stock Based On Redeemability", "label": "Classification Of Common Stock Based On Redeemability [Axis]" } } }, "localname": "ClassificationOfCommonStockBasedOnRedeemabilityAxis", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "stringItemType" }, "scrm_ClassificationOfCommonStockBasedOnRedeemabilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification Of Common Stock Based On Redeemability", "label": "Classification Of Common Stock Based On Redeemability [Domain]" } } }, "localname": "ClassificationOfCommonStockBasedOnRedeemabilityDomain", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "domainItemType" }, "scrm_CommitmentsAndContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitments and contingencies.", "label": "Commitments and Contingencies [Line Items]" } } }, "localname": "CommitmentsAndContingenciesLineItems", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "scrm_CommitmentsAndContingenciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitments and contingencies.", "label": "Commitments and Contingencies [Table]" } } }, "localname": "CommitmentsAndContingenciesTable", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "scrm_CommonStockSharesLockInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock shares lock in period.", "label": "Common stock shares lock in period", "terseLabel": "Common stock shares lock in period" } } }, "localname": "CommonStockSharesLockInPeriod", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "scrm_CommonStockSharesLockInPeriodOne": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock shares lock in period one", "label": "Common stock shares lock in period one", "terseLabel": "Common stock shares lock in period one" } } }, "localname": "CommonStockSharesLockInPeriodOne", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "scrm_CommonStockSharesSurrender": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "Common Stock, Shares, surrender", "documentation": "Common stock, shares, surrender.", "label": "Common Stock, Shares, surrender", "verboseLabel": "Common Stock, Shares, surrender" } } }, "localname": "CommonStockSharesSurrender", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficitParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperationsParenthetical" ], "xbrltype": "sharesItemType" }, "scrm_CommonStockSharesSurrenderValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Common Stock, shares surrender, value", "documentation": "Common stock, shares surrender, value.", "label": "Common Stock, shares surrender, value", "verboseLabel": "Common Stock, shares surrender, value" } } }, "localname": "CommonStockSharesSurrenderValue", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficitParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperationsParenthetical" ], "xbrltype": "monetaryItemType" }, "scrm_CumulativeAccretionOfCarryingValueToRedemptionValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cumulative Accretion Of Carrying Value To Redemption Value", "label": "Cumulative Accretion Of Carrying Value To Redemption Value", "terseLabel": "Accretion of carrying value to redemption value" } } }, "localname": "CumulativeAccretionOfCarryingValueToRedemptionValue", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfProceedsFromTemporaryEquityToOutstandingValueDetail" ], "xbrltype": "monetaryItemType" }, "scrm_CumulativeFairValueOfPublicWarrantsAtIssuance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cumulative Fair Value Of Public Warrants At Issuance", "label": "Cumulative Fair Value Of Public Warrants At Issuance", "terseLabel": "Fair value Of Public Warrants At Issuance" } } }, "localname": "CumulativeFairValueOfPublicWarrantsAtIssuance", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfProceedsFromTemporaryEquityToOutstandingValueDetail" ], "xbrltype": "monetaryItemType" }, "scrm_CumulativeGrossProceedsFromTemporaryEquity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cumulative Gross Proceeds From Temporary Equity", "label": "Cumulative Gross Proceeds From Temporary Equity", "terseLabel": "Gross proceeds" } } }, "localname": "CumulativeGrossProceedsFromTemporaryEquity", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfProceedsFromTemporaryEquityToOutstandingValueDetail" ], "xbrltype": "monetaryItemType" }, "scrm_DateBeforeWhichBusinessCombinationShallBeConsummatedOne.": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date before which business combination shall be consummated one.", "label": "Date before which business combination shall be consummated one.", "verboseLabel": "Date before which business combination shall be consummated one." } } }, "localname": "DateBeforeWhichBusinessCombinationShallBeConsummatedOne.", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "dateItemType" }, "scrm_DateBeforeWhichBusinessCombinationShallBeConsummatedTwo.": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date before which business combination shall be consummated two.", "label": "Date before which business combination shall be consummated two.", "verboseLabel": "Date before which business combination shall be consummated two." } } }, "localname": "DateBeforeWhichBusinessCombinationShallBeConsummatedTwo.", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "dateItemType" }, "scrm_DeferredOfferingCostIncludedInAccruedExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred offering cost included in accrued expenses.", "label": "Deferred Offering Cost Included In Accrued Expenses", "terseLabel": "Deferred offering costs included in accrued expenses" } } }, "localname": "DeferredOfferingCostIncludedInAccruedExpenses", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "scrm_DeferredUnderwritingCommissionNonCurrent": { "auth_ref": [], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred underwriting commission non current.", "label": "Deferred Underwriting Commission Non Current", "terseLabel": "Deferred underwriting compensation" } } }, "localname": "DeferredUnderwritingCommissionNonCurrent", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "scrm_DeferredUnderwritingCommissionNonCurrent.": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred underwriting commission non current.", "label": "Deferred underwriting commission non current.", "verboseLabel": "Deferred underwriting commission non current." } } }, "localname": "DeferredUnderwritingCommissionNonCurrent.", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "monetaryItemType" }, "scrm_DeferredUnderwritingCommissionPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred underwriting commission per unit.", "label": "Deferred Underwriting Commission Per Unit", "terseLabel": "Deferred underwriting commission per unit, shares" } } }, "localname": "DeferredUnderwritingCommissionPerUnit", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "scrm_DeferredUnderwritingCommissionsNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred underwriting commissions noncurrent.", "label": "Deferred Underwriting Commissions Noncurrent", "terseLabel": "Deferred underwriting commissions noncurrent" } } }, "localname": "DeferredUnderwritingCommissionsNoncurrent", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "scrm_DeferredUnderwritingFeeIncurredButNotPaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred underwriting fee incurred but not paid.", "label": "Deferred Underwriting Fee Incurred But Not Paid", "terseLabel": "Deferred underwriting fee payable" } } }, "localname": "DeferredUnderwritingFeeIncurredButNotPaid", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "scrm_DenominatorAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Denominator.", "label": "Denominator [Abstract]", "terseLabel": "Denominator:" } } }, "localname": "DenominatorAbstract", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "stringItemType" }, "scrm_DisclosureInTabularFormOfReconciliationOfProceedsFromTemporaryEquityToOutstandingValueTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure In Tabular Form Of Reconciliation Of Proceeds From Temporary Equity To Outstanding Value [Table Text Block].", "label": "Disclosure In Tabular Form Of Reconciliation Of Proceeds From Temporary Equity To Outstanding Value [Table Text Block]", "terseLabel": "Summary of Reconciliation Of Proceeds From Temporary Equity To Outstanding Value (Detail)" } } }, "localname": "DisclosureInTabularFormOfReconciliationOfProceedsFromTemporaryEquityToOutstandingValueTableTextBlock", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "scrm_EarningsPerShareBasicAndDilutedLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnings Per Share Basic And Diluted", "label": "Earnings Per Share Basic And Diluted [Line Items]", "terseLabel": "Basic and diluted net income per ordinary" } } }, "localname": "EarningsPerShareBasicAndDilutedLineItems", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "stringItemType" }, "scrm_EarningsPerShareBasicAndDilutedTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnings Per Share Basic And Diluted", "label": "Earnings Per Share Basic And Diluted [Table]", "terseLabel": "Earnings Per Share Basic And Diluted" } } }, "localname": "EarningsPerShareBasicAndDilutedTable", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "stringItemType" }, "scrm_FounderSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Founder shares.", "label": "Founder Shares [Member]" } } }, "localname": "FounderSharesMember", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "scrm_InitialPublicOfferAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial public offer.", "label": "Initial Public Offer [Abstract]" } } }, "localname": "InitialPublicOfferAbstract", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "xbrltype": "stringItemType" }, "scrm_InitialPublicOfferLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial public offer.", "label": "Initial Public Offer [Line Items]" } } }, "localname": "InitialPublicOfferLineItems", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "scrm_InitialPublicOfferTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial public offer.", "label": "Initial Public Offer [Table]" } } }, "localname": "InitialPublicOfferTable", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "scrm_InitialPublicOfferTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial public offer.", "label": "Initial Public Offer [Text Block]", "terseLabel": "Initial Public Offering" } } }, "localname": "InitialPublicOfferTextBlock", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/InitialPublicOffering" ], "xbrltype": "textBlockItemType" }, "scrm_MaximumReleasePermittedToBeWithdrawn": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Maximum release permitted to be withdrawn.", "label": "Maximum release permitted to be withdrawn", "verboseLabel": "Maximum release permitted to be withdrawn" } } }, "localname": "MaximumReleasePermittedToBeWithdrawn", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "monetaryItemType" }, "scrm_MeasurementInputProbabilityRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement Input Probability Rate.", "label": "Measurement Input Probability Rate [Member]", "terseLabel": "Probability of completing Business Combination" } } }, "localname": "MeasurementInputProbabilityRateMember", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesDetail", "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesParentheticalDetail" ], "xbrltype": "domainItemType" }, "scrm_MinimumLockInPeriodforTransferAssignOrSellWarrantsAfterCompletionOfIpo": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum lock In period\u00a0for transfer, assign or sell warrants after completion of IPO.", "label": "Minimum Lock In PeriodFor Transfer, Assign Or Sell Warrants After Completion Of IPO", "terseLabel": "Minimum lock In period\u00a0for transfer, assign or sell warrants after completion of IPO" } } }, "localname": "MinimumLockInPeriodforTransferAssignOrSellWarrantsAfterCompletionOfIpo", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "scrm_MinimumNetworthNeededToConsummateBusinessCombination": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum Networth Needed To Consummate Business Combination", "label": "Minimum Networth Needed To Consummate Business Combination", "terseLabel": "Minimum networth needed to consummate business combination" } } }, "localname": "MinimumNetworthNeededToConsummateBusinessCombination", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "monetaryItemType" }, "scrm_MinimumPercentageOfNetAssetsOfTheAcquire": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum Percentage Of Net Assets Of The Acquire.", "label": "Minimum percentage of net assets of the acquire", "terseLabel": "Minimum percentage of net assets of the acquire" } } }, "localname": "MinimumPercentageOfNetAssetsOfTheAcquire", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "percentItemType" }, "scrm_MinimumPercentageOfPublicSharesThatCanBeTransferredWithoutRestriction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum Percentage Of Public Shares That Can Be Transferred Without Restriction", "label": "Minimum Percentage Of Public Shares That Can Be Transferred Without Restriction", "verboseLabel": "Minimum percentage of public shares that can be transferred without restriction" } } }, "localname": "MinimumPercentageOfPublicSharesThatCanBeTransferredWithoutRestriction", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "percentItemType" }, "scrm_NonRedeemableCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non Redeemable Common Stock", "label": "Non Redeemable Common Stock [Member]" } } }, "localname": "NonRedeemableCommonStockMember", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "domainItemType" }, "scrm_NumberOfConsecutiveTradingDaysForDeterminingSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of consecutive trading days for determining share price.", "label": "Number Of Consecutive Trading Days For Determining Share Price", "terseLabel": "Number of consecutive trading days for determining share price" } } }, "localname": "NumberOfConsecutiveTradingDaysForDeterminingSharePrice", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "scrm_NumberOfDaysAfterTheTheCutOffDateWithinWhichPublicShareholdersShallBeRedeemedInCaseBusinessCombinationIsNotConsummated": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "number of days after the the cut off date within which public shareholders shall be redeemed in case business combination is not consummated.", "label": "number of days after the the cut off date within which public shareholders shall be redeemed in case business combination is not consummated", "terseLabel": "Number of days after the the cut off date within which public shareholders shall be redeemed in case business combination is not consummated" } } }, "localname": "NumberOfDaysAfterTheTheCutOffDateWithinWhichPublicShareholdersShallBeRedeemedInCaseBusinessCombinationIsNotConsummated", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "durationItemType" }, "scrm_NumberOfTradingDaysForDeterminingSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of trading days for determining share price.", "label": "Number Of Trading Days For Determining Share Price", "terseLabel": "Number of trading days for determining share price" } } }, "localname": "NumberOfTradingDaysForDeterminingSharePrice", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "scrm_NumberOfTradingDaysForDeterminingTheSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Trading Days For Determining The Share Price", "label": "Number Of Trading Days For Determining The Share Price", "terseLabel": "Number of trading days for determining the share price" } } }, "localname": "NumberOfTradingDaysForDeterminingTheSharePrice", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "scrm_OfferingCostsChargesToTemporaryEquity.": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Offering costs charges to temporary equity.", "label": "Offering costs charges to temporary equity.", "terseLabel": "Offering costs charged to temporary equity" } } }, "localname": "OfferingCostsChargesToTemporaryEquity.", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "scrm_OfferingCostsExpensed.": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Offering costs expensed.", "label": "Offering costs expensed.", "terseLabel": "Offering costs expensed" } } }, "localname": "OfferingCostsExpensed.", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "scrm_OfferingCostspolicyTextBlockPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Offering Costs [Policy Text Block]", "label": "Offering Costs Policy Text Block [Policy Text Block]", "terseLabel": "Offering costs" } } }, "localname": "OfferingCostspolicyTextBlockPolicyTextBlock", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "scrm_OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ordinary Shares Subject To Possible Redemption.", "label": "Ordinary Shares Subject To Possible Redemption [Policy Text Block]", "terseLabel": "Class\u00a0A Ordinary Shares subject to possible redemption" } } }, "localname": "OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "scrm_OrganizationAndPlanOfOperationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organization And Plan Of Operation", "label": "Organization And Plan Of Operation [Line Items]" } } }, "localname": "OrganizationAndPlanOfOperationLineItems", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "stringItemType" }, "scrm_OrganizationAndPlanOfOperationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organization And Plan Of Operation", "label": "Organization And Plan Of Operation [Table]" } } }, "localname": "OrganizationAndPlanOfOperationTable", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "stringItemType" }, "scrm_OtherOfferingCosts.": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other offering costs.", "label": "Other offering costs.", "terseLabel": "Other offering costs" } } }, "localname": "OtherOfferingCosts.", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "monetaryItemType" }, "scrm_OverAllotmentOptionPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Over allotment option period.", "label": "Over Allotment Option Period", "terseLabel": "Over allotment option period" } } }, "localname": "OverAllotmentOptionPeriod", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "scrm_PaymentOfUnderwritersDiscount": { "auth_ref": [], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment of underwriters discount.", "label": "Payment Of Underwriters Discount", "negatedLabel": "Payment of underwriters' discount" } } }, "localname": "PaymentOfUnderwritersDiscount", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "scrm_PerShareToBeMaintainedInTheTrustAccount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per Share To Be Maintained In The Trust Account", "label": "Per Share To Be Maintained In The Trust Account", "verboseLabel": "Per share to be maintained in the trust account" } } }, "localname": "PerShareToBeMaintainedInTheTrustAccount", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "perShareItemType" }, "scrm_PerShareValueOfRestrictedInvestments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per Share Value Of Restricted Investments", "label": "Per Share Value Of Restricted Investments", "terseLabel": "Per share value of restricted investments" } } }, "localname": "PerShareValueOfRestrictedInvestments", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "perShareItemType" }, "scrm_PercentageOfCommonStockIssuedAndOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage Of Common Stock Issued And Outstanding", "label": "Percentage Of Common Stock Issued And Outstanding", "terseLabel": "Percentage of common stock issued and outstanding" } } }, "localname": "PercentageOfCommonStockIssuedAndOutstanding", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "scrm_PercentageOfOwnershipHeldByInitialShareholders": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of ownership held by initial shareholders.", "label": "Percentage Of Ownership Held By Initial Shareholders", "terseLabel": "Percentage of ownership held by initial shareholders" } } }, "localname": "PercentageOfOwnershipHeldByInitialShareholders", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "scrm_PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of public shares to be redeemed in case business combination is not consummated.", "label": "Percentage of public shares to be redeemed in case business combination is not consummated", "verboseLabel": "Percentage of public shares to be redeemed in case business combination is not consummated" } } }, "localname": "PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "percentItemType" }, "scrm_PrivatePlacementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement.", "label": "Private Placement [Abstract]" } } }, "localname": "PrivatePlacementAbstract", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "xbrltype": "stringItemType" }, "scrm_PrivatePlacementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement.", "label": "Private Placement [Line Items]" } } }, "localname": "PrivatePlacementLineItems", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "scrm_PrivatePlacementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement.", "label": "Private Placement [Table]" } } }, "localname": "PrivatePlacementTable", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "scrm_PrivatePlacementTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement.", "label": "Private Placement [Text Block]", "terseLabel": "Private Placement" } } }, "localname": "PrivatePlacementTextBlock", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/PrivatePlacement" ], "xbrltype": "textBlockItemType" }, "scrm_PrivatePlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Placement Warrants", "label": "Private Placement Warrants [Member]", "terseLabel": "Private Placement Warrants [Member]", "verboseLabel": "Private placement warrants [Member]" } } }, "localname": "PrivatePlacementWarrantsMember", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsScheduleOfFairValueHierarchyTheCompanySLiabilitiesThatWereAccountedForAtFairValueOnARecurringBasisDetail", "http://www.screamingeagleacquisitioncorp.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "scrm_ProceedsFromTrustAccountForWorkingCapitalPurposes": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from trust account for working capital purposes.", "label": "Proceeds From Trust Account For Working Capital Purposes", "terseLabel": "Proceeds from Trust Account for Working Capital Purposes" } } }, "localname": "ProceedsFromTrustAccountForWorkingCapitalPurposes", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "scrm_PromissoryNoteIssuedToTheSponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory Note Issued To The Sponsor", "label": "Promissory Note Issued To The Sponsor [Member]" } } }, "localname": "PromissoryNoteIssuedToTheSponsorMember", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "scrm_PublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public Warrants [Member]", "label": "Public Warrants [Member]", "terseLabel": "Public Warrants [Member]" } } }, "localname": "PublicWarrantsMember", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "scrm_RedeemableCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non Redeemable Common Stock", "label": "Redeemable Common Stock [Member]" } } }, "localname": "RedeemableCommonStockMember", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "domainItemType" }, "scrm_RedemptionOfWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption of warrants Member", "label": "Redemption of warrants [Member]", "terseLabel": "Redemption of warrants [Member]" } } }, "localname": "RedemptionOfWarrantsMember", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "scrm_RelatedPartyTransactionExpensesPayablePerMonth": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Related Party Transaction Expenses Payable Per Month", "label": "Related Party Transaction Expenses Payable Per Month", "terseLabel": "Related party transaction expenses payable per month" } } }, "localname": "RelatedPartyTransactionExpensesPayablePerMonth", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "scrm_RelatedPartyTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Line Items]" } } }, "localname": "RelatedPartyTransactionsLineItems", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "scrm_SharePriceEqualOrExceedsEighteenRupeesPerDollarMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Price Equal or Exceeds Eighteen Rupees per dollar", "label": "Share Price Equal or Exceeds Eighteen Rupees per dollar [Member]", "terseLabel": "Share Price Equal or Exceeds Eighteen Rupees per dollar [Member]" } } }, "localname": "SharePriceEqualOrExceedsEighteenRupeesPerDollarMember", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "scrm_ShareRedemptionTriggerPriceAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share redemption Trigger Price [Axis]", "label": "Share redemption Trigger Price [Axis]", "terseLabel": "Share redemption Trigger Price [Axis]" } } }, "localname": "ShareRedemptionTriggerPriceAxis", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "scrm_ShareRedemptionTriggerPriceDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share redemption Trigger Price [Domain]", "label": "Share redemption Trigger Price [Domain]", "terseLabel": "Share redemption Trigger Price [Domain]" } } }, "localname": "ShareRedemptionTriggerPriceDomain", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "scrm_ShareholdersDeficitLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shareholders' deficit.", "label": "Shareholders Deficit [Line Items]" } } }, "localname": "ShareholdersDeficitLineItems", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "scrm_ShareholdersDeficitTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shareholders' deficit.", "label": "Shareholders Deficit [Table]" } } }, "localname": "ShareholdersDeficitTable", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "scrm_SpacMarketDataPublishedByThirdPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SPAC Market Data Published By Third Party [Member]" } } }, "localname": "SpacMarketDataPublishedByThirdPartyMember", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesParentheticalDetail" ], "xbrltype": "domainItemType" }, "scrm_SponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sponsor", "label": "Sponsor [Member]" } } }, "localname": "SponsorMember", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "scrm_TemporaryEquityIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Temporary Equity Issuance Costs", "label": "Temporary Equity Issuance Costs", "terseLabel": "Class\u00a0A ordinary share issuance costs" } } }, "localname": "TemporaryEquityIssuanceCosts", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfProceedsFromTemporaryEquityToOutstandingValueDetail" ], "xbrltype": "monetaryItemType" }, "scrm_TermOfRestrictedInvestments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term Of Restricted Investments", "label": "Term Of Restricted Investments", "terseLabel": "Term of restricted investments" } } }, "localname": "TermOfRestrictedInvestments", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "durationItemType" }, "scrm_TimeLimitForTheConsummationOfBusinessCombinationOne.": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Time limit for the consummation of business combination one.", "label": "Time limit for the consummation of business combination one.", "terseLabel": "Time limit for the consummation of business combination one." } } }, "localname": "TimeLimitForTheConsummationOfBusinessCombinationOne.", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "durationItemType" }, "scrm_TimeLimitForTheConsummationOfBusinessCombinationTwo.": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Time limit for the consummation of business combination two.", "label": "Time limit for the consummation of business combination two.", "terseLabel": "Time limit for the consummation of business combination two." } } }, "localname": "TimeLimitForTheConsummationOfBusinessCombinationTwo.", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "durationItemType" }, "scrm_TotalNumberOfTradingDaysForDetermningTheSharePrice.": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total number of trading days for determning the share price.", "label": "Total number of trading days for determning the share price.", "terseLabel": "Total number of trading days for determining the share price" } } }, "localname": "TotalNumberOfTradingDaysForDetermningTheSharePrice.", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "scrm_TransactionCostsShareIssue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transaction Costs Share Issue", "label": "Transaction Costs Share Issue", "terseLabel": "Transaction costs share issue", "verboseLabel": "Transaction costs share issue" } } }, "localname": "TransactionCostsShareIssue", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "scrm_TrustAccountLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trust account.", "label": "Trust Account [Line Items]" } } }, "localname": "TrustAccountLineItems", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountSummaryOfAvailableForSaleSecuritiesReconciliationDetail" ], "xbrltype": "stringItemType" }, "scrm_TrustAccountTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trust account.", "label": "Trust Account [Table]" } } }, "localname": "TrustAccountTable", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountSummaryOfAvailableForSaleSecuritiesReconciliationDetail" ], "xbrltype": "stringItemType" }, "scrm_TrustAccountTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trust account.", "label": "Trust Account [Text Block]", "terseLabel": "Trust Account" } } }, "localname": "TrustAccountTextBlock", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/TrustAccount" ], "xbrltype": "textBlockItemType" }, "scrm_U.s.GovernmentTreasurySecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "U.S. government treasury securities.", "label": "U.S. Government Treasury Securities [Member]" } } }, "localname": "U.s.GovernmentTreasurySecuritiesMember", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountSummaryOfAvailableForSaleSecuritiesReconciliationDetail" ], "xbrltype": "domainItemType" }, "scrm_UnderwritingFees.": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Underwriting fees.", "label": "Underwriting fees.", "terseLabel": "Underwriting fees" } } }, "localname": "UnderwritingFees.", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "monetaryItemType" }, "scrm_UnitedStatesTreasuryBillsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "United states treasury bills.", "label": "United States Treasury Bills [Line Items]" } } }, "localname": "UnitedStatesTreasuryBillsLineItems", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "scrm_UnitedStatesTreasuryBillsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "United states treasury bills.", "label": "United States Treasury Bills [Member]", "terseLabel": "US Treasury Bills [Member]" } } }, "localname": "UnitedStatesTreasuryBillsMember", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "scrm_WarrantIssuanceTransactionCosts": { "auth_ref": [], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Warrant issuance transaction costs.", "label": "Warrant Issuance Transaction Costs", "terseLabel": "Warrant issuance transaction costs" } } }, "localname": "WarrantIssuanceTransactionCosts", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "scrm_WarrantLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Liability.", "label": "Warrant Liability [Member]" } } }, "localname": "WarrantLiabilityMember", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfTheChangeInTheFairValueOfTheWarrantLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "scrm_WarrantLiabilityPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Liability", "label": "Warrant Liability [Policy Text Block]", "terseLabel": "Warrant liability" } } }, "localname": "WarrantLiabilityPolicyTextBlock", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "scrm_WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants exercisable term from the date of completion of business combination.", "label": "Warrants Exercisable Term From The Date Of Completion Of Business Combination", "terseLabel": "Warrants exercisable term from the date of completion of business combination" } } }, "localname": "WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "scrm_WarrantsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants [Line Items]", "label": "Warrants [Line Items]" } } }, "localname": "WarrantsLineItems", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "scrm_WarrantsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants [Table]", "label": "Warrants [Table]" } } }, "localname": "WarrantsTable", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "scrm_WarrantsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants [Text Block]", "label": "Warrants [Text Block]", "terseLabel": "Warrants" } } }, "localname": "WarrantsTextBlock", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/Warrants" ], "xbrltype": "textBlockItemType" }, "scrm_WorkingCapitalDeficiency": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Working capital deficiency.", "label": "Working Capital Deficiency", "terseLabel": "Working capital deficiency" } } }, "localname": "WorkingCapitalDeficiency", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "monetaryItemType" }, "scrm_WorkingCapitalLoansConvertibleIntoEquityWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Working Capital Loans Convertible Into Equity Warrants", "label": "Working Capital Loans Convertible Into Equity Warrants", "verboseLabel": "Working capital loans convertible into equity warrants" } } }, "localname": "WorkingCapitalLoansConvertibleIntoEquityWarrants", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "monetaryItemType" }, "scrm_WorkingCapitalLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Working Capital Loans", "label": "Working Capital Loans [Member]" } } }, "localname": "WorkingCapitalLoansMember", "nsuri": "http://www.screamingeagleacquisitioncorp.com/20230331", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r164", "r165", "r166", "r167", "r206", "r291", "r307", "r320", "r321", "r331", "r335", "r337", "r363", "r371", "r372", "r373", "r374", "r375", "r376" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r164", "r165", "r166", "r167", "r206", "r291", "r307", "r320", "r321", "r331", "r335", "r337", "r363", "r371", "r372", "r373", "r374", "r375", "r376" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r164", "r165", "r166", "r167", "r198", "r206", "r208", "r209", "r210", "r267", "r291", "r307", "r320", "r321", "r331", "r335", "r337", "r360", "r363", "r372", "r373", "r374", "r375", "r376" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r164", "r165", "r166", "r167", "r198", "r206", "r208", "r209", "r210", "r267", "r291", "r307", "r320", "r321", "r331", "r335", "r337", "r360", "r363", "r372", "r373", "r374", "r375", "r376" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r83", "r106", "r107", "r108", "r109", "r110", "r111", "r112", "r113", "r114", "r116", "r117", "r118", "r119", "r120", "r121", "r130", "r152", "r153", "r222", "r229", "r230", "r231", "r232", "r249", "r250", "r251", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperationsParenthetical" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r83", "r106", "r107", "r108", "r109", "r110", "r111", "r112", "r113", "r114", "r116", "r117", "r118", "r119", "r120", "r121", "r130", "r152", "r153", "r222", "r229", "r230", "r231", "r232", "r249", "r250", "r251", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperationsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r12" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r69", "r77" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.", "label": "Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r6", "r336" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional\u00a0paid-in\u00a0capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r211", "r212", "r213", "r350", "r351", "r352", "r365" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": { "auth_ref": [ "r40", "r44", "r45" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.", "label": "Adjustments to Additional Paid in Capital, Warrant Issued", "terseLabel": "Fair value of public warrants at issuance" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_Assets": { "auth_ref": [ "r67", "r73", "r88", "r105", "r142", "r144", "r146", "r150", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r223", "r225", "r240", "r336", "r361", "r362", "r369" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS:" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r85", "r93", "r105", "r150", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r223", "r225", "r240", "r336", "r361", "r362", "r369" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldInTrustNoncurrent": { "auth_ref": [ "r346" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.", "label": "Assets Held-in-trust, Noncurrent", "terseLabel": "Cash and investments held in Trust Account", "verboseLabel": "Assets held-in-trust, noncurrent" } } }, "localname": "AssetsHeldInTrustNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets", "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalUnitsMember": { "auth_ref": [ "r80" ], "lang": { "en-us": { "role": { "documentation": "Type of ownership interest in a corporation. Class of capital units or capital shares.", "label": "Capital Units [Member]" } } }, "localname": "CapitalUnitsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_Cash": { "auth_ref": [ "r318", "r319", "r336", "r345" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash", "verboseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r28", "r87", "r323" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets", "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r29", "r66" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Investment Held in Trust Account" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents with respect to unrestricted balances.", "label": "Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash equivalents" } } }, "localname": "CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r23", "r28", "r30" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash at end of period", "periodStartLabel": "Cash at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r23", "r59" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net change in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash, FDIC Insured Amount", "terseLabel": "Cash insured with federal insurance corporation" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r89", "r90", "r91", "r105", "r124", "r125", "r127", "r129", "r132", "r133", "r150", "r168", "r170", "r171", "r172", "r175", "r176", "r181", "r182", "r184", "r188", "r195", "r240", "r322", "r344", "r347", "r353" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets", "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheetsParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficit", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficitParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/CoverPage", "http://www.screamingeagleacquisitioncorp.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail", "http://www.screamingeagleacquisitioncorp.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r47", "r49" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]", "terseLabel": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsScheduleOfFairValueHierarchyTheCompanySLiabilitiesThatWereAccountedForAtFairValueOnARecurringBasisDetail", "http://www.screamingeagleacquisitioncorp.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]", "terseLabel": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsScheduleOfFairValueHierarchyTheCompanySLiabilitiesThatWereAccountedForAtFairValueOnARecurringBasisDetail", "http://www.screamingeagleacquisitioncorp.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r196" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Class of warrants or rights exercise price per warrant", "verboseLabel": "Class of warrants or rights exercise price per share" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r196" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "terseLabel": "Class of warrants or rights number of securities covered by the warrants or rights" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Number of warrants or rights outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r15", "r70", "r76" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsDisclosureTextBlock": { "auth_ref": [ "r39" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.", "label": "Commitments Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "terseLabel": "Common Class A [Member]" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets", "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheetsParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficit", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations", "http://www.screamingeagleacquisitioncorp.com/role/CoverPage", "http://www.screamingeagleacquisitioncorp.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail", "http://www.screamingeagleacquisitioncorp.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets", "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheetsParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficit", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficitParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/CoverPage", "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockConversionBasis": { "auth_ref": [ "r91" ], "lang": { "en-us": { "role": { "documentation": "Description of basis for conversion of convertible common stock.", "label": "Common Stock, Conversion Basis", "terseLabel": "Stock Conversion Basis" } } }, "localname": "CommonStockConversionBasis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r350", "r351", "r365" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Ordinary Shares [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common Stock, Par or Stated Value Per Share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheetsParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheetsParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheetsParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r5", "r44" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common Stock, Shares, Outstanding", "verboseLabel": "Common stock, shares, outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheetsParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r5", "r336" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common Stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r72", "r137" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r41", "r178" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Debt instrument conversion price per share", "verboseLabel": "Debt instrument, convertible, conversion price" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r60", "r61", "r177", "r248", "r329", "r330" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt instrument face value" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of unrealized gain (loss) in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain (Loss), before Tax", "terseLabel": "Gross Holding Gain" } } }, "localname": "DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountSummaryOfAvailableForSaleSecuritiesReconciliationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Available-for-Sale and Held-to-Maturity, after Allowance for Credit Loss [Abstract]" } } }, "localname": "DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossCurrent": { "auth_ref": [ "r359" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount excluding accrued interest, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity), classified as current.", "label": "Debt Securities, Held-to-Maturity, Excluding Accrued Interest, after Allowance for Credit Loss, Current", "terseLabel": "Quoted Prices in Active Markets (Level 1)" } } }, "localname": "DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountSummaryOfAvailableForSaleSecuritiesReconciliationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestBeforeAllowanceForCreditLossCurrent": { "auth_ref": [ "r359" ], "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Debt Securities, Held-to-Maturity", "documentation": "Amount excluding accrued interest, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity), classified as current.", "label": "Debt Securities, Held-to-Maturity, Excluding Accrued Interest, before Allowance for Credit Loss, Current", "terseLabel": "Debt securities, held-to-maturity", "verboseLabel": "Amortized Cost" } } }, "localname": "DebtSecuritiesHeldToMaturityExcludingAccruedInterestBeforeAllowanceForCreditLossCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountSummaryOfAvailableForSaleSecuritiesReconciliationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesNoncurrent": { "auth_ref": [ "r94" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Noncurrent", "verboseLabel": "Warrant liability" } } }, "localname": "DerivativeLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesReportingOfDerivativeActivity": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for derivatives entered into for trading purposes and those entered into for purposes other than trading including where and when derivative financial instruments and derivative commodity instruments and their related gains or losses are reported in the entity's statements of financial position, cash flows, and results of operations.", "label": "Derivatives, Reporting of Derivative Activity [Policy Text Block]", "terseLabel": "Derivative financial instruments" } } }, "localname": "DerivativesReportingOfDerivativeActivity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DueToAffiliateCurrent": { "auth_ref": [ "r2", "r63", "r79", "r349" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Affiliate, Current", "verboseLabel": "Due to affiliate current" } } }, "localname": "DueToAffiliateCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r101", "r111", "r112", "r114", "r115", "r116", "r122", "r124", "r127", "r128", "r129", "r130", "r231", "r232", "r305", "r306", "r325" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic net income per ordinary share", "verboseLabel": "Basic net income per share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations", "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r101", "r111", "r112", "r114", "r115", "r116", "r124", "r127", "r128", "r129", "r130", "r231", "r232", "r305", "r306", "r325" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted net income per ordinary share", "verboseLabel": "Diluted net income per share" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations", "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r33", "r34" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "verboseLabel": "Net income per ordinary share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareReconciliationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share Reconciliation [Abstract]", "terseLabel": "Numerator:" } } }, "localname": "EarningsPerShareReconciliationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r44", "r82", "r98", "r99", "r100", "r106", "r107", "r108", "r110", "r117", "r120", "r131", "r151", "r197", "r211", "r212", "r213", "r221", "r222", "r230", "r241", "r242", "r243", "r244", "r245", "r246", "r251", "r308", "r309", "r310" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficit", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficitParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/CoverPage", "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r26", "r42" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "verboseLabel": "Fair Value Adjustment of Warrants" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsScheduleOfFairValueHierarchyTheCompanySLiabilitiesThatWereAccountedForAtFairValueOnARecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r233", "r234", "r239" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsScheduleOfFairValueHierarchyTheCompanySLiabilitiesThatWereAccountedForAtFairValueOnARecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesDetail", "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [ "r53" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesDetail", "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r53" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Summary of quantitative information regarding Level 3 fair value measurements inputs as their measurement dates" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r54" ], "lang": { "en-us": { "role": { "documentation": "Class of asset.", "label": "Asset Class [Domain]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r54", "r56" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r52", "r56" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r179", "r199", "r200", "r201", "r202", "r203", "r204", "r234", "r264", "r265", "r266", "r329", "r330", "r332", "r333", "r334" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsScheduleOfFairValueHierarchyTheCompanySLiabilitiesThatWereAccountedForAtFairValueOnARecurringBasisDetail", "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesDetail", "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfTheChangeInTheFairValueOfTheWarrantLiabilitiesDetail", "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountSummaryOfAvailableForSaleSecuritiesReconciliationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r238" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Recurring Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r179", "r199", "r204", "r234", "r264", "r332", "r333", "r334" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountSummaryOfAvailableForSaleSecuritiesReconciliationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r179", "r199", "r200", "r201", "r202", "r203", "r204", "r234", "r266", "r329", "r330", "r332", "r333", "r334" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsScheduleOfFairValueHierarchyTheCompanySLiabilitiesThatWereAccountedForAtFairValueOnARecurringBasisDetail", "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesDetail", "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfTheChangeInTheFairValueOfTheWarrantLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfTheChangeInTheFairValueOfTheWarrantLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r54", "r56" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfTheChangeInTheFairValueOfTheWarrantLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r54", "r56" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Summary of The change in the fair value of the warrant liabilities" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r237" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "terseLabel": "Change in fair value of derivative warrant liability" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfTheChangeInTheFairValueOfTheWarrantLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "auth_ref": [ "r55" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "verboseLabel": "Issuance of Private Warrants on January 10, 2022" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfTheChangeInTheFairValueOfTheWarrantLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net", "verboseLabel": "Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r54" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Level 3 Derivative warrant liability Ending Balance", "periodStartLabel": "Level 3 Derivative warrant liability Beginning Balance" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfTheChangeInTheFairValueOfTheWarrantLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r179", "r199", "r200", "r201", "r202", "r203", "r204", "r264", "r265", "r266", "r329", "r330", "r332", "r333", "r334" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsScheduleOfFairValueHierarchyTheCompanySLiabilitiesThatWereAccountedForAtFairValueOnARecurringBasisDetail", "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesDetail", "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfTheChangeInTheFairValueOfTheWarrantLiabilitiesDetail", "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountSummaryOfAvailableForSaleSecuritiesReconciliationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r57", "r58" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair value of financial instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r148", "r149", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r180", "r193", "r227", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r328", "r355", "r356", "r357", "r377", "r378", "r379", "r380", "r381", "r382", "r383" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfTheChangeInTheFairValueOfTheWarrantLiabilitiesDetail", "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountSummaryOfAvailableForSaleSecuritiesReconciliationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r97", "r214", "r215", "r217", "r218", "r219", "r220" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r25" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r25" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r18", "r141" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "negatedLabel": "Interest income from investments held in Trust Account", "terseLabel": "Interest from investments held in Trust Account" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r13", "r105", "r150", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r224", "r225", "r226", "r240", "r326", "r361", "r369", "r370" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r10", "r68", "r75", "r336", "r348", "r358", "r367" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and shareholders' (deficit)" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND SHAREHOLDERS' (DEFICIT):" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r14", "r86", "r105", "r150", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r224", "r225", "r226", "r240", "r336", "r361", "r369", "r370" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities": { "auth_ref": [ "r0" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of estimated accrued costs to dispose of assets or other items expected to be sold in liquidation.", "label": "Liquidation Basis of Accounting, Accrued Costs to Dispose of Assets and Liabilities", "verboseLabel": "Liquidation basis of accounting, accrued costs to dispose of assets and liabilities" } } }, "localname": "LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_MeasurementInputExercisePriceMember": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using agreed upon price for exchange of underlying asset.", "label": "Measurement Input, Exercise Price [Member]", "terseLabel": "Exercise price" } } }, "localname": "MeasurementInputExercisePriceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.", "label": "Measurement Input, Expected Dividend Rate [Member]", "terseLabel": "Dividend yield" } } }, "localname": "MeasurementInputExpectedDividendRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Measurement Input, Expected Term [Member]", "terseLabel": "Term" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input, Price Volatility [Member]", "verboseLabel": "Volatility" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input, Risk Free Interest Rate [Member]", "terseLabel": "Risk-free rate" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputSharePriceMember": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using share price of saleable stock.", "label": "Measurement Input, Share Price [Member]", "terseLabel": "Ordinary share stock price" } } }, "localname": "MeasurementInputSharePriceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r235" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesDetail", "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesDetail", "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r364" ], "lang": { "en-us": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountSummaryOfAvailableForSaleSecuritiesReconciliationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r134", "r140" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "terseLabel": "Organization and Plan of Business Operations" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationAndPlanOfBusinessOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r102" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r102" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow": { "order": 15.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r23", "r24", "r27" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow": { "order": 8.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r17", "r27", "r71", "r78", "r84", "r95", "r96", "r100", "r105", "r109", "r111", "r112", "r114", "r115", "r119", "r120", "r126", "r142", "r143", "r145", "r147", "r150", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r232", "r240", "r327", "r361" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Net Income", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income", "totalLabel": "Net income", "verboseLabel": "Allocation of net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficit", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations", "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently issued accounting standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r11", "r64", "r349" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Notes Payable, Related Parties, Current", "terseLabel": "Notes payable to related party current" } } }, "localname": "NotesPayableRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "terseLabel": "Operating costs", "verboseLabel": "Offering and formation cost" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations", "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r142", "r143", "r145", "r147", "r327" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r22" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "negatedLabel": "Payment of offering costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireRestrictedInvestments": { "auth_ref": [ "r19" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire investments (not to include restricted cash) that are pledged or subject to withdrawal restrictions.", "label": "Payments to Acquire Restricted Investments", "negatedLabel": "Principal deposited in Trust Account", "terseLabel": "Payments to Acquire Restricted Investments" } } }, "localname": "PaymentsToAcquireRestrictedInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow", "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r4", "r181" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred Stock, Par or Stated Value Per Share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheetsParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred Stock, Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheetsParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r4", "r181" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred Stock, Shares Issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheetsParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred Stock, Shares Outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheetsParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r4", "r336" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r92", "r162", "r163", "r324" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r20" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Proceeds from initial public offer", "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from Issuance Initial Public Offering", "terseLabel": "Proceeds from sale of units in initial public offering", "verboseLabel": "Proceeds from Issuance Initial Public Offering" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow", "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r20" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Proceeds from Issuance of Private Placement", "terseLabel": "Proceeds from Issuance of Private Placement" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r20" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Proceeds from the issuance of warrants", "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "terseLabel": "Proceeds from private placement of warrants", "verboseLabel": "Proceeds from the issuance of warrants" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow", "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "auth_ref": [ "r20" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.", "label": "Proceeds from Issuance or Sale of Equity", "terseLabel": "Proceeds from Issuance or Sale of Equity" } } }, "localname": "ProceedsFromIssuanceOrSaleOfEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r205", "r254", "r255" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r81", "r254", "r255", "r368" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r81" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": { "auth_ref": [ "r62" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Expenses from Transactions with Related Party", "terseLabel": "Expenses from transactions with related party" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r205", "r254", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r368" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r252", "r253", "r255", "r256", "r257" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r21" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayments of Notes Payable", "negatedLabel": "Repayment of promissory note\u2014related party" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r21" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayments of Related Party Debt", "negatedLabel": "Repayment of advances from Sponsor" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r7", "r45", "r74", "r312", "r317", "r336" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r82", "r106", "r107", "r108", "r110", "r117", "r120", "r151", "r211", "r212", "r213", "r221", "r222", "r230", "r308", "r310" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated Deficit [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Sale of stock issue price per share", "verboseLabel": "Sale of stock issue price per share" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.", "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]", "terseLabel": "Summary of Available-for-sale Securities Reconciliation" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r233", "r234" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r64", "r65" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r207" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "terseLabel": "Forfeiture of Class B shares, Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price", "verboseLabel": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, Shares", "periodStartLabel": "Beginning balance, Shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r31", "r103" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r89", "r90", "r91", "r105", "r124", "r125", "r127", "r129", "r132", "r133", "r150", "r168", "r170", "r171", "r172", "r175", "r176", "r181", "r182", "r184", "r188", "r195", "r240", "r322", "r344", "r347", "r353" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets", "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheetsParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficit", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficitParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/CoverPage", "http://www.screamingeagleacquisitioncorp.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail", "http://www.screamingeagleacquisitioncorp.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r16", "r44", "r82", "r98", "r99", "r100", "r106", "r107", "r108", "r110", "r117", "r120", "r131", "r151", "r197", "r211", "r212", "r213", "r221", "r222", "r230", "r241", "r242", "r243", "r244", "r245", "r246", "r251", "r308", "r309", "r310" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficit", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficitParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/CoverPage", "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets", "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheetsParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficit", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficitParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperationsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r106", "r107", "r108", "r131", "r292" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets", "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheetsParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficit", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficitParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperationsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited": { "auth_ref": [ "r50" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of forfeited shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Granted, Value, Share-based Payment Arrangement, Forfeited", "terseLabel": "Forfeiture of Class B shares, Amount" } } }, "localname": "StockGrantedDuringPeriodValueSharebasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Stock issued during the period shares for services" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r4", "r5", "r44", "r45" ], "lang": { "en-us": { "role": { "definitionGuidance": "Stock issued during the period shares new issues", "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Stock issued during the period shares new issues", "verboseLabel": "Stock issued during period shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares (or other type of equity) forfeited during the period.", "label": "Shares Issued, Shares, Share-based Payment Arrangement, Forfeited", "terseLabel": "Shares Issued, Shares, Share-based Payment Arrangement, Forfeited", "verboseLabel": "Stock forfeited during the period shares" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value, Issued for Services", "terseLabel": "Stock issued durig the period value for services" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r5", "r8", "r9", "r38", "r336", "r348", "r358", "r367" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance, Amount", "periodStartLabel": "Beginning balance, Amount", "totalLabel": "Total shareholders' (deficit)" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets", "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Shareholders' (deficit):" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r48", "r104", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r194", "r197", "r228" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Shareholders' Equity (Deficit)" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficit" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityNoteStockSplit": { "auth_ref": [ "r46" ], "lang": { "en-us": { "role": { "documentation": "Description of the stock split arrangement. Also provide the retroactive effect given by a stock split that occurs after the balance date but before the release of financial statements.", "label": "Stockholders' Equity Note, Stock Split", "terseLabel": "Stockholders' Equity Note, Stock Split" } } }, "localname": "StockholdersEquityNoteStockSplit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r247", "r259" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r247", "r259" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r247", "r259" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SubsequentEventsAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r247", "r259" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SubsequentEventsAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r258", "r260" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail", "http://www.screamingeagleacquisitioncorp.com/role/PrivatePlacementAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Elements [Abstract]", "terseLabel": "Supplemental disclosure of non-cash investing and financing activities:" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of accretion of temporary equity to its redemption value during the period.", "label": "Temporary Equity, Accretion to Redemption Value", "negatedLabel": "Accretion of Class\u00a0A ordinary shares subject to possible redemption" } } }, "localname": "TemporaryEquityAccretionToRedemptionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r168", "r170", "r171", "r172", "r175", "r176" ], "calculation": { "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "terseLabel": "Class\u00a0A ordinary shares subject to possible redemption", "verboseLabel": "Class\u00a0A ordinary shares subject to possible redemption; 75,000,000 and 75,000,000 shares at $10.20 and $10.09 redemption value at March\u00a031, 2023 and December\u00a031, 2022, respectively" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheets", "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfProceedsFromTemporaryEquityToOutstandingValueDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityRedemptionPricePerShare": { "auth_ref": [ "r1", "r43" ], "lang": { "en-us": { "role": { "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Redemption Price Per Share", "terseLabel": "Temporary Equity, Redemption Price Per Share", "verboseLabel": "Temporary equity, redemption price per share" } } }, "localname": "TemporaryEquityRedemptionPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheetsParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/OrganizationConsolidationAndPresentationOfFinancialStatementsDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesIssued": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Issued", "terseLabel": "Temporary Equity, Shares Issued" } } }, "localname": "TemporaryEquitySharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding", "terseLabel": "Temporary Equity, Shares Outstanding" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedBalanceSheetsParenthetical", "http://www.screamingeagleacquisitioncorp.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r148", "r149", "r180", "r193", "r227", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r355", "r356", "r357", "r377", "r378", "r379", "r380", "r381", "r382", "r383" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfTheChangeInTheFairValueOfTheWarrantLiabilitiesDetail", "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountAdditionalInformationDetail", "http://www.screamingeagleacquisitioncorp.com/role/TrustAccountSummaryOfAvailableForSaleSecuritiesReconciliationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r216" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Accrued interest and penalties on unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r35", "r36", "r37", "r135", "r136", "r138", "r139" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants and Rights Note Disclosure [Abstract]" } } }, "localname": "WarrantsAndRightsNoteDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_WarrantsAndRightsOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.", "label": "Warrants and Rights Outstanding", "terseLabel": "Warrants and Rights Outstanding" } } }, "localname": "WarrantsAndRightsOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsScheduleOfFairValueHierarchyTheCompanySLiabilitiesThatWereAccountedForAtFairValueOnARecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "auth_ref": [ "r236" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.", "label": "Warrants and Rights Outstanding, Measurement Input", "terseLabel": "Warrants and Rights Outstanding, Measurement Input", "verboseLabel": "Warrants and Rights Outstanding, Measurement Input" } } }, "localname": "WarrantsAndRightsOutstandingMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesDetail", "http://www.screamingeagleacquisitioncorp.com/role/RecurringFairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsInputsAsTheirMeasurementDatesParentheticalDetail" ], "xbrltype": "decimalItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r123", "r129" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted weighted average shares outstanding" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation": { "auth_ref": [ "r32" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock subject to repurchase or cancellation determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period. Common stock subject to repurchase are outstanding common shares that are contingently returnable (that is, subject to recall).", "label": "Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation", "terseLabel": "Weighted average number of ordinary shares" } } }, "localname": "WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/CondensedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r122", "r129" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic weighted average shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.screamingeagleacquisitioncorp.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "sharesItemType" } }, "unitCount": 8 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=95464943&loc=SL35686261-199414", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2646-109256", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r338": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r339": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r341": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r342": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r343": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(b))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r377": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r378": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r379": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r381": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r382": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r383": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r39": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.C)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r48": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "c(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(1),(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04.16)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 60 0001193125-23-140808-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-140808-xbrl.zip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